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Abstract
Cytochrome P-450 (P450) metabolises N,N-dialkylamides to their 
corresponding N-dealkylated products via formation of an N-hydroxyalkyl-N- 
alkylamide intermediate. The first-step of these oxidative dealkylations, has been 
studied both by the use of probe substrates able to trap intramolecularly the reactive 
intermediate, and also by the use of the intermolecular spin trapping agent PBN, 
together with ESR analysis. The results obtained indicate that oxidative dealkylation of 
amides occurs via hydrogen atom abstraction from the alkyl carbon atom a- to the 
amide nitrogen leading to the formation of a carbon-centred radical intermediate. Such 
an intermediate can subsequently undergo hydroxyl group insertion, from the activated 
haem-oxygen complex of P450, to give the N-hydroxyalkyl intermediate. No evidence 
for an iminium ion intermediate was obtained. Dealkylation of chiral substrates reveals 
little stereoselectivity in the dealkylation reactions. In contrast, by using fixed- 
conformation probe substrates, a regioselectivity for the oxidation of the Z- group was 
observed. Comparison of these results with those of a biomimetic system and with 
semi-empirical M.O. calculations suggests that these reactions are kinetically rather 
than thermodynamically driven. Finally, the effects of the generation of a carbon- 
centred radical intermediate during amide metabolism on the P450 enzyme system were 
analysed. Oxidation of N,N-dimethylformamide and N,N-dimethylacetamide results in 
the inactivation of the metabolising enzyme. PBN, but not ascorbic acid or glutathione, 
protects against this inactivation. Such inactivation is due to the carbon-centred radical 
species attacking the prosthetic haem group of the enzyme, resulting in the formation of 
a modified haem that retains its tetrapyrrolic structure. The modified haem can be 
synthesised from haemin by reaction with a chemically-generated a-carbon-centred 
radical. The full characterisation of the structure of the modified haem requires further 
work, but preliminary studies reveal it to be the result of attack at the vinyl or meso 
positions of the haem rather than at the pyrrolic nitrogen atoms.
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Flavin adenine dinucleotide, oxidised form
FADH2 Flavin adenine dinucleotide, reduced form
Flavin adenine nucleotide, oxidised form
FMNH2 Flavin adenine nucleotide, reduced form
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GSH
Gas chromatography
GCMS Gas chromatography mass spectroscopy
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HPLC High performance liquid chromatography
TV
IR Infra-red spectroscopy
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M.O. Molecular orbital
m.p. Melting point
MS Mass spectroscopy
MTBSTFA N-methyl-N-terf-butyldimethylsilyltrifluoroacetamide 
NADP Nicotine adenine dinucleotide phosphate, oxidised form
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PBN . N- /g/T-butyl- ct-phenylnitrone
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SOD Superoxide dismutase
TPPFe(^) tetraphenylporphirinatoiron (III) chloride
UV Ultra-violet spectroscopy
Vmax Maximum reaction velocity
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CHAPTER 1 
Introduction
In this introduction the following will be discussed:
• the constitution of the cytochrome P450-containing monooxygenase system
(P450)
• characteristics of substrate binding
• biomimetic system of P450
• mechanistic features of some reactions catalysed by P450
• amides as substrates for P450
The utilisation of oxygen is a function that most living organisms, both unicellular 
prokaryotic or large multicellular eukaryotics, must be able to perform. Such organisms 
must be capable of oxygen insertion into a wide variety of molecules in order both to 
anabolize the compounds necessary for structure building and energy utilisation and 
catabolize noxious compounds for ready disposal. Well over 200 enzymes are known to 
utilise dioxygen as substrate. 1» 2 Many such reactions are carried out by enzymes 
containing a haem prosthetic group at their active site.
Oxygen utilising enzymes have been divided into two categories based on whether 
oxygen atoms from dioxygen are directly incorporated into the substrate (the oxygenases) 
or whether the substrate is oxidised without oxygen incorporation (the oxidases). The 
oxygenases have been further subdivided into the dioxygenases, which incorporate both 
dioxygen atoms into the organic substrate, and the mono-oxygenases, which only 
incorporate one oxygen atom with the other being concomitantly reduced to water.
The group of mono-oxygenase enzymes known as the cytochromes P-450 
monooxygenase system has been the subject of intense investigation over the last 30
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years, due primarily to the important role play in a wide variety of living process, as well
as to particular features of their structures and of the chemistry they carry out.
1.1 Constitution of the  cy tochrom e ( P 4 5 0 ) - c O n t a i n i n g  m ono-oxygenase 
system
P450s are a class of lipophilic enzymes located in the endoplasmic reticulum of 
cells. Most methods used to elucidate the constitution of the P450-containing oxygenase 
system have followed three main steps; purification of mammalian liver subcellular 
preparation (microsomes), solubilization of the enzyme system and experiments involving 
reconstitution of the oxygenase activity. It is generally agreed that two membrane-bound 
protein components, the haem P450 and an NADPH-dependent flavin containing P450 
reductase are needed for reconstituting the NADPH-linked oxidation activity.
1.1.1 Cytochrome P450
In mammals, cytochrome P450 enzymes are found mainly in the endoplasmic 
reticulum of the liver and in the mitochondria of the adrenal cortex. However, they are 
also present in many other organs and tissues including the lung, kidney, testes, ovary, 
brain, placenta, pancreas, spleen, intestine, skin and nasal epithelium. Other than the 
liver, kidney and adrenal cortex, the role of P450 in many of these organs is poorly 
understood. As a group P450 operates on an apparently unlimited number of compounds, 
being responsible, more than any other enzyme system, for initiating biotransformation.
P450s are members of a large family of haem-containing enzymes that are the 
terminal monooxygenases for the metabolism of a large number and variety of 
endogenous substrates and xenobiotics.^* ^ P450 is recognised as a superfamily of 
monooxygenases displaying wide substrate acceptability. Recent updates on new 
sequences list 146 members of the P450 superfamily.^ This is consistent with the 
diversity observed in biological compartmentalisation: in most bacteria, the forms are 
soluble; in eukaryotic organisms, most are membrane bound. The term “cytochrome
    CHAPTER i
P450” refers to a family of isomeric enzymes (or isozymes) constituted by a polypeptide
chain with an approximate molecular weight of 50 kDa that contains an iron^ l^
protophorphyrin IX prosthetic group (Figure 1.1). A cysteine residue of the polypeptide
presents a thiolate ion that can ligate to the haem iron in one of the axial positions, while
the other axial position is usually occupied by a molecule of water.
COOH COOH
Figure 1.1 Haem group (protoporphyrin IX).
The common characteristic of these isozymes is the absorption in the UV 
spectrum at 450 nm of the reduced P450-carbon monoxide (CO) complex. Indeed, the 
prefix “P” refers to their pigment-like nature. In fact, many P450 isozymes form CO 
complexes that absorb at wavelengths slightly shifted from 450 nm, with an overall range 
lying between .447 and 452 nm. The absorption maximum at around 450 nm (known as 
the Soret peak) in these cytochromes is due to an n-» k * electronic transition in the 
haemoprotein caused by the ligation of the sulfur-containing residue to the haem 
prosthetic groiip.^
The unusual diversity of distribution of P450s is matched by their ability to 
catalyse a considerable array of reactions (shown in Figure 1.2) including C-, N- and S- 
oxygenation, dealkylations, deaminations and dehalogenations. It is believed that the
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electron-donating character of the sulfur ligand triggers the unique chemical reactivity of
this enzyme system, especially the reductive cleavage of molecular oxygen and the 
insertion into non-activated C-H bonds.^ This ability to oxidise a wide range of substrates 
has given rise to the term “mixed-function oxidases” to describe the P450 activity.
A simplified mechanism for the monoxygenase activity of P450 is as follows:
RH + NADPH 4-H + 4-O 2 --------► ROH + NADP^+HjO
In addition to their ability of metabolise foreign compounds, their endogenous 
role lies in the metabolism of lipids, eicosanoids and the steroid hormones. ®
P450 is known as an enzyme that plays a central role in either detoxification or 
activation of xenobiotics. Over the last twenty years it has become apparent that there are 
many distinct forms of P450 in liver microsomes, each of which possess overlapping but 
distinguishable specificity to foreign substrates.^» 10
The detoxification pathway is characterised by the conversion of lipid soluble 
foreign compounds to. products that are more water soluble. This is achieved by the 
insertion of a polar functionality. These metabolites are then subjected to second phase 
conjugation reactions that generate even more polar products which are subsequently 
excreted via the urine and faeces. The P450-dependent metabolism of xenobiotics usually 
leads to the formation of biologically inactive metabolites. However, in certain cases such 
metabolism may lead to the activation of previously harmless chemicals to reactive species 
that may possess toxic effects
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Aromatic hydroxylation
acetanilide
HO
/7-hydroxyacetanilide
Olefin epoxidation
V
Aromatic epoxidation
H
Heteroatom release 
\
— ^  C= 0  + HX
H
X = N , S , 0
'A\
/
Heteroatom oxidation
'R
\ -  -
X ■ ■ O X= N, S
Fignre 1.2 Some representative examples of P450-dependent metabolism of-drugs 
and industrial chemicals
Though there exists, even for a single substrate, a range of P450-catalysed 
metabolic fates it is generally accepted that the mechanism of bioactivation to toxic 
metabolites involves the formation of an electrophilic species. Such species can react with 
cellular nucleophiles such as proteins or nucleic acids leading to an abnormal 
physiological state.
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The basal-level P450 Gonteots of cello may be drastically affected by n wide range
of factors; including diet; living habit» physiological state and exposure to chemicals. 
Most, if not all, of the P450 isozymes are inducible by chemicals such as phénobarbital, 
3-methylcholanthrene (3MC), pregnenolone 16-a-carbonitrile (PCN), ethanol, 
polychlorinated biphenyls (PCB), isosafrole and clofibrate. Such induction is of prime 
importance in the potentiation of the P450 dependent bioactivation of toxic chemicals. It 
is also of relevance regarding the presence of P450 isoforms in particular tissues, 
especially P4501 and P450 HE and, to a lesser extent P450 IVAl, all which are known to 
be involved in activation-dependent toxicological responses.
1.1.2 The catalytic cycle 6 f P450
An overall scheme for the P450 catalytic cycle is presented in Figure 1.3. To 
clarify the oxidation state of Pd50» the oxidised and the reduced forms are represented by 
Fe^+ and Fe-+, respectively. The scheme shows seven representative states of P450, but 
does not include every possible state.
In the resting state P450 is in the oxidised form. The P45Q-catalysed reaction is 
considered to be initiated by substrate binding to the enzyme (step 1). Substrate binding 
induces confonnational changes around tlie haem and increases the redox potential of tlie 
haem iron from -300 mV to -170 mV. Substrate-bond P450 therefore becomes more 
e a s ily  re d u c e d .H  Electrons are transferred to P450 in the substrate-bound form^step 2 )  
from the specific electron carrier proteins that coexist with the P450s.
CHAPTER I
SUFirst e“
Second e “
SH
SH
2H
SOH
[Fc-O]
SHSOH
Figure 1 .3 . Schematic diagram of cytochrome P-450 monooxygenase reaction. SH 
represents a substrate and SOH is the product.__________________________________
P450 in the oxidised state (SH-Fe^+) has low affinity for dioxygen but in the 
reduced state (SH-Fe-+) it has high affinity, like other haem proteins. A dioxygen 
molecule binds to the reduced haem iron at the sixth coordination position, trans to the 
thiolate anion (step 3). The substrate haem dioxygen complex may be considered as the 
Fe^+-superoxide complex SH-Fe^+-02\ formally the product of intramolecular electron 
transfer from the Fe-+ centre to the dioxygen ligand. Oxygenated P450 is easily 
autooxidised into SH-Fe^^ with O? re lease.H ow ever, if a second electron transfer to 
P450 is faster than autooxidation (step 4 ) ,  the result is the formation of SH-Fe-+-02". 
Subsequently, step 5, it is widely accepted that Fe-+-02" reacts with two protons, 
liberating HoO while forming an active iron-oxo, Fe^+=0, centre. The activated oxygen
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atom in this functionality may react with a substrate molecule residing in close proximity,
step 6. This forms an oxygenated product that may be released, step 7, to regenerate the 
initial state of P450. ^ -^20 Each reaction cycle usually takes 1-10 seconds in membrane- 
bound P450, but in some case it can take less than 0.05 seconds.^l
1.1.3 NADPH-dependent flavin containing P450 reductase
The NADPH-cytochrome P-450 reductase is a flavoprotein, with a molecular 
weight of about 76 kDa, containing two prosthetic groups: FAD and FMN. The FAD 
group is the acceptor of the initial electron from NADPH, while the FMN group is the 
electron donor to P450 as summarised in Figure 1.4.--
P450 (ox)FAD FMNHNADPH
NADP ► P450 (red)FMN
Figure 1.4 Schematic representation of the transport of electrons to P450.
However, it is also known that cytochrome bs can supply electrons to P450. This 
contribution of cytochrome appears to be different from one form of P450 to another, 
and also is dependent upon the characteristics of the substrates.^
It has been confirmed that the first electron for the reduction of ferric ion in P450 
is always supplied from NADPH-cytochrome P-450 reductase, whereas the second 
electron for the activation of the haem-bound oxygen atoms can come from either the 
reductase or from the reduced cytochrome hs, as shown in Figure 1.5.
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lOÏ ROH
NADPH  ►Flavoprotein -------;► Cyt.P450
i
I
C ytb5
Figure 1.5 Electron transfers to the P450 mono-oxygenase system of mammalian 
liver microsomes* The pathway of first and second electrons are indicated by solid and 
broken arrows, respectively. The mono-oxygenase reaction is shown by the 
transformation of a substrate (RH) into its oxygenated product (ROH)._____________
Thus, the overall characteristics of the liver mammalian cytochrome P450 mona 
oxygenase systems Can be summarised as follows: they are (i) always found in 
association with the membrane of the endoplasmic reticulum (microsomes), (ii) 
constituted by NADPH-cytochromc P-450 reductase and cytochrome P-450, and (iii) 
supported by NADH cytochrome bs reductase and cytochrome
1.2 Substrate-cytochrome P-450 interactions
The interaction of a substrate with P450 produces observable changes in the 
UV/visible spectrum arising from characteristic perturbations of the haem iron. These 
changes are normally determined as differences between the spectrum of oxidised 
microsomes plus xenobiotic agent and that of oxidised microsomes alone.^ '^* Generally 
three major types of difference spectra are observed. Type 1 spectra, produced by 
compounds such as benzphetamine, biphenyl and am in o p y rin e ,2 9  are characterised by a 
peak at 385 nm and a trough around 420 nm. Type II spectra, produced by compounds 
such as aniline, n-octylamine and imidazole,^^ are characterised by a peak at 430 nm and 
a broad trough between 390 and 430 nm. Finally reverse type I spectra, produced by 
compounds containing an alcoholic OH group,^^ are the mirror image of type I spectra.
The importance of hydrophobic interactions between the substrate and the groups 
in the binding site of P450 has been demonstrated* Optical studies on substrate binding to
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P450 in hepatic microsomes have shown that more lipophilic substrates bind more tightly 
to the en zy m e .3 2  Moreover, hydrophobic interactions have been shown to be a 
predominant force in the binding to P450 of the various substituted aryl hydroperoxides 
that have been used as artificial oxygen do n ors.33
1.3 Biomimetic systems o f cytochrome P-450
In recent years, significant effort has been devoted to developing simple synthetic 
models of the active site of P450. A major requirement of ouch oyotomo io the ability to 
perform the broad spectrum of P450-catalysed reactions, namely hydroxylation of 
aromatic rings, including the NIH-shift, the hydroxylation of non-activated C-H bonds, 
the epoxidation of double bonds and the oxidative cleavage of non-activated C-C bonds in 
a regio-and stereospecific manner. Synthetic tetraarylporphyrins (Figure 1.6) are 
recognised as one of the most efficient biomimetic systems. They are readily prepared, 
bind a variety of metals (M= Fe, Co, Cr, Mn, Ru and so on), and have been used 
extensively to model the natural haem prosthetic group protoporphyrin 3536
In these tetraarylporphyrin derivatives, bulky substituents in the orT/w-position of 
the aryl rings reduce the tendency of the natural haem to agglomerate in solution and also 
help protect the mgjo-carbons (that is those carrying the aryl substituents) from oxidation. 
In addition, the inclusion of aryl groups possessing variety of substituents provides 
porphyrins with varying solubilities and substrate specificity. Currently, the m eta lO h ) 
5,10,15,20-tetraphenylporphyrines, and their aryl analogues are extensively used for 
modelling the reactions performed by P450s, peroxidases and catalases. A variety of 
metals can be used; most commonly FeOH) and MnOH) complexes have met with 
considerable success^^
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Porphines Mill Phenyl substituent 
o m p
(TPP)Felll(CI) Fe H H H
(TPP)Crlll(Cl) Cr H H H
(TPP)Mnlll(Cl) Mn H H H
(F20TPP)CoHI(Cl) Co F F F
(Cl8TPP)FeIII(Cl) . Fe a H H
(agTPP)Mn"I(Cl) Mn Cl H H
F ig u re  1.6 Some exam ples of biom im etic metalloporphines (TTP = 
tetraphenylporphine; M = metal).___________ _________________________________
Tlie Success of these biomimetic systems may be judged by their ability to effect 
the hydroxylation of unactivated alkanes (Figure 1.7), the most difficult of P450- 
mediated oxidations.^®* 40
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OHbiomimetic
system
OH
Figure 1.7 Example of hydroxylation of unactivated alkanes.
1.3.1 The porphyrin-iodosobenzene system
Grovcs^i has shown that the oxidation reactions carried out by synthetic 
porphyrins in the presence of iodosobenzene presents similar mechanistic features to 
those of P450. The proposed mechanism for hydrocarbon hydroxylation involves an 
oxoiron (IV) porphyrin radical (Figure 1.8). This is expected to have considerable oxy 
radical character, allowing the abstraction of a hydrogen atom from a carbon-hydrogen 
bond approaching parallel to the porphyrin plane (Figure 1.9).
<
Figure 1.8 Structure of the postulated oxoiron(IV) porphyrin radical.
The shape-selectivity of the hydroxylations, and the sensitivity of these reactions 
to relatively small changes in the steric environment of the porphyrin periphery, were 
considered to be consistent with such an approach. Recombination of the Fe(IV)OH 
complex with the alkyl radical gives rise to the product alcohol, while occasional escape 
of the radical rationalises the formation of brominated products in the presence of
BrCCb.
12
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OH
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Figure 1.9 Mechanism of alkane hydroxylation catalysed by ferric porphyrins.
However, for amine dealkylation an alternative mechanism has been proposed. 
The presence of an intramolecular isotope effect < 3 together with the electronic effects of 
the R group, is interpreted as an indication that the mechanism involves the abstraction of 
an electron from the substrate, followed by deprotonation (Figure
Fe
H
R ^-N -6-R 3  +
R2 H 
H
r 1 _ N _ ( Î ; _ r 3
R^-N -C -R ^ +
R^l l
m
n
ffl
— >►
O m
H
^  riJn - ( ! ; - r3 +
I I 
r 2 H
r 1 _ N _ C - r 3  
I  I 
R2 H
OH
r1_N _C _r3 
I I 
r 2 H
Figure 1.10 Proposed mechanism for the biomimetic oxidation reaction of amines 
using iodosohenzene as source of oxygen.
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1.3.2 The porphyrin-alkylhydroperoxide system
Alkanes are easily hydroxylated in presence of TPPFeGH) and /err-butyl 
hydroperoxide,^ whereas the epoxidation of alkenes is more difficult when compared 
with oxidation by TPPFeG") and io d o s o b e n z e n e  45:46 Alkylhydroperoxides are also 
efficient oxygen sources for the metalloporphyrin-mediated oxidation of alkanes, though 
marked differences are o b s e rv e d  .47
Unfortunately one of the major issues, namely whether the breakdown of the 0 - 0  
bond in the metal-hydroperoxide complex is homolytic or heterolytic, has yet to be 
clarified with certainty. Homolytic breakdown will form an [Fe=0]^ complex, while the 
heterolytic breakdown will result in the formation of an [F e= 0 ]* h  c o m p le x 4 4 ; 48 ; 49  
(Figure 1.11).
F e i ^  + ‘ BuOOH
O
O
n
+ ^ B u O  + H +  a)
m
+  ^BuOH b)
F igure 1.11 Homolytic (a) and heterolytic (b) breakdown of alkylhydroperoxides in 
the presence of porphyrin.__________________________________________
This is an important point, because the [Fe=0]^^ complex is able to abstract a 
hydrogen atom from the substrate forming an [Fe-OH]^ species that hydroxylates the 
carbon-centred radical so-formed.^* 51 Alternatively, the [Fe-OH]^ complex is not able 
to abstract a hydrogen atom, but its formation, via homolytic breakdown of tert- 
butylhydroperoxide, leads to the formation of the fg/T-butoxyl radical species. This 
species is then able to abstract a hydrogen atom from the substrate.52;47
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Conflicting reports exist relating to the formation of the iron-oxo species from the
reaction of porphyrins with alkyl- and acylhydroperoxides (ROOM). On the one hand,
B ruice53;54 has reported that the pKa of the leaving group (RO ) affects the reaction more
for the acyl analogues. This would imply a heterolytic breakdown for acyl
hydroperoxides and homolytic for alkyl hydroperoxides. On the other hand, Traylor 55
observed that in the reaction between peracids and porphyrin the cleavage of the 0 - 0
bound is heterolytic. With this assumption they compared the isotope effect and the
acidity of the solvent on the reactions of porphyrins with peroxides and peracid s.4® ;55
Both types of peroxy compound present similar sensitivities indicating that a similar
heterolytic mechanism operates for both. Moreover, these authors found that the acidity
of the leaving group displays similar effects for hydroperoxides and peracids.48; 55
Traylor 50 has proposed a mechanism that can rationalise the heterolytic cleavage 
of the 0 -0  bond with the difficulties in the oxidation of alkenes and the presence of an 
alkoxyl radical. Thus, heterolytic cleavage of the 0 - 0  bond generate the [F e= 0]^  
complex which subsequently can react with the hydroperoxide:
+ ROOH ---------^  [Fe=0]“* + ROH
[Fe=0]™ + ROOH ______^  [Fe-OH]™ + ROO
The system therefore generates the products anticipated from homolytic 
breakdown of the hydroperoxide.
Whatever the mechanistic characteristics of the cleavage of the 0 - 0  bond, it is 
generally accepted that in the presence of compounds like imidazole, that can bind to the 
centre of the porphyrin, the cleavage is heterolytic. 51; 56; 57; 58 Traylor 48 has also 
reported that the heterolytic mechanism can be promoted by the presence of water and 
alcohols. It is believed that binding of an extra ligand to the metal of the porphyrin 
increases the electron density of the metal .59
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1.4 Mechanism of the P450-mediated mono-oxygenation of xenobiotics
P450 carries out oxidative reactions with typical mixed-function oxidase 
stoichiometry:
R + NAD(P)H + H* + O2 ---------- ^  RO + HjO + N A D (P f
Five types of oxidative reactions will be discussed:
• aliphatic hydroxylation,
• olefins epoxidation,
• aromatic hydroxylation,
• heteroatom release,
• heteroatom oxygenation.
During the catalytic cycle of substrate oxidation by P450 it is believed that the 
transfer of the oxygen atom from the enzyme to the substrate occurs from an activated 
iron-oxygen complex that several authors refer to as a perferryl oxygen, formally 
(Fe=O)5+.50 It has been suggested that this complex acts like an electrode, able to abstract 
a hydrogen atom, or electron, from the s u b s t r a te . 4^ The species so-generated in the 
porphyrin then transfers a hydroxyl group to the radical centre generated in the substrate. 
After oxygen addition, the oxygenated product dissociates to leave the iron in its original 
ferric state. The initial hydrogen atom abstraction or the electron transfer is identified as 
the rate-determining step of the react!on.^l
An exception to this mechanism is represented by the situation in which the 
oxygen atom in the haem is unable to interact with the newly-formed substrate radical 
because of a rearrangement or aromatization of the substrate, as reported for 4,4-dialkyl- 
1,4-dihydropyridines^- (Figure 1.12).
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.COaEt
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Figure 1.12. The rearrangement of intermediate cation radicals during the microsomal 
oxidation of 4,4-dialkyl-1,4-dihydropyridines.__________________________________
1.4.1 Aliphatic hydroxylation
The hydroxylation of unactivated carbon atonis is one of the more remarkable 
reactions performed by P450. It is also one that has received a great deal of attention due 
to the critical role this transformation plays in the metabolism of numerous essential 
physiological as well as xenobiotic compounds. G r o v e s , i n  his studies on the 
hydroxylation of norbomane, observed large isotope effects (kn/ko =11.5) together with 
a loss of stereochemistry (postulated to be a result of radical epimerization). Isotope 
effects for other aliphatic hydroxylation reactions have been reported to lie in a range 
between 7 and 14.®* ^
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These data suggest that alkane hydroxylation proceeds by a stepwise process
involving the formation of a carbon-centred free-radical via hydrogen atom abstraction 
(Figure 1.13). Such a scheme is supported by mechanistic probes, as for example bicyclo 
[2.1.0.] pentane^^' ^  and alkylcyclopropanes,^^ able to give rearrangement after an H* 
abstraction.
OH
OHP450
OHH*
OH
F igure 1.13. Mechanism for the P450-mediated aliphatic hydroxylation.
The slow step in the oxygen^transfer sequence is thought to be abstraction of the 
hydrogen atom from the alkane carbon by the perferryl oxygen. Collapse of the 
intermediate alkyl and iron-hydroxyl radical pair is presumably a cage reaction with a 
low-energy barrier. Radical reactions involve a planar radical centre. Thus, hydroxylation 
of aliphatic systems would be expected to involve loss of stereochemical integrity. 
Therefore, the stereospecificity often observed during P450-catalysed hydroxylations 
probably reflects physical factors associated with substrate binding in the enzyme active 
centre.
18
______________________________________________________________________   CHAPTER 1
1.4.2 Olefin epoxidation
The transfer of oxygen to carbon-carbon n bonds proceeds with retention of 
olefin stereochemistry. Such retention does not unambiguously differentiate concerted 
from non-concerted mechanisms. However, studies on the suicide inactivation of P450 
that occurs during the metabolism of unsaturated compounds, as well as on the 
rearrangements that accompany the metabolism of certain olefins, indicates the presence 
of a non-concerted mechanism in this reaction.® For example, synthetic epoxides were 
shown not to destroy the haem of P450 in cases where the destruction of P450 was 
observed during the oxidative metabolism of the parent olefin.®; 70 Ortiz de Montellano 
has deduced the structures of several haem-olefin adducts.^h 72; 73 which correspond to 
the structures expected from attack of the porphyrin pyrrolic nitrogen upon the epoxide. 
However, since epoxides have been shown not be involved, the adduct can only be 
explained by attack at the pyrrolic nitrogen of a transient enzyme intermediate.
The rearrangements observed during the oxidation of trichloroethylene to 
trichloroacetaldehyde, first thought to result from acid-catalysed rearrangement o f the 
epoxide metabolite, appears to occur during the oxygen transfer reaction because 
synthetic trichloroethylene oxide does not rearrange to trichloroacetaldehyde, except 
under non physiological conditions.74; 75
Despite the consistent evidence for a non-concerted mechanism in the P450- 
dependent oxidation of olefins, the precise nature of the oxidation mechanism is still not 
clear. Guengerich and collaborators have postulated the mechanism summarised in Figure 
1.14.14; 76
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F igure 1.14 Proposed mechanism for P450-mediated oxidation of olefins
The Fe^=0 form of P450 forms an initial jr-complex with the double bond. This 
can undergo either electron transfer to generate a transient olefin radical cation, or radical 
attack to generate a (^radical complex. The radical cation itself can subsequently collapse 
to generate the a-cation complex or, alternatively lose a proton to form an allylic radical, 
which is then trapped by the haem hydroxyl species.
The o-radical complex can collapse to form an epoxide or undergo an electron 
transfer to form the a-cation complex. The a-cation complex may collapse to generate the 
epoxide or the corresponding aldehyde or ketone.
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1.4.3 Aromatic hydroxylation
The introduction of an OH group into an aromatic ring by P450 reflects, with few 
exceptions, initial epoxidation of the aromatic ring followed by (i) chemical opening of 
the epoxide ring, (ii) migration of a hydride to the vicinal carbon, the ”N1H shift” ^7 and 
(iii) keto-enol tautomerism (Figure 1.15). Only a fraction of the hydrogen that shifts, H ,^ 
is retained in the product because upon migration it becomes equivalent to and only 
one of the hydrogens is lost in the tautomerization step. Deuterium substitution alters the 
proportion of the shifted hydrogen in the product due to isotope effects on the cleavage of 
the C-H/C-D bonds, but it does not effect the hydroxylation rate since the tautomerization 
occurs after the rate-determining epoxidation step.^
Two mechanisms are possible, a non-concerted mechanism in which the epoxide 
is formed from an intermediate (Figure 1.15 A), and a concerted mechanism by which the 
oxygen atom is inserted directly (Figure 1.15 B). Moreover, the intermediate of the non- 
concerted pathway can produce a ketone directly without formation of the epoxide.
However, for hydroxylation para to a halogen substituent quantitative loss of 
hydrogen at the hydroxylated carbon coupled with small deuterium kinetic isotope effects 
has been interpreted as possible insertion of oxygen directly into the C-H bond (Figure 
1.15 C).78;79
The non-concerted mechanism for the epoxidation of olefins suggests, by 
analogy, that aromatic rings are also oxidised by a non-concerted mechanism. However, 
experimental evidence for the non-concerted mechanism in these reactions is relatively 
weak.
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NIH shift
keto-enol
taatomerism HO
Figure 1.15 Alternative mechanisms for the hydroxylation of aromatic rings.
A reaction pathway that reconciles the observations consistent with both of a non- 
concerted mechanism and a concerted mechanism, has been proposed (Figure 1.16).^^* 
^  In this, the first step is rate-determining and involves one-electron oxidation of the 
aromatic ring to give an aromatic radical cation and the one-electron reduced oxygenated 
haem intermediate [Fe=0]^ (which has o-radical cation character). Deprotonation of the 
aromatic cation radical and subsequent hydroxylation generates the hydroxylated products 
without formation of epoxide intermediates. Alternatively, a a-cation complex can 
originate epoxides that subsequently undergo rearrangement or alkylation of the 
porphyrin.
The presence of a cation radical intermediate is compatible with the observed 
correlation between the kinetic parameters (Vrmyf^m) of the hydroxylation reactions and 
the Hammett parameter of the substituent,^ indicating the presence of a transition
7 7
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State in which a positive charge is developed. Moreover, correlation between the rate of 
oxidation of substituted halobenzenes and toluenes and the oxidation potential o f the 
arenes has been noted.^^
F igure  1.16. Proposed mechanism for the hydroxylation of aromatic rings.
1.4.4 Heteroatom release
In heteroatom release, oxygen is transferred to the carbon adjacent (a ) to the 
heteroatom. Hydroxylation of heteroatom-containing substrates normally demonstrates a 
marked regioselectivity for the «-position as compared with /5-, y- or more distant 
positions.®^ Such reactions are observed for compounds containing nitrogen, sulfur, 
oxygen and halogens. The present discussion focuses on amines because of their 
structural similarities to amides, the subject of this thesis.
For amines, the explanation of the regioselectivity in these reactions invokes a 
pathway in which P450 initially abstracts an electron from the nitrogen atom.®- The 
aminium cation radical so-formed can then undergo one of the two possible reactions.
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loss of a hydrogen atom or loss of a proton. Both pathways lead to heteroatom loss.
Comparison of the electrochemical and enzymic oxidation of amines reveals similar 
patterns of regioselectivity and kinetic deuterium isotope effects.®^ Because 
electrochemical oxidation of amines involve one-electron transfer from nitrogen,®^* ®5 
enzymic N-dealkylation presumably follows a similar pathway.®^* ®7
N-cyclopropyl probes have been used to investigate further the mechanism of 
these reactions. Cyclopropyl radicals are known to rearrange rapidly {k > 108 g-1) upon 
formation.®®' ®^  If formed in an active site of an enzyme, such species are highly reactive 
and destructive. Indeed, these compounds have been used as diagnostic suicide 
inactivators of P450.^ '^ l The mechanism-based inactivation o f P450 by 
cyclopropylamine is reported to be due to a single electron transfer followed by ring 
opening (Figure 1 .17).^ '^
e
F ig u re  1.17 Proposed mechanism for the suicide inactivation of P45Ô by 
cyclopropylamines.
This mechanism accords with the results of Guengerich and MacDonald 14 who 
observed a correlation between the log of the rate constant for the inactivation of P450 
and the single-electron transfer-cyclopropane ring opening sequence.
Thus, the evidence reported so-far indicates that one-electron oxidation is the first 
step in the P450 catalysed oxidation of heteroatom-containing compounds. In most cases, 
such an electron transfer results in overall a-hydroxylation and subsequent heteroatom 
release (Figure 1.18).
24
HR ---- C-----X------
H
► R-----C *X -
1 c*f\
-H" \  -
1
H i
V  'H
/
\
y C -----O + HX
H
/ " O H -" 
Heteroatom release
Figure 1.18 Mechanism of the oxidation of heteroatom-containing compounds.
1.4.5 Heteroatom oxygenation
Many heteroatom oxygenation reactions, that in the literature are reported to be 
catalysed by P450, can be attributed to another mixed-function oxidase, the flavin- 
containing monoxygenase.62 Several examples of sulfur oxidation and of the oxygenation 
of trivalent phosphorus are known.^» ^  While many N- oxygenations are also 
attributed to P450, there are very few cases in which strong evidence exists for the 
involvement of this enzyme in these reactions.^’1^ 1
Heteroatom oxygenation reactions are conceptually related to the heteroatom 
release reaction. In heteroatom oxygenation, an oxygen atom becomes bonded to the 
heteroatom, whereas in heteroatom release, the oxygen atom is transferred to the'carbon 
atom adjacent (a) to the heteroatom . The relationship between these two 
biotransformations is further underscored by the observation that for an isoelectronically 
substituted series of compounds, e.g. amines and phosphines, the predominant metabolic 
process tends to favour heteroatom oxygenation over heteroatom release as the elements 
progress down a group in the periodic table. Thus alkyl amines produce predominantly 
intermediate a-hydroxyamines, whereas the isoelectronic alkylphosphines generate 
phosphine oxides. Alkyl ethers produce putative a-hydroxyethers, whereas the 
isoelectronic alkyl sulfides generate sulfoxides. ^ 4
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Guengerich and M a c D o n a ld ^ 4  have suggested that the first step in heteroatom
oxygenation is one-electron oxidation of the heteroatom, as for heteroatom release. If <x- 
hydrogens are available, they will tend to be abstracted before oxygen rebound van occur 
to give heteroatom oxygenation, and heteroatom release will result. Heteroatom 
oxygenation is favoured under two conditions, where (1) no a-hydrogens are available, 
as in the cases of aromatic a m id e s  102 and certain primary amines^, or (2) the radical 
system has properties that render it relatively stable, as in the case of su lfides^ or 
phosphines.^
Studies in which the ionisation potentials of the heteroatom towards for one-
electron oxidation were correlated with the rate o f enzymic oxidation indicated that an
order R3P>R3N>R2S>RI~R20>RBr>RCl>RF holds for close structural analogues.® ® ; 
102; 103
In summary, heteroatom oxygenation preferentially occurs for those heteroatoms 
that have relatively low  first-electron  ionisation potentials and that form  
thermodynamically stable heteroatom oxides. The primary reason for this metabolic
preference is the stability of the heteroatom radical cation (e.g. RCH2XR ) relative to the 
carbon centred radical (e.g., RCHXR). Heteroatom release occurs preferentially for 
those atoms in which the a-carbon radical is more stable than the corresponding 
heteroatom radical cation.
1.5 Amides
1.5.1 Biological relevance o f the amides
Many toxic and carcinogenic compounds do not themselves produce a toxic 
response. Rather they need to be activated, usually to an electrophilic form capable of 
reacting with biological nucleophiles. Similarly, many existing drugs require activation to 
exercise their therapeutic action. Liver P450s play a strategic role in these 
biotransformations of foreign organic compounds.
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Many of the xenobiotic compounds that are exposed to P450 metabolism are
based on the dialkylamino functionality, R^R^N-, whether as tertiary amines (e.g..
nicotine, I -( 1 -phenylcycIohexyI)piperi dines, the tricycle anti depressants), dialkylamides
(e.g. benzodiazepine anxiolytics, industrial solvents, insects repellents, barbiturates) or
related groups such as dialkylnitrosoamines (environmental carcinogens) and
dialkyltriazenes (anticancer agents). The amide group is present in a wide variety of
compounds that are extensively used as drugs , cosmetics and pesticides. Various amines
and amides are known, or suspected, mutagenic c o m p o u n d s . 104 N,N-Dialkylamides
possess a range of biological activities. For example, NJ^-diethylnicotinamide is a
respiratory stimulant, 105 N,N-diethyl-3-toluamide is the most used insect repellent
worldwide,103 cotinine is the major tobacco metabolite, 107 N,N-dimethylformamide is an
industrial solvent suspected to be ca rc in o g e n ic  108 while miscellaneous N-alkyl and N,N-
dialkylamides show activity against same forms of c a n c e r . 109; HO All these compounds
are known to undergo oxidative N-dealkylation or oxidation upon liver metabolism in
vivo. Thus, a study of the details of the mechanism of these P450-dependent reactions
ought to provide useful information that should further the understanding of both their
hazard and utility.
1.5.2 Chemical properties o f amides of relevance to their metabolism
In contrast to amines, P450-dependent metabolism of amides has received little 
mechanistic attention. Since both compounds undergo P450-dependent metabolism to 
generate N-dealkylation products through the formation either a carbinolamine or 
carbinolamide, it is tempting to suggest that they follow the same pathway. However, 
there are some important differences between the two that must be taken into account.
Aliphatic amines are relatively strong bases due to the fact that the non-bonded 
electron pair in the sp5 orbital is readily available for the formation of a new covalent 
bond. In amides, however, the presence of the carbonyl moiety causes resonance 
delocalization of the electron pair, resulting in these electrons being less available. Indeed,
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the protonation of amides takes place at the oxygen atom rather than at the nitrogen. ^  * 1
Moreover, the presence of the electron-withdrawing carbonyl group results in amides
having much higher ionisation potentials than the corresponding amines.
Another interesting difference between amides and amines is seen in UV/visible 
spectra generated upon interaction of the substrate with P450. Under reducing conditions, 
amines typically give type II spectra.28 This is believed to be due to the nucleophilicity of 
the electron pair, allowing these compounds to bind to the haem. Amides are known to 
give type I spectra.28 It is thought that the interaction of amides with the haem group 
takes place through the carbonyl oxygen rather than the nitrogen atom. Numerous 
examples are reported on the formation of complexes of amides in which the carbonyl 
group is bound to a variety of metals. 111 ; 112; 113
A complex formed between N,N-dimethylformamide and the FeW =0 species 
generated during oxidation of 5,10,15,20-tetrabis(2,6-dichlorophenylporphyrinato) Fe^ ^^  
in the presence of dim ethylform am ide and m-chloroperoxybenzoic acid has been
characterised. 114
1.5.3 Comparison o f the P450-dependent metabolism of amines and 
amides
The oxidative N-dealkylation of amines by P450 has been extensively investigated 
and considerable indirect evidence can be found in support of a mechanism involving 
initial and rate-limiting electron abstraction from amine nitrogen. This evidence can be 
summarised as follows:
• oxidations of 1,4-dihydropyridines results in loss of alkyl radicals from the 4-
position , ^ 2
• cyclopropylamines are suicide substrates for P450,^- 93
• kinetic deuterium isotope effects observed for N-dealkylation of N,N- 
dimethylanilines,^ dihydropyridine dehydrogenation 115 and several other amines
117 are small; this is in contrast to the large kinetic isotope deuterium effects often 
observed for 0-dealkylation 118; 119 and carbon hydroxylation. 121 ; 122
 —       CHAPTER 1
These results have been inteipreted64; 92; 93; 122 as implying that the mechanism
of the P450-mediated N-dealkylation reaction proceeds via an initial one-electron 
abstraction (Figure 1.19; path b).
In contrast, P450-dependent N-dealkylation of amides shows a large kinetic 
isotope deuterium e f f e c t s . l2 3  Moreover, the P450-mediated metabolism of N- 
cyclopropylamides does not lead to suicide inactivation of the enzyme, despite the fact 
that N-dealkylation o c c u rs .l2 4 ; 125 These, together with the higher ionisation potential of 
amides, suggest that the N-dealkylation of amides occurs via hydrogen atom abstraction 
with the formation of a carbon-centrcd radical intermediate (Figure \. \9\ pafha).
c re = u
R i _ N  cHg ^ -------------------------CH.
EFe-OH
R2
EFe-0"
EFe-OH EFe-OH^ EFe-OH
r
^  EFe-OH
— n = c h 3
R  ^— —N ------- CH2OH
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EFe-OH
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R^ — NH
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Figure^ 1.19 Pathways for N-dealIllation of amides and amides. Patha involves the 
rate-limiting hydrogen atom abstraction and should show large kinetic deuterium isotope 
effects, while b involves rate-limiting electron abstraction and should show small 
kinetic deuterium isotope effects. For amines R% and Ro can be alkyl or aryl. For 
amides Ri is RCO or ArCO and Ro can be alkyl or aryl._______________________
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The postulated formation of a carbon-centred radical species in amide metabolism
was investigated by Iley and C o n s ta n t in o .  ^ 25 yjje strategy adopted involved the use of 
two substrate probes (shown in Figure 1.20) that were designed to intercept two of the 
possible intermediates, i.e. the cation radical (1 of Figure 1.10) and the carbon centred 
radical (3 of Figure 1.20).
<a
Figure 1.20 Substrates used for the trapping of reactive intermediates formed durin*- 
the microsomal metabolism of amides. A) the cyclopropylamide designed to trap the 
radical cation B) the N-methylcyclopropylamide designed to trap the carbon-centred 
radical.
The hypothesis is that a cyclopropyl ring adjacent to a radical centre, either the 
amide cation radical or a carbon-centred radical, can potentially intercept the 
intermediates, diverting them to rearranged products, as indicated in Figure 2.21. 
However, neither compound resulted in any ring opening product, even though N- 
dealkylation was o b se rv e d . 125
r
(B) o  O
R2 'r2  ^ R '"  V  V
__________________________________  RZ_______________
F igure 1.21 Potential mechanism of the microsomal metabolism of (A) cyclopropyl 
amide and (B) methylcyclopropylamide.________________
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Thus although kinetic data strongly suggest a mechanism for amide metabolism
involving hydrogen atom abstraction as the rate-determining step, direct experimental 
evidence for the presence of a carbon-centred radical intermediate has yet to be produced.
1.6 Scope of the thesis
This thesis reports an investigation that attempts to elucidate further the 
mechanism of the oxidative metabolism of NJ^-dialkylamides by P450. The first section 
is concerned with methods directed at trapping reaction intermediates using two different 
approaches, namely direct trapping by functional groups present in the substrate (Chapter 
II) and the use of a spin trapping ESR technique to detect the postulated carbon-centred 
radical (Chapter III). In the second part of the thesis, the investigation is concerned with 
two structural aspects of the N-dealkylation reactions, regioselectivity (Chapter IV) and 
stereoselectivity (Chapter V). The strategy employs a comparison of the kinetic 
parameters of the m icrosom al P450-catalysed reactions with both the 
TPPFe(lH)//ertBu.CX)H biomimetic system and theoretical molecular orbital calculations. 
In the third and final part, the effects of the reactive intermediates on the enzyme itself 
were investigated. In this section, attention is focused on the industrial solvents N,N- 
dimethylformamide and N,N-dimethylacetamide in an attempt to obtain more information 
relating to their metabolism-based toxicity.
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CH APTER 2
Trapping of the reactive intermediates of the F450-dependent metabolism
of N ,N -dialkylam ides
The present chapter describes the following studies related to the mechanism of 
the microsomal oxidation of tertiary amides:
• attempts to intramolecularly trap iminium species
• attempts to intermolecularly trap iminium species
• intramolecular trapping of carbon-centred radical intermediates using C- and N- 
alkenyl substrates.
2.1 In troduction
As discussed in Chapter 1, the metabolism of tertiary amides is believed to occur 
via rate-determining hydrogen atom abstraction from the a-carbon, with the formation of 
a carbon-centred radical intermediate. This intermediate can undergo insertion of an 
activated hydroxyl group frorh the P450-haem oxoiron complex, leading to the formation 
of a relatively stable carbinolamide product.
Despite the kinetic data supporting this hypothesis, 1"^  the formation of such an 
intermediate remains speculative. One previous attempt to trap the carbon-centred-radical 
intermediates proved unsuccessful.^ The system employed involved a probe substrate 
characterised by the presence o f an N-cyclopropylinethyl group, the postulated carbon- 
centred radical, if formed, should be trapped following the mechanism in Figure 2.1.
-  — . ' -  - V
Figure 2 .1  Postulated ring opening reaction due to the formation of a carbon-centred 
radical during the microsomal metabolism of N-cyclopropylmethyl amide.____________
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However, although the substrate underwent metabolism o f  the
cyclopropylmethyl group, it did so without any detectable ring opening.3 The authors 
suggested that the formation of the carbon-centred radical cannot be ruled out, as it may 
be that such a radical is trapped by the haem-hydroxyl moiety of the enzyme faster than it 
can rearrange. This situation has certainly been observed for saturated hydrocarbons 
substrates.^ Thus it may be that the failure to detect the carbon-centred radical 
intermediate results from either (i) such a species not being formed, or (ii) the probe 
substrate used not being ideal for the intramolecular trapping. Clearly, further 
investigation into the nature of the reactive intermediates formed during the microsomal 
oxidation of tertiary amides is needed in order to obtain a better understanding of the 
mechanistic aspects of these reactions.
From mechanistic point of view, tertiary amides may undergo P-450-mediated 
metabolism through the mechanism illustrated in Figure 2.2.
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Figure 2 .2  Potential pathways for the oxidative N-dealkylation of NJ^-dialkylamides.
CHAPTER 2
Amide (1), can undergo two alternative first step reactions, namely electron 
abstraction, leading to the formation of the cation radical intermediate ( 2 ) (path, a), and 
hydrogen atom abstraction (path b), leading to the formation of the carbon-centred radical 
intermediate (3). Intermediate (3), may then undergo loss of a hydrogen atom to form 
the iminium ion intermediate (4 ) or, alternatively, the loss of a proton to generate the 
carbon-centred radical (3). Both (3 ) and (4) can subsequently form the carbinolamide 
product (5), by hydroxyl group insertion from the P450 haem-hydroxyl complex. 
Alternatively, the carbon centred radical (3 ) can undergo electron abstraction to generate 
the iminium ion (4), or insertion of hydroxyl group to lead to the formation of the 
carbinolamide product (5). Moreover it is worth noting that the carbinolamine product 
from tertiary amine metabolism is reported to exist in equilibrium with the iminium ion 
species.^® Indeed, formation of iminium ion species from the rearrangement of 
carbinolamines in solution is reported.^ This latter mechanism is believed to be 
responsible for the toxic effects observed upon metabolism of tertiary amines.^ Formation 
of an iminium ion from carbinolamides under the same conditions is not reported. This 
different result ean be rationalised by considering the electron availability at the nitrogen 
atoms in the carbinol compounds obtained from these two class of substrates. The 
electron delocalising effect of the carbonyl group in the carbinolamide probably results in 
the OH group being much less likely to be expelled.
In this part of the thesis, the attempts to identify two of the possible 
intermediates of the P450-mediated oxidation of N,N-diaIkylamides, namely the carbon- 
centred radical intermediate (3) and the iminium ion (4) will be presented and discussed. 
The main goal is, actually, the identification of the carbon-centred radical (3), largely 
because of the strong indirect indications, reported in the literature,I-^ that it is the more 
probable intermediate in these metabolic oxidations. However, due to the potential 
formation of an iminium ion species even from carbon-centred radical, attempts to 
identify this intermediate were also carried out.
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Intermolecular trapping of carbon-centred radical intermediates will be described 
in detail in the next chapter. However, the basic approach involves the use of a spin 
trapping agent capable of stabilising short-lived carbon-centred radicals and rendering 
them detectable by electron spin resonance (ESR).
Intramolecular trapping of the potential carbon-centred radical intermediates 
involves the use of various unsaturated groups inserted in the substrate molecules, as 
illustrated in Figure 2.3. These unsaturated groups should be able to trap the unpaired 
electron of the radical to generate a rearranged product, in this case a cyclic compound.
CH
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JN .CH3
\
CH3
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CHg a
.CH3
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N-methyl-N-pyrydil 
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N-alkenyl and N-alkynyl substrates
N-methyl-N-(3-butenyl)
benzamlde N-benzyl-N-(3-butenyl)
benzamlde
N-methyl-N-(3-butynyl)
benzamlde
F igure  2 .3  Substrate probes for the intramolecular trapping of carbon-centred radical 
intermediates.
--------------------------------------------------------------------------------------       CHAPTKR 2
The probe substrates can be divided into two classes: the C-alkenyl compounds,
in which the alkenyl group is attached to the carbonyl carbon atom, and the N-alkenyl
compounds, in which the alkenyl group is attached to the amide nitrogen atom. The
proposed pathway for the trapping of any carbon-centred radical intermediates produced
by these substrates is shown in Figure 2.4.
a) O
r r" CL YCH2 CHa c i ^  .CH '-----(
^ r3 ^  \
P?
b)
o
" "  YvCHg
OH
Figure 2 .4  Proposed mechanism for the trapping of carbon-centred radical intermediate.
Intramolecular trapping should present kinetic advantages over the intermolecular 
counterpart. Intermolecularly trapping will have kinetic constants comparable with those 
of the insertion of the hydroxyl group from the P450-haem-hydroxyl complex. In 
contrast, the internal trapping of the radical intermediate has time constants reported to be 
generally much smaller than insertion of a hydroxyl group,5; 10 making cyclisation the 
favoured reaction.
Attempts to trap the iminium ion intermediate centred on two strategies, 
intermolecularly using the nucleophiles CN and BD4 , and intramolecularly using a 
substrate containing a nucleophilic group able to capture the electrophilic intermediate.
CHAPTKR 2
The substrate used for the intramolecular trapping on irninium ion is illustrated in Figure 
2.5.
0
1 1 \
OH
N^-dimethyl-2-hydroxy benzamide
F igure 2 .5  Substrate probe used for the intramolecular trapping of iminium ion 
intermediates
The use o f ‘CN as an intermolecular trap for iminium ion species is reported to 
have been successful in the microsomal P450 metabolism of tertiary amines such as 
nicotine. 6 ; 10; li  Reaction with X N  therefore should lead to the formation of an N- 
cyanomethylamide derivative, easily identifiable by normal analytical procedures (Figure 
2.6). The use of sodium borodeuteride as a trap follows the same principle. Reaction 
between the iminium ion intermediate, if formed, and the borodeuteride ion should lead to 
the formation of deuterated substrate (Figure 2.4) which should be identifiable by mass 
spectroscopic analysis.
«P4 O
Figure 2 . 6  Scheme for the intermolecular trapping of iminium ion species by “CN and 
BD4 .
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Intramolecular trapping of the iminium ion intermediate relies upon the presence 
of the hydroxyl group in the ortho position. If formed, the iminium ion should lead to 
cyclisation (Figure 2.7) alongside concomitant déméthylation.
air-a'k-o
01
V
Figure 2 .7  Cyclic trapping of an iminium ion intermediate.
2 .2 . Iminium ion trap p in g
2 .2 .1  Trapping of im inium  ion by “CN
As a preliminary to the study of the intermolecular trapping during metabolism of 
N,N-dimethylbenzamide, oxidation of N,N-dimethylaniline was performed in the 
presence of either NaCN or NaBD^. This substrate was chosen because it has been 
reported that metabolism occurs via iminium ion f o r m a t i o n . ^ ^ D u e  to the structural 
similarity to N,N-dimethylbenzamide, this amine is an ideal positive control for these 
experiments.
• Identification of the products
Since CN" is a well known P450 inhibitor, optimum conditions for the 
metabolism incubations in the presence of NaCN were established by varying both the 
concentration of N,N-dimethylaniline between 0.5 and 10  mM and also of sodium 
cyanide between 1 and 10 mM. The best experimental conditions were found to be a 
substrate concentration of 10 mM and a sodium cyanide concentration of 1 mM. At that 
concentration sodium cyanide does not appreciably inhibit the P450-dependent 
metabolism of N,N-dimethylaniline.
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A typical gas chromatogram/mass spectral (GCMS) analysis of a sample 
obtained after 30 minutes incubation of 10  mM N.N-dimethylaniline in the presence of 1 
mM sodium cyanide is reported in Figure 2.8. The products of the reactions were 
identified by comparison of their mass spectra and chromatographic profile with those 
obtained from pure synthetic standards. The identified products are reported in Table 2.1. 
Clearly sodium cyanide is an efficient trap for the iminium ion species. Moreover, 
formation of the expected N-demethylated metabolite is strong evidence that P450 
oxidation of the substrate is not inhibited by the trap at these concentrations.
Having optimised the experimental conditions for trapping the iminium ion 
formed by N,N-dimethylaniline, attention was directed towards the possible involvement 
o f the iminium ion intermediate in the metabolism of N,N-dimethylbenzamide. 
Microsomal incubations using 10  mM N,N-dimethylbenzamide were performed in the 
presence of 1 mM sodium cyanide. A typical GCMS analysis obtained after 30 minutes 
microsomal incubation is shown in Figure 2.9. The products of the reaction were 
identified, as before, by comparison of their mass spectra and gas chromatographic data 
with those obtained from pure synthetic standards. The identified products of the reaction 
are given in Table 2 .2 . Microsomal metabolism of N,N-dimethylbenzamide in the 
presence of sodium cyanide results in the formation of only one metabolite, N- 
methylbenzamide. No evidence for the formation of N-cyanomethyl-N-methylbenzamide 
was obtained under any experimental conditions. To ascertain whether sodium cyanide 
interferes with the metabolism of the substrate, and therefore with iminium ion formation, 
incubations using increased concentrations of N,N-dimethylbenzamide were performed. 
All incubations failed to show any detectable formation of N-cyanomethyl-N- 
methylbenzamide. Synthetic N-cyanomethyl-N-methylbenzamide was analysed under the 
same conditions to determine if it would degrade under the analytical conditions. The 
GCMS (result (c) of Figure 2.9) indicates that such an intermediate, if formed, would be 
clearly detectable. Thus the P450-dependent metabolism of N,N-dimethylbenzamide does 
not occur via the formation of "CN trappable iminium ion intermediates.
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F igure 2 .8  GCMS from microsomal incubation of (a) 10 mM N.N-dimethylaniline in 
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Figure 2 .9  GCMS from microsomal incubation of (a) 10 m \l N,N-dimethylbenzamide 
in the presence of I mM sodium cyanide, and of synthetic standards (b) N- 
methylbenzamide and (c) N-cyanomethyl-N-methylbenzamide.______________________
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Peak Compound identified
Retention Time: 4.47 minutes N,N-dim ethylaniline
Retention Time: 4.73 minutes N-methylaniline
Retention Time: 9.16 minutes N-cyanom ethyl-N-m ethylaniline
Table 2 .1  Products identified from the microsomal oxidation of N,N-dimethylaniline in 
the presence of sodium cyanide.
Peak Compound identified
Retention Time: 9.09 minutes N-methylbenzamide
Retention Time: 9.34 minutes N,N-dim ethylbenzam ide
Table 2 .2  Products identified from the microsomal oxidation o f N,N- 
dimethylbenzamide in the presence of sodium cyanide.
• Quantitative study of the microsomal oxidation of N,N- 
dimethylbenzamide and N,N-dimethyIaniline in the presence of 
sodium cyanide
As CN" has a high affinity for the haem iron, the effect of 1 mM NaCN as a 
competitive inhibitor upon the metabolism of N,N-dimethyIbenzamide and N,N- 
dimethyianiline was examined. The results obtained, expressed as the initial rates for the 
total metabolism of the substrates, together with the derived kinetic constants, Vmax and 
Km, are reported in Table 2.3. The results indicate that the presence of sodium cyanide 
has no effect on the metabolism of the substrates.
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Vi for total metabolism (mM/h/nmol P450)
[Substrate]
(mM)
NjN-dim ethyl
benzamide
N ,N -dim ethyl
benzamide
and
1 mM NaCN
N,N-dim ethyl
aniline
N ,N -d im ethyl
aniline
and
1 mM NaCN
0 .5 0.60 ± 0.03 0.55 ± 0.04 0.92 ± 0.04 0.88 ± 0 .05
1.0 1.01 ± 0.06 0.94 ± 0.06 1.38 ± 0.09 1.31 ± 0.07
3 .0 1.84 ±0.11 1.75 ±0.08 2.04 ±0.16 1.98 ±0.11
10.0 2.19 ±0.16 2.18 ±0 .06 2.46 ±0.11 2.44 ± 0.07
20 .0 2.81 ± 0.07 2.78 ±0.11 2.55 ± 0.05 2.57 ±0.11
Vmax
(mM/h/nmol
P450)
3.10 ±0.21 3.07 ±0.11 2.7 ± 0.06 2.68 ± 0.05
Km (mM-l) 2.06 ± 0 .1 2 2 .6 6  ± 0.08 0.96 ± 0.04 1.07 ± 0 .03
Vmax/Km 1.50 1.15 2.81 2.51
Table 2 .3  Initial rates and derived kinetic parameters for the microsomal oxidation of 
N,N-dimethylbenzamide and N,N-dimethylaniline.____________
2.2.2. Trapping of iminium ion by sodium borodeuteride (NaBD4)
• Identification of the products -
Optimal experimental conditions were obtained by using N,N-dimethylaniline as 
substrate. Incubations involved substrate concentrations between 0.5 and 10 mM, while 
sodium borodeuteride concentrations ranged from 1 to 10 mM. Analysis of the products 
was achieved by GCMS. Figure 2.10 illustrates typical GCMS results while Table 2 .4  
reports the identified products after 30 minutes of microsomal oxidation of 10 mM N,N- 
dimethylaniline in the presence of 5 mM sodium borodeuteride. These are the optimum 
experimental conditions resulting from this study.
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Products of the metabolism were identified by comparison of their mass spectra 
with those obtained from synthetic standards. Comparison of the mass spectrum of N,N- 
dimethylanilinc obtained from the microsomal incubations with that obtained from pure 
N,N-dimethylaniiine (Figure 2 . 11) clearly reveals that deuterium incorporation into the 
substrate has taken place.
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F igure 2 . 1 0 GCMS results of microsomal incubation of 10 mM N,N-dimethylaniline in 
the presence of 5 mM sodium borodeuteride.
Peak Compound identified
Retention Time: 4.47 m inutes N,N -dim ethyIaniIine
Retention Time: 4.73 m inutes N-m ethvlaniline
Table 2 .4  Identified products of the microsomal metabolism of N,N-dimethylaniline
CHAPTKR 2
F igure 2 .1 1 Mass spectra of (a) pure N,N-dimethyIaniline and (b) N,N-dimethylaniline 
obtained from microsomal incubation in the presence of sodium borodeuteride. ______
These results are good evidence for the formation of an iminium ion intermediate 
which is reduced by the sodium borodeuteride present in the solution, leading to the 
formation of deuterated starting material. Since the major peak in the mass spectrum of 
N,N-dimethylaniline is the (M-1) peak at M/Z 120, the M/Z 121 peak in the spectrum 
obtained from microsomal metabolism can be assigned to the incorporation of one D 
atom. The presence of M/Z 123 and 124 peaks thus signify the incorporation of two, 
three and four deuterium atoms, respectively, into the product. The presence of these 
higher mass species suggests that the deuterated N,N-dimethylanilines undergo further 
P450 oxidation via iminium ion formation. This is quite surprising because two 
successive metabolic cycles of the same substrate molecule would be expected to be an 
unlikely process.
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Given the efficient trapping o f the iminium ion intermediate by sodium
borodeuteride, identical experimental conditions were employed for the microsomal
metabolism of N,N-dimethylbenzamide.
Figure 2 .1 2  and Table 2.5 report the GCMS of a typical microsomal incubation 
of 10 mM N,N-dimethyl benzamide in presence of 5 mM sodium borodeuteride.
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Figure 2 . 1 2  GCMS results from the microsomal incubation of 10 mM N,N- 
dimethylbenzamide in the presence of 5 mM sodium borodeuteride._________________
Peak Compound identified -
Retention Time: 9.34 m inutes N ,N -dim ethylbcnzam ide
Retention Time; 9.09 m inutes N -m cthylbenzam ide
Table 2 .5  Products identified after 30 minutes microsomal oxidation of 10 mM N,N- 
dimethylbenzamide in presence of sodium borodeuteride.
Comparison of the mass spectra o f the products obtained from metabolism of 
N,N-dimethylbenzamide with those of synthetic standards reveals that no deuterated 
N,N-dimethylbenzamide was detected under any of the experimental conditions. This 
result can be interpreted either as indicating that microsomal metabolism of tertiary amides 
does not occur via iminium ion formation or that intermolecular trapping of such an
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intermediate is not efficient. This latter possibility seems unlikely, given the effective
trapping of iminium ion intermediates during the metabolism of N.N-dimethylaniline. The
conclusion is that during the microsomal P450-dependent metabolism of tertiaiy amides
iminium ion species are not formed.
• Quantitative study o f the microsomal metabolism of N,N- 
dimethylaniline and N,N-dimethylbenzamide in the presence of 
sodium borodeuteride
To obtain further information on the effects of sodium borodeuteride on the 
microsomal oxidation of the amine and amide substrates, a quantitative analysis of these 
reactions was carried out. Microsomal incubations were performed with the substrate 
concentration varying between 1 and 10 mM in the presence of 5 mM of sodium 
borodeuteride. The measured rates for the microsomal oxidations of N,N-dimethylaniline 
and N,N-dimethyIbenzamide, together with the derived kinetic parameters, are presented 
in Table 2.6.
Vi total metabolism (mM/h/nmol P450)
[Substrate]
(mM)
N ,N -
dim ethylanili
ne
N ,N - . 
d im ethylanili 
ne
and NaBD4
N ,N -dim ethyl
benzamide
N ,N -d im ethy l 
benzam ide 
and NaBD4
0 .5 0.92 ± 0.03 0.69 ± 0.03 0.60 ± 0.05 0.60 ± 0.04
1 . 0 1.38 ± 0.08 1 .0 2  ±0.07 1 .00  ± 0.06 1,03 ± 0.03
3 .0 2.04 ± 0.06 1.57 ± 0.07 1.84 ±0.09 1.82 ± 0 ,1 0
5 .0 2.26 ± 0 .1 1 1.81 ± 0.06 1.91 ±0.11 1.94 ± 0.05
1 0 . 0 2.46 ± 0.12 1.99 ± 0.09 2.19 ±0.06 2.21 ± 0.07
Vmax
(mM/h/nmol
P450)
2.70 ±0.11 2.20 ± 0.09 3.10 ±0.12 3.08 ±0.13
Km  (mM-1) 0.96 ± 0.06 1.15 ±0.08 2.06 ± 0.14 2.07 ± 0.09
Vmax/Km 2.81 1.91 1.50 1.48
Table 2 . 6  Observed rates for the microsomal metabolism of N,N-dimethylaniline and 
N,N-dimethylbenzamide in the presence and in absence of 5 mM sodium borodeuteride.
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These data indicate that metabolism of N,N-dimethylbenzamide is not effected 
by the presence of sodium borodeuteride. In contrast, the “metabolism of N,N- 
dimethylaniline is significantly inhibited by the presence of the BD4" ion. Analysis of the 
kinetic parameters for the N,N-dimethylaniline reaction indicates that Vmax is reduced 
while Km remains relatively constant. This is consistent with non-competitive inhibition, 
in which the rate of product formation from the reaction intermediates is reduced. Clearly, 
this must be the case if the intermediate iminium ion is reduced back to starting material.
The kinetic data, together with the qualitative analysis of the products of the
reactions, indicate that in the case of N.N-dimethylaniline microsomal oxidation occurs
via formation of an iminium ion, whereas in the case of N.N-dimethylbenzamide
microsomal oxidation does not lead to the formation of any trappable iminium ion 
species.
2.2.3 Attempts to trap an iminium ion intramolecularly
As illustrated in Figure 2.7, N,N-dimethyl-2-hydroxybenzamide has the 
potential to trap, intramolecularly, iminium ion intermediates. Such trapping should result 
in the formation of the cyclic product, 3-methyl-4-oxobenz-l,3-oxazinane. Typical 
GCMS results obtained from microsomal oxidation of 10 mM N,N-dimethyl-2 - 
hydroxybenzamide are shown in Figure 2.13. Identification of the products was achieved 
by comparison with synthetic standards (Table 2.6).
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11.21 min
11.21 min
11.56 min
F igure  2 .13  GCMS of the ethyl acetate extracts from microsomal oxidation of 1G mM 
N,N-dimethyl-2-hydroxy benzamide at (a) time 0  and (b) time 30 minutes.
Peak Compound identified
Retention Time: 11.21 m inutes N ,N -dim ethyI-2 -hvdroxy benzam ide
Retention Time: 11.56 m inutes N -m etbyl-2 -h.vdroxvbenzamide
Table 2 . 6  Products identified from the microsomal oxidation of 10 mM N,N-dimethyl- 
2 -hy droxybenzami de.
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No cyclic product was identified under any experimental condition. A synthetic
standard of 3-methyl-4-oxobenz-l,3-oxazinane was analysed using the same analytical 
conditions, to verify that such a compound is not formed in any of the experiments. 
Analysis of the incubations by HPLC, to avoid any possibility that extraction was 
inefficient, also revealed that no cyclisation product was present. Thus, it would appear 
that microsomal metabolism of the amide does not occur via iminium ion formation.
Finally, the initial rates of metabolism and the derived kinetic parameters Km and 
Vmax were determined and compared with those for the microsomal oxidation of N,N- 
dimethyl benzamide. The results are presented in Table 2.7. The results confirm that the 
increasing of polarity of the substrate affects metabolism as illustrated by a comparison of 
the Vmax/Km values of the two substrates tested. The smaller value for the 2 -hydroxy 
derivative previous reports that rates increase with increasing lipophilicity.l^; 14
Vi (mM/h/nmolP450)
[Substrate]
(mM)
F rom
N .N -dim ethyi
benzam ide
From
N ,N-dim ethyl-2- 
hydroxy benzam ide
0 .5 0.60 ± 0.05 0.28 ± 0 .0 2
1 . 0 1 .01  ± 0.06 0.51 ±0.05
3 .0 1.84 ±0.11 0.96 ± 0.03
5 .0 1.91 ±0 .10 1.34 ± 0.09
1 0 . 0 2.18 ± 0.14 1.62 ± 0.15
Vmax
(mM/h/nmolP450)
3.1 ± 0.20 2.57 ± 0.09
Km  (mM-1) 2.06 ±0 .1 2 4.06 ± 0.31
Vmax/Km 1.50 0.63
Table 2 .7  Initial rates of formation and derived kinetic parameters for the microsomal 
oxidation of NJ^-dimethylbenzamide and N,N-dimethyl-2-hydroxybenzamide.
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2.3. Trapping of carbon centred radicals
2.3.1 Using the N ,N -dim ethy!acrylam ide system
The potential pathway for microsomal oxidation of N,N-dimethyIacrylamide 
involving carbon-centred radicals is illustrated in Figure 2.14. The carbon-centred radical 
intermediate 2 can undergo direct insertion of the hydroxyl group from the activated P450 
haem-oxygen complex, leading to the N-demethylated product 3. Alternatively it can be 
trapped by the double bond of the acryloyl functionality, giving, via cyclisation, the N- 
methyl-3-hydroxy pyrrolidinone product, 4 (Figure 2.14).
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F igure 2 .1 4  Potential P450-dependent oxidation pathway of N,N-dimethyl acrylamide.
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2.3.1.1 Chemical cyclisation and AM I semi-empiricai molecular orbital
calculations
Semi-empiricai M.O. calculated heats of formation for ttie species in Table 2 .8  
were obtained using the AMI self-consistent field model. Interestingly, the difference 
between the heats of formation of N,N-dimethylcrylamide and its carbon-centred radical,
98.1 kJ mol-1, is comparable to the analogous difference reported for N,N- 
dimethylbenzamide, 119.9 kJ mol-1.3 Thus there is relatively little energetic difference in 
the formation of the carbon-centred radical for acrylamide. Furthermore, the cyclisation of 
the carbon-centred radical seems to be an energetically favoured process, as indicated 
from the difference, 9.2 kJ mol ',  between the heats of formation of the open 
chain/cyclised carbon-centred radicals.
Com pound
AHf (Kj/mol.)
N ,N -dim ethylacrylam ide - 58.6
0
II 1
CH2 CH3
775 .9
r S " "
CHz CHg
3 9 .5
0
30 .3
Table 2 . 8  Heats of formation (AHf) calculated by the AMI model for N,N-dimethyl 
acrylamide and its postulated radical intermediates
The efficiency of the acryloyl system for trapping the carbon-centred radical was 
tested by chemic^ly generating the carbon-centred radical intermediate 2  of Figure 2.14
fromN-chloromethyl-N-methylacrylamide.
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The GC results are illustrated in Figure 2.15, and identified by comparison of their mass 
spectra with that obtained from synthetic standards reported in Table 2.9.
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F igure 2 .1 5  GCMS traces obtained from the reaction involving chemical generation of 
the carbon-centred radical 2  of figure 2.17.
Peak Compound identified
Retention Time: 10.00 m inutes N -chlorom ethyl-N -m ethylacrylam ide
Retention Time: 4.48 m inutes N-m ethylpyrrolidinone
Retention Time: 6.62 m inutes N ,N -dim ethvlacrylam ide
1 a Die 2.9 Products identified from the cyclisation of the chemically generated carbon 
centred-radical 2  of Figure 2.17.
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In this chemical system, the carbon-centred radical can either abstract a hydrogen 
atom directly from BujSnH to form N,N-dimethylacrylamide. or it can cyclise and then 
abstract a hydrogen atom to form N-methyl-2-pyrrolidinone. Both products are formed 
and quantification indicates that cyclisation is favoured by 4 to 1 over N,N- 
dimethylacrylamide formation,
2.3.1.2 T rapping  of ca rb o n -cen tred  radicals during  the P450-dependent 
metabolism of N,N-dimethyI acrylam lde
A typical HPLC analysis of a microsomal incubation of 10 mM N,N-dimethyl 
acrylamlde after 30 minutes is illustrated in Figure 2.19. The products of the reaction 
were identified by comparison of their retention times and diode array spectra with those 
of synthetic standards and are summarised in Table 2.10.
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Peak Product identified
Retention Time; 6.94 m inutes N ,N -dim ethylacrylam ide
Retention Time: 5.40 m inutes N -m ethyl-3-hydroxYlDvrrolidinone
i t y ^ i ^ d r   ^ ïuentitied from the microsomal metabolism of N,N-dimethyl
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It is interesting to note that no N-demethylated product was found. The results 
are consistent with the formation of a carbon-centred radical intermediate which is then 
intramolecularly trapped to give the cyclic metabolite N-methyl-3 -hydroxy-2 - 
pyrrolidinone. The absence of the N-demethylated product indicates that cyclisation is the 
favoured reaction with respect to hydroxylation. Given that cyclisation is more favoured 
in the case of microsomal oxidation than in the case of analogous chemical system. It is 
possible that interactions between the enzyme and the substrate influence the proximity of 
the radical centre to the double bond. Further investigation of this aspect of the reaction 
was not undertaken.
The results of a kinedc analysis o f the microsomal metabolism of N.N-dimethyl 
acrylamide are reported in Table 2.11.
[S ubstrate]
(mM)
Vi for formation of N-methyi-3 - 
hydroxy-2 -pyrro lid inone
(mM/h/nmol P450)
0 .5 0.23 ± 0.02
1 . 0 0.37 ± 0.05
3 .0 0 .6 6  ± 0.06
5 .0 0.78 ± 0.08
1 0 . 0 0.90 ±0.11
Vmax (niM/h/nmolP450) 1.07 ± 0.08
Km (mM-I) 1.85 ± 0.09
Vmax/Km 0.58
Table 2 . 1 1  Initial rates and kinetic parameters for the microsomal oxidation of N,N- 
dimethylaciylamide.
These are unremarkable, but reveal a rate oz one-third of that for N,N- 
dimethylbenzamide. This probably reflects the greater hydrophilicity of the acrylamide.
2.3.2 N-methyl-N-pyridylmethylacrylamide
Having verified that the acryloyl system is an effective trap for carbon-centred 
radical intermediates in amide dealkylation, a further substrate was investigate, namely N-
64
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methyl-N-pyridylmethylacrylamide. The presence of the aryl ring should favour
hydrogen atom abstraction from the carbon atom a-to  the ring due to resonance
stabilisation of the carbon-centred radical intermediate. A potential pathway for this
substrate is illustrated in Figure 2.20. Hydrogen abstraction can theoretically occur from
both a-carbon atoms, leading to the formation of two carbon-centred intermediates, 2  and
3 (Figure 2.17). These can then undergo intramolecular cyclisation to give compound, 4
and 6  (Figure 2.17).
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F igure 2 .1 7  Potential pathway for the microsomal oxidation of N-methyl-N- 
pyridylmethylacrylamide.________ __ ___________________________
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HPLC analysis of the microsomal incubation of 10 mM N-methyl-N-
pyridylmethylacryiamide gave the chromatogram illustrated in Figure 2.18. Table 2.12
reports the products of the reaction, identified by comparison of their UV spectra with
those of synthetic standards.
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F ig u re  2 .1 8  HPLC chromatograms of the microsomal oxidation of 10 mM N-methyl- 
N- pyridylmethylacrylamide, at time (a) 0 and (b) 30 minutes.
Peak Compound identified
Retention Time: 8.76 m inutes N -m ethyl-N -
pyridylm ethylacrylam ide
Retention Time: 5.08 m inutes 3-hydroxycotinine
Table 2 .1 2  Products o f the m icrosom al oxidation of N -m ethyl-N- 
pyridylmethylacrylamide.
Significantly, reaction occurs exclusively in the N-alkyl group to form the cyclic 
product 3-hydroxycotinine, and no N-dealkylated product is observed. Moreover, no
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reaction at the N-methyl group could be detected. These results indicate that substrate
metabolism occurs via hydrogen atom abstraction to form a carbon-centred radical
intermediate. The presence of the aromatic ring directs the reaction toward N-alkyl rather
than N-methyl oxidation.
Kinetic parameters for this reaction are reported in Table 2.13. Comparison of 
these data with those obtained for the metabolism of N,N-dimethylacrylamide, indicate 
that the N-pyridylmethyl compound is metabolised 2-3 times faster, further supporting a 
reaction mechanism involving hydrogen atom abstraction from the a-carbon.
Vi (mM/h/nmol P450)
[substra te]
(mM)
3-hydroxycotinine
0 .5 0.55 ± 0.03
1 . 0 0 .8 6  ± 0.08
3 .0 1.41 ±0.06
5 .0 1.61 ± 0 .1 0
1 0 . 0 1.80 ± 0 .1 2
Vmax (mM/h/nmol P450) 2.05 ±0.12
Km (mM-l) 1.36 ±0.06
Vmax/Km 1.51
Table 2 .1 3  Initial rates of formation and kinetic parameters of the microsomal oxidation
of N-methyl-N-pyridylmethylbenzamide.
2.3.3 Using N ,N -dim ethyl- 2-vinylbenzam lde
A potential pathway for the microsomal oxidation of N,N-dimethyI-2- 
vinylbenzamide is shown in Figure 2.19. Formation of the carbon-centred radical 
intermediate 2 can lead either to insertion of the hydroxyl group from P450 to give the
CHAPTER 2
carbinolamide and, subsequently, the N-demethylated product 3 , or to cyclisation and the 
formation of product 4.
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Figure 2 .1 9  Potential pathways for the microsomal oxidation of N,N-dimethyl-2 - 
vinylbenzamide.
A typical GCMS analysis of the microsomal incubation of 10 mM N,N- 
dimethyl-2-vinylbenzamide obtained after 30 minutes is shown in Figure 2.20.
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F igure 2 .2 0  GCMS analysis of the microsomal incubation of 10 mM N,N-dimethyl-2 - 
vinylbenzamide, spectrum a) N-methyl-2-vinylbenzamide, spectrum b) N,N-dimethyl-2 - 
vinylbenzamide and spectrum c) metabolite resulting to insertion of an oxygen atom to 
N,N-dimethyl-2 -vinylbenzamide.________________
The peak with retention time of 12.45 minutes was identified as the substrate, by 
comparison of the mass spectrum with that of the synthetic standard. The 11.95 minute 
peak has a mass spectral profile of which the major features are
• an M/Z value of 191, equivalent to the mass of the substrate plus an oxygen atom
• the loss of a fragment of mass 3 1, equivalent to the group M-CH2OH.
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This mass spectraJ profile is consistent with the three compounds illustrated in 
Figure 2.21.
0 0 0
% CCII
CHg 1CH2 0 H
1) 2) 3)
F igure 2 .2 1  Potential structure of the oxygenated metabolite formed upon metabolism 
of N,N-di methyl benzamide.
N-hydroxymethyl-N-methyl-2-vinylbenzamide (compound 1 ), is an unlikely 
candidate since treatment of the sample by base (which is carried out prior to analysis) 
would result in the N-demethylated product.^: ^
To further clarify the structure of the 11.95 minutes metabolite ethyl acetate 
extracts from the base treated incubation mixture were divided in two aliquots; one was 
subjected to treatment by strong base (5 M KOH; 1 hour), the other to acylation by 
trifluoroacetic acid.
Compound 2) of Figure 2.21 would be expected to undergo acylation 
O O
Uy *
CHgOH
CF3COOH
O—COCF3
Thus if the 11.95 minute peak corresponds to compound 2) it should disappear 
after trifluoroacetic treatment. Alternatively, compound 1 ) should disappear after basic 
treatment to form N-methyl-2-vinylbenzamide, whereas if it corresponds to compound 3  ) 
treatment with strong base should lead to a diol via opening of the epoxide. Figure 2.22 
reports the typical GC traces of these samples.____________________________________
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F igure  2.22 GC traces of the extracts of microsomal incubation of 10 mM N,N- 
dimethyl-2-vinyl benzamide, after a) normal base treatment, b) 5 M NaOH 1 hour 
treatment and c) after trifluoroacetic acid treatment.
The 11.95 minute peak is not affected by base but disappears as a consequence 
of the acylation reaction. Moreover, upon trifluoroacetic acid a new peak appears, with a 
retention time of 22.26 minutes, consistent with an acylated product. The results point to 
the 11.95 minutes peak as corresponding to compound 2 ) of Figure 2.21.
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2.4 Using N-alkenyl and  N -alkynyl substrates
The N-alkenyl and N-alkynyl substrate probes used in this study are the 
compounds illustrated in Figure 2.3. It has been reported that double and triple bonds are 
able to intramolecularly trap a carbon-centred radical to generate cyclic products through 
rearrangement. This being so, the potential microsomal oxidative pathways for
N-(3-butenyl)-N-methylbenzamide and N-(3-butynyl)-N-methylbenzamide are illustrated 
in Figures 2.23 and 2.24.
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F igure 2 .2 3  Potential pathways for the microsomal oxidation of N-(3-butenyl)-N- 
methylbenzamide.
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F igure 2 .2 4  Potential pathways for the microsomal oxidation of N-(3-butynyl)-N- 
methylbenzamide.________________________________________________
Hydrogen atom abstraction from the carbon a -  to the nitrogen can lead to the 
formation of two potential carbon-centred radical intermediates, 2 and 3 of Figures 2.23 
and 2.24. Both radical intermediates can undergo hydroxyl group insertion from the P450 
haem-oxoiron complex to give the dealkylated metabolites 4 and 5. Alternatively, the
'7Q
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carbon-centred radical derived from the N-methyl group can undergo intermolecular
trapping by either endo- or exo- cyclisation to yield the metabolites 6  and 7 (Figures 2.26
and 2.24).
Initially AMI semi-empirical calculations of the heats of formation of the radical 
species illustrated in Figure 2.23 and 2.24, were calculated. These were accompanied by 
reactions involving the chemical formation of the carbon-centred radicals. Subsequently, 
microsomal oxidation of the substrate was performed.
2.4.1 AMI semi-empirical molecular orbital calculations and cyclisation  
of chemically generated radicals
The heats of formation of the postulated carbon-centred radical intermediates of 
the reactions illustrated in Figure 2.23 and 2.24 were calculated by the self-consistent 
field semi-emphirical AMI model (Table 2.14). The results indicate the oxidation of the 
N-methyl is disfavoured with respect to the N-alkyl group. Moreover, cyclisation, from 
thermodynamic considerations, should lead to the formation of the six-membered ring 
compound. This contrast with reports that similar radical cyclisation reactions result in the 
formation of a five- rather than six-membered ring p r o d u c t , ! 8 ; 19; 20; due to a less 
strained transition state in the formation of the five membered ring product. However, the 
ratio of the five- to six- membered rings depends upon the substituents attached to the 
olefinic bond. Systems containing amido groups are reported to yield a considerable 
amount of the larger ring product.^l; 22 Moreover, the situation changes when radical 
cyclisation is reversible; under thermodynamic conditions, six-membered ring products 
are reported to be formed predominantly.23; 24
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Com pound AHf (kj/m ol.)
N -(3-bu tenyl)-N -m ethylbenzam ide 30
130
133
85
c y o - 75
N (3-butynyl)-N -m ethylbenzam lde 187
^  CH3
276
& 291
243
250
Table 2.14 Heats of formation (AHf) of N-(3 -butenyl)-N-methylbenzamide, N-(3- 
butynyl)-N-methyIbenzamide and the postulated carbon-centred radicals formed during 
their microsomal oxidation.
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To ascertain the efficiency of the intramolecular trapping systems adopted, the
cyclisation of the chemically generated N-methylene carbon-centred radical 3 (Figure
2.23 and 2.24) was studied. Figures 2.25 and 2.26 report typical GCMS obtained from
the reaction of the N-(3-butenyl)-N-chloromethyIbenzamide and N-(3-butynyl)-N-
chloromethylbenzamide respectively, with BusSnH/AIBN. Tables 2.15 and 2.16 detail
the products of reactions identified by comparison with those of synthetic standards.
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N. 47550- N. 609
25-
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N. 592
«WV « xa n-WM MJ. W w KMI»
3MI X-r
5'as -la
N. 609
F igure 2 .2 5  GSMS obtained from the cyclisation of the chemically generated N-methyl 
radical from N-(3-butenyl)-N-chloromethylbenzamide.____________________________
Peak C om pound Identified Yield
N. 475 N -(3-bu teny l)-N -
m ethylbenzam ide
2
N. 592 N -benzoyl-3-m ethylpyrro lid in 5
N. 609 N -benzoylp iperid ine 1
Table 2 .1 5  Products identified from the cyclisation of the chemically generated N- 
methyl radical from N-(3-butenyl)-N-chloromethylbenzamide.
C H A P T K R 2
100-1 
80- 
6 0 - 
4 0 - 
20 -  
0 —  
0 250
? T II.?
?T  il?
a T lia
N. 468 N. 539
N. 662
_L
500
I I
750 1000
scan number
N. 468
111_____
ta
N. 539
N. 662
Figure 2 .26  GSMS obtained from the cyclisation of the chemically generated N 
methylene radical fromN-(3-butynyl)-N-chloromethylbenzamide__________________ _
Peak C om pound identified Y ield
N. 468 N -(3-bu tynyI)-N -
methylbenzamide
2 .5
N. 539 N -benzoyl-3-
m ethylenepyrrolid ine
5 .0
N. 662 N -b e n z o y l-1 ,2,5,6- 
te trahydropyrid ine
0 .5
Table 2 .16  Products identified from the cyclisation of the chemically generated N- 
methylene radical from N-(3-butynyl)-N-chloromethylbenzamide.
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The carbon-centred radical so-generated cyclises via both endo and exo
pathways. The ratio of five- versus six-membered compounds was then calculated; the 
results indicate that formation of the five-membered ring product is favoured by a factor 
of 5 and 10 for N-butenyl and N-butynyl amide, respectively. Furthermore, cyclisation of 
the carbon-centred radical appears to be favoured over hydrogen atom insertion from 
BusSnH by a factor of 2 for both compounds.
The results indicate that this alternative intramolecular trapping system is 
potentially very effective. They also suggest that the more probable products of the radical 
cyclisation will contain a five-membered ring, resulting from exo cyclisation. Moreover, 
given that cyclisation is likely to be more rapid than P450-dependent insertion of a 
hydroxyl group, these cyclic products are anticipated to be the main metabolites of these 
reactions.
2.4.2 M icrosomal oxidation o f N-(3-butenyl)-N -m ethyIbenzam ide and  N- 
(3-butynyl)-N -m ethylbenzam ide
Typical GCMS obtained after 30 minutes of microsomal incubation of 10 mM 
N-(3-butenyl)-N-methylbenzamide or N-(3-butynyl)-N-methylbenzamide are reported in 
Figures 2.27 and 2.28, respectively. Again, the products of the reactions were identified 
by comparison of their mass spectra with those of synthetic standards analysed under 
similar conditions (Tables 2.17 and 2.18).
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Figure 2.27  GCMS trace obtained after 30 minutes from microsomal oxidation of 10 
mM Nr-(3-butenyI)-N-methyl benzami de._________
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F igure 2 ,28  GCMS trace obtained after 30 minutes from microsomal oxidation of 10 
mM N-{3-butynyl)-N-methylbenzamide.
Peak Compound identified
Retention Time: 9.18 m inutes N -(3-butenyl)-N -m ethylbenzam ide
Retention Time: 7.39 m inutes N-m ethylbenzam ide
Retention Time: 9.30 m inutes N -(3-butenyl)benzam ide
Table 2 .1 7  Products identified after 30 minutes microsomal oxidation of 10 mM N-(3- 
butenyl)-N-methyl benzamide.
Peak Compound identified
Retention Time: 9.43 m inutes N -(3-butynyl)-N -m ethylbenzam ide
Retention Time: 7.40 m inutes N-m ethylbenzam ide
Retention Time: 9.29 m inutes N -(3-butynyl)benzam ide
Retention Time: 13.45 m inutes l-benzoylp ioeridone
Table 2 .1 8  Products identified after 30 minutes microsomal oxidation of 10 mM N-(3- 
butynyl)-N-methylbenzamide.
The results point to some unexpected features of these microsomal P450- 
dependent reactions. First, the metabolism of N-methyl-N-(butenyl)benzamide does not 
result in the formation of any cyclic metabolite. Indeed, the only two products of the 
reactions are those due to N-demethylation or N-dealkylation. Second, the metabolism of 
N-methyl N (3 butynyl)bcnzamide leads to the formation of a single cyclic compound, 
other than the two products o f the N-demethylation and N-dealkylation. Quite 
surprisingly, this metabolite is the six-membered ring product, arising from the less 
favoured endo cyclisation.
The rates of formation and the derived kinetic parameters for tlicse reactions are 
presented in Tables 2.19 and 2.20.
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Vi (mM/h/nmol P450)
[Substrate] (mM) Total m etabolism N -m ethyl
benzam ide
N -(3 -bu teny l)
benzam ide
0 .5 1.42 ± 0.04 0.45 ± 0.03 0.91 ± 0.04
1 .0 1.91 ± 0.06 0.64 ± 0.07 1.19 ±0.06
5 .0 2.61 ±0 .16 1.00 ±0.10 1.59 ±0.11
10 .0 2.74 ±0 .14 1.07 ± 0.08 1.65 ±0.15
Vmax
(mM/h/nmoI P450)
2.88 ±0.1 1.16 ±0.06 1.73 ± 0.09
Km (mM-l) 0.51 ±0.03 0.80 ± 0.04 0.45 + 0.03
Vmax/Km 5.65 1.45 3.81
Table 2 .1 9  Initial rates of metabolism and kinetic parameters for the microsomal 
oxidation of N-(3-butenyl)-N-methylbenzamide.
V i (mM/h/nmol P450)
[Substrate]
(mM)
Total
m etabolism
N -m ethyl
benzam ide
N -(3-butenyl)
benzamide
l-b en zo y l-4 -
p iperidone
0 .5 1.52 ±0.12 0.39 ± 0.06 0.27 ± 0.05 0.21 ± 0.03
1 .0 2.02 ±0.15 0.58 ± 0.05 0.70 ± 0.06 0.33 ± 0.04
5 .0 2.74 ± 0.21 0.93 ± 0.07 0.89 ± 0.07 0.60 ± Ô.04
10 .0 2.86 ±0.31 1.00 ± 0.06 1.03 ±0.08 0.66 ± 0.07
Vmax
(mM/h/nmoI
P450)
3.01 ±0.11 l .I0 ± 0 .0 6 1.20 ±0.08 0.75 ±0.03
Km (mM-l) 0.49 ± 0.04 0.90 ± 0.05 1.71 ±0.09 1.25 ± 0.06
Vmax/Km 6.10 1.22 0.70 0.60
Table 2 .2 0  Initial rates of metabolism and kinetic parameters for the microsomal 
oxidation of N-(3-butynyI)-N-methylbenzamide.
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These results confirm that metabolism of N-methyl-N-(butenyl) benzamide leads
to the formation of only the N-demethylated and N-dealkylated products. Quantitative 
analysis of the metabolism of N-methyl-N-(3-butynyl)benzamide indicates that cyclisation 
occurs at a comparable rate with respect to the hydroxyl group insertion at the carbon- 
centred radical intermediate. This observation is quite surprising since cyclisation should 
be more favoured. This difference between the theoretical prediction, and also the results 
from the microsomal metabolism o f the C-alkenyl substrates, and with the present 
observations for the oxidation of these N-alkenyl substrates, can be ascribed to greater 
freedom of motion in the N-alkenyl system. The differences observed between the 
chemical cyclisation and the microsomal oxidations, are probably due to interactions 
between the substrate and enzyme in the active site imposing a constrained spatial 
conformation on the substrate.
To explore further the failure o f the trapping of the radical by the N-butenyl 
system, the metabolism of the N-benzyl-N-(3-butenyl)benzamide was examined. This 
substrate was chosen because the presence of the aromatic ring should enhance hydrogen 
atom abstraction by P450 and stabilise the carbon-centred radical intermediate so-formed.
2.4.3 Microsomal oxidation o f N-benzyl-N-(3-butenyl) benzamide
Typical GCMS results after 30minutes of metabolism of 10 mM N-benzyl-N- 
(3-butenyl)benzamide are reported in Figure 2.29. The products of the microsomal 
metabolism of the substrate were identified by comparison of their mass spectra with 
those of synthetic standards (Table 2.21).
Microsomal metabolism of the substrate does not result in the formation of any 
cyclic product. The kinetic parameters of the reaction are reported in Table 2.22.
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F igure  2 .2 9 Typical GCMS profile of samples obtained after 30 minutes incubation of 
10 mM N-benzyl-N-(3-butenyl)benzamlde. ________________________________
Peak Compound identified
Retention Time; 15.45 m inutes N -benzyl-N -(3-butenyl)benzam ide
Retention Time; 9.37 m inutes N-(3-butenyl)benzam ide
Retention Time: 15.53 m inutes N-benzyibenzamide
Table 2 .21  Products identified from the microsomal metabolism of N-benzyl-N- 
(butenyl)benzamide.
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v | (mM/h/nmol P450)
[Substrate]
(mM)
Total metabolism N-(3-botenyl)
benzamide
N -benzy l
benzamide
0 .5 1.67 ± 0.07 0.96 ± 0.04 0.36 ± 0.05
1 .0 2.30 ± 0 .1 2 1.40 ± 0.06 0.53 ± 0.03
3 .0 3.07 ± 0.21 1.97 ±0.11 0.77 ± 0.05
5 .0 3.30 ± 0 .16 2.15 ±0.14 0.85 ± 0.07
10 .0 3.49 ± 0.29 2.31 ± 0.21 0.92 ± 0.07
Vmax
(mM/h/nmol P450)
3.70 ±0.11 2.50 ±0.11 1.00 ±0 .05
Km (mM-l) 0.61 ± 0.03 0.80 ± 0.02 0.90 ± 0.04
Vmax/Km 6.00 3.10 1.11
Table 2.23 Initial rates of metaboiism and kinetic parameters for the microsomal 
oxidation of N-ben2yl-N-(3-butenyl)benzamide.
The results indicate that microsomal metabolism of N-benzyl-N-(3- 
butenyl)benzamide leads to the formation of the two products of N-dealkylation. No 
cyclic metabolites are observed. Thus, the N-alkenyl system is not able to trap the carbon- 
centred radical intermediate formed during the microsomal metabolism. These results are 
quite surprising given that chemical generation of the radical intermediate yields a cyclic 
product. Moreover, comparison o f the rate of metabolism between the substrate that 
undergoes efficient intramolecular trapping and that which does not undergo radical 
trapping is not particularly helpful.
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2.5 Conclusions
First, attempts to detect iminium ion species failed. It is unlikely that this is due 
to the ineffectiveness of the systems used, both because of their reported reliability in the 
detection of such intermediates,^»^^»^^^^^^ and also because iminium ion species were 
successfully detected using N,N-dimethylaniline. Thus, it is clear that formation of 
iminium ion species can be ruled out in the metabolic dealkylation o f amides. By 
implication, electron transfer from the carbon centred radical 3 in Figure 2.2, and also 
hydrogen atom abstraction from the cation radical 2 can be ruled out. Moreover, while for 
amines, formation of an iminium ion is reported to occur from the carbinolamine reaction 
product,^  such iminium ion formation does not occur for amides. The lower availability 
of the nitrogen non-bonding electron pair in carbinolamides as compared with 
carbinolamines probably accounts for this.^^î 30; 31; 32
In contrast, trapping of the carbon-centred radical intermediate produced during 
the microsomal P450 oxidation of tertiary amides has been successful. The formation of 
this intermediate has been demonstrated by the detection of characteristic, rearranged 
metabolites during the oxidation of the substrate probes. The formation of cyclic 
metabolites can be explained only by a mechanism that involves formation of a carbon- 
centred radical intermediate. On the basis of these observations, the pathway o f the 
microsomal oxidation of tertiary amides is shown in Figure 2.30.
The substrate undergoes hydrogen atom abstraction to form a carbon-centred 
radical intermediate, that undergoes hydroxyl group insertion, from the P450 haem 
activated oxygen complex, to give the carbinolamide product. In certain instances, this 
compound can be detected as a product of N-methylamides under physiological 
conditions,^ though for N-alkylamides substrate it hydrolyses spontaneously to give the 
N-dealkylated product.
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F igure 2 .3 0  Proposed pathway of the microsomal oxidation of tertiary amides.
Analysis of the efficiency of the intermolecular trapping systems adopted in the 
present study reveals that the C-alkenyl substrates are more efficient than the N-alkenyl 
substrate in trapping the radical intermediate. Comparison of the kinetic parameters for 
these reactions does not indicate that the C-alkenyl are significantly more metabolised than 
the N-alkenyl substrates. Thus, the lower efficiency of the N-alkenyl substrates as 
trapping systems for carbon centred radicals intermediate is not related to a limitation of 
their metabolism.
It is possible that, in the active site of the enzyme, these differences may relate to 
a different position of the radical trapping group with respect to the radical centre. 
Because of the restricted rotation around the C-N bond in amides, in the C-alkenyl 
substrates the alkenyl has a relatively fixed conformation with respect to the radical 
centre. For the N-alkenyl substrates, the trapping group can move relatively freely with 
respect to the radical centre. Thus, it is possible to argue that capture of the carbon- 
centred radical by the C-alkenyl substrate is statistically more probable it is by of the Nr 
alkenyl substrate.
The overall conclusion from this part of the study, is that there is direct evidence 
that the microsomal oxidation o f tertiary amides occurs via hydrogen atom abstraction 
from the carbon atom a  to nitrogen, resulting in the formation of a carbon-centred radical 
intermediate.
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CHAPTER 3
ESR stodies of the microsomal P450 metabolism of tertiary amides
3.1 Introduction
ESR is considered the least ambiguous method for the detection of free radicals. 
Unfortunately, it is not always possible to directly observe the free radicals of interest as 
their concentration may be below the limit of detection {ca, 10-8 M, a practical limit is 
probably ca. 10^ M).^ In addition, some radicals, even if present at a concentration 
greater than 10^ M, are not observable at room or physiological temperature as their spin 
relaxation times are very short, making their linewidth too broad to be observed by ESR.
The spin trapping technique has been developed to overcome the problems 
associated with detection of the transient free radicals in chemical and biological 
systems.2-7; This technique is characterised by the addition of the free radical of interest 
to a diamagnetic compound to produce a relatively long-lived nitroxyl free radical 
product, that can accumulate sufficiently to be studied by ESR.
Nitroxyls are relatively stable because the unpaired electron is stabilised by 
resonance:
-i* _R2 N—O — ► R2N“ 0
Two kind of spin traps have been developed, nitrones and nitroso compounds. 
Nitroso compounds can provide considerably more information than nitrones as the 
radical to be trapped adds directly to the nitroso nitrogen:
R— N==0 + Rx ---- R— N— 0*
Rx
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In this case coupling of the unpaired electron with the hydrogen atoms attached
to the carbon atom of the R^* radical occur. With nitrones, some information is lost 
because the trapped radical adds to the carbon atom adjacent to the nitrooen:
Hp Hp O
R^— C = N — r2  ► Ri—C — N— R2
R
The use of PBN (for the structure of PBN, see Figure 3.1) in the present study
was justified in part because it is one of the most effective reported spin trapping agents
for biological systems in vivo and in and because it has both hydrophilic and
lipophilic character. This latter property makes it ideal for the analysis of microsomal and
similar systems since it has the dual potential of capturing free radicals both in the
hydrophobic pocket of the active site of P450 as well as in solution if such radicals are 
released.9;tO
The information about the radical trapped is contained in the multiplicity and 
magnitude of the hyperfine splitting in the spin adduct. The solvent is known to have a 
major effect on the hyperfine splitting constant. In general, increases in solvent polarity 
produce an increases in the nitrogen-hyperfine splitting as the spin density on the nitrogen 
increases. Concomitantly, the ^-hydrogen splitting constant usually (but not always) 
increase.^ Empirically, it has been demonstrated that for a particular spin adduct in 
different solvents, a^ and apH can be linearly correlated with the polarity of the
solvent.^->13
The present study involves attempts to trap the postulated carbon-centred radical 
by intermolecular trapping with PBN. The expected reaction is that summarised in Figure 
3.1, where the short lived carbou-ceutrcd radical is ‘'stabilised” by being the bound to the 
spin trap. The amide substrates used in the present study are illustrated in Figure 3.2.
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Figure 3.1 Spin trapping of the amide carbon-centred radical by PBN
-CH;
N,N-dimethyIbenzamide N-Benzyl-N-methylbenzamide
Figure 3 .2  Amides used in the study.
3.2 ESR analysis of the m icrosom al oxidation o f N,N-dimethylbenzamide 
and N’benzyl-N-m ethjlbenzamide
Microsomal incubation of 5 mM N-benzyl-N-methylbenzamide in the presence 
of a 15 mM solution of the spin trapping agent PBN gave, after extraction into a 2/1
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solution of chloroform/ methanol, as used in experiments elsewhere,^-the typical ESR 
spectrum recorded in Figure 3.3.
o  400
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-200  -
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3300 3340
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3380 3420 3460
TRl
F igure 3 .3  ESR spectrum of a chloroform/methanol extract of the microsomal 
incubation of N-methyl-N-benzyl benzamide 5 mM after 30 m i n u t e s . _____________
To avoid false positive signals, the spectrum from a series of control incubations 
were recorded. The results, Figure 3.4, indicate that the ESR signal is recorded only if 
the full metabolic system (enzymes and cofactors), substrate and PBN are present. 
Ouüssion of one of these component results in the absence of a detectable ESR signal.
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Figure 3 .4  ESR spectra of controls incubations: (a) microsomal monooxygense system 
and PBN 30 mM, (b) microsomes, 5 mM substrate and 15 mM PBN (without NADPH 
regenerating system), (c) NADPH regenerating system and 15 mM PBN and (d) 5mM 
substrate, 15 mM PBN and NADPH regenerating system.
Furthermore, because of the reported efficiency of PBN in trapping the hydroxyl 
radical,! control reactions of microsomal metabolism of the substrate in the presence of 
PBN and varying concentration of superoxide dismutase (SOD) were carried out. The 
results are shown in Figure 3.5.
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F igure 3 .5  ESR spectra of chloroform/methanol extracts from microsomal incubations 
of 5 mM N-benzyl-N-methylbenzamide carried out in presence of 15 mM PBN and (a) 
50, (b) 100 and (c) 300 SOD units.
The presence of SOD does not modify the ESR spectra at any of the 
concentrations used, This is a good indication that the signal is not due to the trapping of 
reactive oxygen radicals by PBN.
Particular attention was also paid to the choice of the concentrations of PBN and 
substrate. High concentrations of both substrate and PBN should lead to high 
concentrations of radical adduct and thus to a better signal. However, it is possible that
_________________   ;_______________________________________________CFfAPTER 3
the spin trapping agent interferes with substrate metabolism by competing for the active
site. It is known that high concentrations of PBN (> 50 mM in vitro and > 100 mM in
vivo) interact with P450 resulting in inhibition of substrate metabolism.^^^ In all the
microsomal reactions carried out here the PBN concentration was kept below 50 mM. To
maximise the probability of trapping of the radical, the relative ratio of PBN to substrate
was examined. The best signals are obtained using a PBN/substrate ratio of 3 to 1.
Subsequently, all microsomal oxidations of the amides were carried out using a substrate
concentration of 5 mM In the presence of 15 mM PBN. These concentrations being the
best compromise between intensity of the signal and reciprocal interference of the P45Û-
dependent metabolism.
Figure 3.6 is a typical ESR spectrum obtained from chloroform/methanol 
extracts of the microsomal incubation of 5 mM N,N-dimethyl benzamide in the presence 
of 15 mM PBN. This spectrum, like that for N-benzyl-N-methylbenzamide, displays the 
typical triplet of doublets of the nitroxyl radical from which the hyperfine splitting 
constants summarised in Table 3 .1 are obtained.
H / G
— I
mo
F igure 3 .6  ESR spectrum of the chloroform/methanol extracts of the microsomal 
incubation of 5 mM N,N-dimethylbenzamide in the presence of 15 mM PBN_________
Substrate »N apH
(G ) (G )
N,N-dimethyl benzamide 14 .8 6 .5
N-methyl-N-benzyl benzamide 15 .0 4 .6
Table 3 .1  Hyperfine splitting constants for the radicals spectra obtained from 
microsomal metabolism of 5 mM N,N-dimethylbenzamide or N-benzyl-N- 
methylbenzamide in the presence of 15 mM PBN.
The spectral parameters reported in Table 3 .1 compare favourably with literature 
data for the chemically generated, PBN trapped carbon-centred radicals of N,N-dimethyl 
formamide and N,N-diethyl acetamide (aN= 14.7 and 15.1 G, ap^= 2.8 and 1 0 ,  
respectively).Agreement of the ax values is excellent, while the measured ap^ splitting 
is slightly higher. This probably reflects the different solvents used in the experiments 
(chloroform/methanol 2/1) compared to that used in the experiments reported in the
literature ( b e n z e n e ) .
3.2.1 Identification o f the PBN-N,N-dimethylbenzaniide adduct
Although it is clear that a radical species is trapped by PBN, its structure cannot 
be determined from spectral parameters alone. Therefore, a different approach was 
employed to identify the structure of the PBN adduct. Assuming (based on the results in 
Chapter 2) that the reaction involves hydrogen atom abstraction from the carbon a  to 
nitrogen, then the structure of the PBN-trapped radical will be that shown in Figure 3.7. 
This PBN-N,N-dimethylbenzamide adduct was then synthesised by reaction of N- 
chloromethyl-N-methylbenzamide with BugSnH/AlBN and PBN, and its ESR spectrum 
is shown in Figure 3.8. This spectrum displays the same six line pattern obtained from 
the extracts of the microsomal oxidation of N,N-dimethylbenzamide and the same 
nitrogen and hydrogen hyperfine splitting constants: ax= 14.8 G and ap^= 6.4 G.
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Figure 3.7 Proposed pathway for the formation of the PBN adduct.
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Figure 3 .8  ESR spectrum of the PBN adduct derived from N,N-dimethylbenzamide in 
chloroform/methanol (2/1)._________
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This result seems to strongly indicate that the carbon-centred radical adduct with
PBN is the product of the microsomal oxidation of N.N-dimethylbenzamide formed in
presence of PBN. However, Table 3.1 reveals that the differences in the hyperfine
splitting constants between the different carbon-centred PBN-adducts is small. Thus.
more conclusive evidence is needed to confirm the structure of the radical intermediates
generated in the P450 oxidation of amides. This was obtained from HPLC analysis of the
microsomal reaction mixtures involving N,N-dimethylbenzamide performed in presence
of PBN. Comparison of the chromatograms obtained from these reactions with that for
the synthetic PBN-adduct standard (Figure 3.10 and 3.11, respectively) reveals that one
of the new peaks that appears in the chromatogram of the microsomal reaction has the
same retention time as the synthetic adduct (14.1 min). It should be noted that this adduct
has the hydroxylamine structure (Figure 3.9) rather than nitroxyl structure seen in the 
ESR spectrum.
a OHg-C—M'oh CH,
Figure 3.9 Postulted structure of the adduct from the microsomal metabolism of_N,N- 
dimethy 1 benzamide in presence of PBN.
The other products of the microsomal reaction are reported in Table 3.2. 
Comparison of the UV spectra (recorded by a diode array detector) of the synthetic PBN- 
Njvî-dimethylbcnzamide adduct with that of the peak with retention time 14.1 minutes in 
the chromatogram obtained for the microsomal reaction, illustrated in Figure 3.12 
provides confirmatory evidence that the two structure are identical. Moreover, such a 
product is formed only in incubations were PBN is present and where metabolism of the 
substrate occurs (Figure 3.10).
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F ig u re  3.10 HPLC chromatograms of microsomal incubations of 5 mM N,N 
dimethylbenzamide carried out (a) without, (b) with 15 mM PBN, and (c) of microsomal 
incubations of 15 mM PBN carried out without substrate.
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F igure 3 .1 1  HPLC chromatogram of the standard PB N-N,N-di methyl benzamide 
adduct.
Peak Compound identified
Retention time: 6.5 m inutes N -m ethyl-N -hydroxym ethyl"
benzamide
Retention time: 7.7 m inutes N-methyl benzamide
Retention tim e: 11.1 m inutes N,N-dimethyl benzam ide
Retention tim e: 14.1 m inutes PBN-N,N-dimethyl benzam ide 
adduct
Retention tim e: 15.5 m inutes PBN
Table 3 .2  Products identified from the HPLC analysis of a 30 minutes microsomal 
incubation of 5 mM N,N-dimethyl benzamide carried out in presence of 15 mM PBN.
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F igure 3 .12  Diode array UV spectra of the PBN-adduct produced (a) during 
microsomal oxidation of 5 mM NJ\f-dimethyl benzamide in presence of 15 mM PBN and 
(b) synthetically.________________________________
In conclusion, the microsomal metabolism of N.N-dimethiylbenzamide involves 
the abstraction of a hydrogen atom from the carbon atom a  to nitrogen to form a carbon- 
centred radical that is trapped intermolecularly by PBN or undergoes insertion of a 
hydroxyl group leading to the formation of the carbinolamide product.
3.2.2 Effect of PBN on the  m icrosom al metabolism of N ,N -dim ethyl 
benzamide
Inspection of the chromatograms in higure 3.10 reveals that the presence of 
PBN lowers the relative amounts of both the usual N-methyl- and N-hydroxymethyl-N- 
methylbenzamide products formed. Thus, the effect of PBN on the microsomal
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metabolism of N,N-dimethylbenzamide was studied in more detail. Microsomal
incubations were performed (i) using varying concentrations of PBN at a fixed substrate
concentration and (ii) using varying substrate concentrations at a fixed PBN
concentration. Table 3 3  reports the rates of N-methylbenzamide and adduct production in
the microsomal incubations of N,N-dimethylbenzamide involving a range of PBN
concentrations. Table 3.4 reports the corresponding rates of formation from incubation
performed in the presence of a fixed concentration of PBN.
The results demonstrate that the formation of N-methyl benzamide decreases with 
increasing concentration of PBN until 30 mM, whereas the rate of formation of the PBN 
adduct increases. However, the total rate of metabolism does not change in this range of 
PBN concentrations. In contrast, at a fixed concentration of PBN, an increase in the 
substrate concentration leads to a corresponding increase in the rate of formation of both 
products.
[PBN ]
(mM)
T otal m etabolism
(mM/h/nmol P450)
N -m ethyl
benzam ide
(mM/h/nmol P450)
P B N -N ,N -
d im ethy l 
benzam ide a d d ac t
(mM/h/nmol P450)
0 .0 2.33 ± 0.10 2.33 ± 0.10 0.00
0 .5 2.35 ± 0.06 2.20 ± 0.07 0.15 ±0.01
1 .0 2.33 ± 0.06 2.10 ±0.04 0.23 ± 0.02
5 .0 2.30 ± 0.07 1.87 ± 0.05 0.33 ± 0.08
10.0 2.26 ± 0.06 1.60 ±0.04 0.66 ± 0.03
3 0 .0 2.30 ±0.11 1.29 ±0.11 1.00 ± 0.10
100.0 1.60 ± 0.07 1.15 ± 0.16 0.45 ± 0.14
Table 3 . 3 Rates of the microsomal metabolism of 5 mM N JM^dimethylbenzamide in the
presence of varying concentrations of PBN.
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[Substrate]
(mM)
Total m etabolism
(mM/h/nmol P450)
N -m ethyl
benzam ide
(mM/h/nmol P450)
P B N -N ,N -
dim ethy l
benzam ide
adduct
(mM/h/nmol P450)
0 .5 0.55 ± 0.03 0.39 ± 0.02 0.16 ± 0.01
1 .0 0.91 ± 0.07 0.71 ± 0.04 0.20 ± 0.03
5 .0 2.00 ±0.11 1.50 ± 0.08 0.50 ± 0.09
10.0 2.30 ±0 .14 1.60 ±0.11 0.70 ± 0.04
50 .0 2.61 ± 0.14 2.00 ± 0.06 0.61 ± 0.03
100.0 2.66 ± 0.16 2.18 ±0.11 0.48 ± 0.05
Table 3 .4  Rates of microsomal metabolism of varying concentration of N,N- 
dimethylbenzamide in the presence of 30 mM PBN.
Figure 3.13 shows the time-course of the microsomal metabolism of 10 mM 
N,N-dimethylbenzamide incubated in the presence and absence of 30 mM PBN. From 
these results it is quite clear that the presence of PBN does not interfere with the total 
metabolism of the substrate. The results also indicate that, at the concentrations used in 
the previous part of the study, PBN does not inhibit the metabolism of N,N- 
dimethylbenzamide. However, it does change the pattern of the products, as the carbon- 
centred radical intermediate is partially trapped by PBN (leading to the formation of the 
PBN-adduct) and partially undergoes hydroxylation (to give the N-demethylated 
product).
Although the coupling reaction that leads to the formation of the PBN-adduct is 
reported to be fast,^ it is logical to argue that the addition of the hydroxyl group to the 
carbon-centred radical from the P450-haem oxoiron complexes is a more favoured 
reaction. As an indication the ratio of N-methylbenzamide produced with respect to PBN- 
adduct is 3 > 1. Formation of the intermediate radical occurs in the hydrophobic 
environment of the active site of the enzyme where, even if the non-polar characteristics
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of PBN enables it to accumulate sufficiently to react with the intermediate, the relative
position of the radical with respect to the activated haem group favours the hydroxyl
insertion reaction.
1250
1000-
750-
t •  • • • • • •
S  500- -O
250-
10050 75250
N-methyl benzamide 
from incubation A
N-methyl benzamide 
from incubation B
PBN-adduct 
from incubation B
Total metabolism 
from incubation B
Time (minutes)
Incubation A: Microsomes + NADPH regenerating system 
+ N,N-dimethyl benzamide 10 mM
Incubation B: Microsomes + NADPH regenerating system
+ N,N-dimethyl benzamide 10 mM +PBN 30 mM
F igure  3 .1 3  Time-course of the microsomal metabolism of 10 mM N,N-dimethyl 
benzamide curried out in presence and in absence of 30 mM PBN
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3.3 Comparison o f spin-trapping and intermolecular trapping
A comparison between intramolecular trapping and intermolecular PBN trapping 
was made using the substrates illustrated in Figure 3.14.
c x i - c  a *
N,N-dimetliyl-*2-liydro3^ben2amide N-(3-bDtenyl)-N-tnetliylbenzaiiiide 
N-(3-butynyl)-N-methylbenzamide
Figure 3 .14  Substrates used to compare intermolecular PBN-trapping with 
intramolecular trapping_______________________
Figure 3.15 shows the typical ESR spectra obtained from extracts of the 
microsomal incubations of 10 mM N,N-dimethyl-2-hydroxybenzamide performed in the 
presence of 30 mM PBN. Control incubations confirm that the signal is due to a 
metabolism-dependent PBN radical adduct.
106
CHAPTER 3
li/C
a) b)
H/G
H/G
d)
F igure  3 .15  ESR spectra of chloroform/methanol extracts from incubation of (a) 
microsomes, NADPH regenerating system and 30 mM PBN (control), (b) microsomes, 
10 mM N,N-dimethyl-2-hydroxybenzamide and 30 mM PBN (control), (c) NADPH 
regenerating system, 10 mM N,N-dimethyl-2-hydroxybenzamide and 30 mM PBN 
(control) and (d) microsomes, NADPH regenerating system. 10 mM N,N-dimethyl-2- 
hydroxybenzamide and 30 mM PBN.
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The spectrum is a typical triplet of doublets with hyperfine parameters 3 ^= 15 G
and apH= 6.0 0 . Comparison of these data with those obtained from N,N- 
dimethylbenzamide (Figure 3.6 and Table 3.1), leads to the conclusion that this spectrum 
is due to a carbon-centred radical-PBN adduct. These results provides a further indication 
that metabolism of N,N-dimethyl-2 -hydroxy benzamide occurs via the formation of a 
carbon-centred radical and not an iminium ion.
Typical ESR spectra obtained from chloroform/methanol extracts of microsomal 
oxidation of 10  mM N-(3-butenyl)-N-methylbenzamide and N-(3-butynyl)-N- 
methylbenzamide in the presence of 30 mM PBN are reported in Figures 3.16 and 3.17, 
respectively.
For both substrates microsomal incubation produces a PBN adduct radical 
characterised by a triplet of doublets with hyperfine splitting parameters of aN= 14.8 0  
and apH= 6 .0  G (from N-(3-butenyl)-N-methylbenzamide and aN= 14.75 G and ap"= 6 .3  
G (from N-(3butynyl)-N-methylbenzamide. These data imply that metabolism of these 
substrates produced a carbon-centred radical that is trapped by PBN. It is worth 
emphasising that metabolism of N-(3-butenyl)-N-methylbenzamide yields a carbon- 
centred radical that is trapped by PBN intermolecularly, but not intramolecularly by the 
alkene functional group (Chapter 2 ).
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F igure 3.16 ESR spectra of chloroform/methanol extracts from incubation of: (a) 
microsomes, NADPH regenerating system and 30 mM PBN (control), (b) microsomes, 
10 mM N-(3-butenyl)-N-methylbenzamide and 30 mM PBN (control), (c) NADPH 
regenerating system, 10 mM N-(3-butenyl)-N-methylbenzamide and 30 mM PBN 
(control), and (d) microsomes, NADPH regenerating system, 10 mM N-(3-butenyl)-N- 
methylbenzamide and 30 mM PBN.___________________
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Figuré 3 .17  ESR spectra of chloroform/methanol extracts from incubation of: (a) 
microsomes, NADPH regenerating system and 30 mM PBN (control), (b) microsomes, 
10 mM N-(3-butynyl)-N-methylbenzamide and 30 mM PBN (control), (c) NADPH 
regenerating system, 10 mM N-(3-butynyl)-N-methylbenzamide and 30 mM PBN 
(control), and (d) microsomes, NADPH regenerating system, 10 mM N-(3-butynyl)-N- 
methylbenzamide and 30 mM PBN.___________________________
3.5 Conclusions
The intermolecular spin trapping technique is a successful tool for the detection 
of the radical intermediates formed during the microsomal P450 metabolism of tertiary 
amides. These intermediates have been identified as carbon-centred radicals, giving 
further support to a mechanism involving hydrogen atom abstraction as the first step in 
the P450-dependent metabolism of tertiary amides.
The spectra of the trapped radicals exhibit a triplet of doublets characteristic of a 
nitroxyl radical. The triplet splitting is due to interaction with the nitrogen atom, and
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reported values of aj\j= 14 / 15 G for PBN-trapped carbon ra d ic a l,a re  consistent with
our interpretation of the present results. The doublet structure is due to the coupling of the
p-hydrogen atom, for which apH is reported to be between 2.5 and 4 G for acyl
radicals.-® The values obtained in the present study are somewhat larger, probably due to
the different polarities of the solvent used in this study (chloroform/methanol, 2 / 1) and
that used in analogous investigations (benzene).
The PBN adduct of the carbon-centred radical generated during the microsomal 
metabolism of N,N-dimethylbenzamide was characterised and shown to have the 
structure illustrated in Figure 3.18.
F igure  3 .1 8  Structure of the PBN-adduct formed during microsomal metabolism of 
N,N-dimethylbenzamide.__________________________________________
It has been reported that PBN interacts with P450 to give a type I binding 
spectrum with microsomes from phenobarbital-treated rats, and to have an inhibitory 
effects on the mixed-function oxidation of aminopyrene.^ However, kinetic investigation 
revealed that PBN does not inhibit the overall metabolism of N.N-dimethylbenzamide but 
diverts the reaction to form a new product that is an adduct of PBN and the amide. It 
follows that PBN traps a reaction intermediates, but does not affect the formation of the 
intermediate.
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CHAPTER 4
The regioselectivity of the microsomal metabolism of tertiary amides
The present chapter describes the studies related to the regioselectivity of the 
oxidation of three cyclic amides using the following models:
• semi-empirical AMI molecular orbital calculations,
• P450 biomimetic system,
• rat liver microsomes.
4.1 Introduction
The regioselectivity of biotransformations catalysed by P450 appears to be 
substrate dependent. For example, no regioselectivity is observed in some P450- 
dependent carbon oxidation reactions, as, for example, in the metabolism of norbomane^ 
or in the 5-exohydroxylation of camphor by bacterial P450cam-^ For these reactions, it is 
suggested that the species responsible for the hydrogen abstraction step has access to both 
the pro S and the pro R protons. In contrast, regioselectivity was found for the 
hydroxylation of the E- versus Z- methyl groups in the P450 metabolism of olefins such 
as R(+) pulegone,^ as well as in the metabolism of testosterone and androsterone by 
certain P450 isoenzymes.^ In amines, regioselectivity has also been reported. For 
example, in (S)-nicotine there is preferred abstraction of the 5 '-pro S hydrogen atom,5 
while for tertiary amines such as N-methyl-N,N-diisopropylamine,^ the regioselectivity 
appears to be governed by steric factors.
The N,N-dimethylamides, and the equivalent N,N-diaIkylamides, have non­
equivalent (alkyl) methyl groups (i.e. E- and Z- isomers) as illustrated in Figure 4.1. 
Thus, it is conceivable that two P450-substrate interactions are possible; one that is not 
regioseleetive, the other where E/Z regioselectivity could occur.
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E Fe . Non-regioseiectivity model
Figure 4.1 Hypothetical active site interactions of the “iron-oxo” intermediate of 
P450.
It is reported that, on the basis of AMI self-consistent field molecular orbital 
calculations, abstraction of a hydrogen atom from the methyl group E- to the carbonyl 
oxygen atom is energetically favoured by oa. 5 kj/mol’  ^ over similar hydrogen atom 
abstraction from the Z-methyl group.^ However, at the product level such regioselectivity 
might be obscured by amide bond rotation. While amide bond rotation in aqueous 
solution is faster than P450 tumover,^ it is not known if amide bond rotation can occur 
within the enzyme substrate complex. What is known is that, in solutiori the amide 
rotation rate increases as solvent polarity decreases ^ and that the active site of the closely 
related bacterial P450cam is very n o n - p o la r .^ 0  Therefore, purely on polarity 
considerations, it would seem unlikely that amide bond rotation in the active site would be 
slow enough to give observable regioselectivity. However, it is quite conceivable that the 
enzyme would impose steric constrains on amide bond rotation in the enzyme-substrate 
complex. If P450 is absolutely regiospecific for the E- (or Z-) methyl group, amide 
rotation in the active site is essentially zero.
On the basis of these considerations we chose to investigate the regioseleetive 
aspects of the P450-dependent oxidation of tertiary amides using the series of cyclic 
substrates illustrated in Figure 4.2. These substrates possess fixed conformations due to 
almost completely restricted rotation about the C-N bond.
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1
CH3
N-methyl-2-pyrrolidinone
a
1
CH3
N-methyl-2-piperidinone
Qo
CH3
N-methylcaprolactam
F igure  4 .2  Fixed conformation amides used in the study of the regioselectivity of the 
P450-dependent oxidation of tertiary amides.
These substrates can, theoretically, undergo P450 oxidation in the E- and Z- 
alkyl groups to form two clearly identifiable products (Figure 4.3). The primary oxidation 
products 2 and 3 of Figure 4.3 (a), resulting from N-demethylation and ring 
hydroxylation respectively, potentially can both undergo further metabolism to give the 
secondary product 4 of figure 4.3 (b). Whether these additional pathways occur, and if 
they do, which of the two routes also form the subject of the current investigation.
, /(CH 2)„ /-(C H ^n  C H zO  .( C H jn
1
CHg
1
CH2OH (2)
r(CH2)n
CH3
(3)
(a)
n= 1 
n= 2  
n= 3
/(CH2)n
1 . x .
r(CH2)n
( . . XN" 'OO '  'N '
CH3
I  ,
r(CH2)„ CH2O ,(CH2)„ 
I I
CH2 OH H
(b)
n= 1 
n= 2  
n=3
Figure 4.3 Potential metabolic pathways of the P450-dependent oxidation of cyclic 
amides.
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Three lines of investigations were adopted. First semi-empirical AMI self-
consistent field molecular orbital calculations were performed on the potential radical 
species to identify the most favourable pathway from a thermodynamic point of view. 
Second oxidation of the compounds catalysed by the TPPFe(f^^)//gr/-tbutylhydroperoxide 
P450 biomimetic system was carried out to identify the most oxidisable position from a 
chemical point of view. Finally, the results of the chemical model and the MO calculations 
were compared with those obtained for the microsomal oxidation of these substrates.
4.2 AMI Molecular orbital calculations
Using the semi-empirical AMI self-consistent field molecular orbital model, the 
heats of formation (AHf) were calculated for the amides illustrated in Figure 4.2 and for 
their postulated intermediates. The assumption made for these calculations based on the 
results of the previous chapter, is that the reaction involves abstraction of a hydrogen 
atom from a-carbon to form a carbon-centred radical. The values obtained are 
summarised in Table 4.1.
These heats of formation clearly indicates that the abstraction of the hydrogen 
atom is much more favoured from the ring carbon (E- position) than that of the N-methyl 
group (Z- position). Similar results have been reported before for acyclic N,N- 
dialkylbenzamides, though the differences between the E- and Z- radicals in the present 
case are somewhat greater (98.2 to 102.8 kJ/mopl, E- versus Z- for N,N- 
dimethylbenzamide as opposed to 93.1 to 99.3 kJ/mol’l, E- versus Z- for N-methyl-2- 
pyrroiidinone). Presumably, this is due to the cyclic nature of the E- radical. Using the 
differences in the heats of formation between the starting materials and the radicals 
(A AHf) as an estimate for the differences in the energy barrier to reaction, the ratio of the 
constants for ring and N-methyl carbon-centred radical formation could be calculated 
(Chapter 8 ).
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AHf(kJ/mol*l)
/”(CH2)n(A. n=ln= 2 -168.5-201.9
1
CHa n=3 -215.9
/-(CHgln n=l
n= 2
-75.35
-129.30
1
CH3 n=3 -134.1
/-(CH2)n(A. n=l . n= 2 -69.2- 100.8
1
.CHg n=3 -1 1 2 .0
Table 4 ,1  Heats of formation, AHf, for the cyclic amides and their corresponding 
radicals.
The data are contained in Table 4.2 and indicate that ring hydrogen abstraction is 
favoured by a large factor over the N-methyl hydrogen abstraction. Moreover, the size of 
the ring seems to play a significant role in favouring the hydrogen atom abstraction from 
the E- position, at least on thermodynamic grounds, though there is not a clear 
relationship between ring size and the calculated ratio.
Ring radical/N-methyl rad ical
/“(CHaln(A.
1
CH3
n=l 12 
n=2 100878 
n=3 7376
1 able 4 . 2  Ratio of estimated rate constants for E/Z hydrogen atom abstraction calculated 
from the difference in the heats of formation, A AHf
1
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4.3 Biomimetic O xidation
• Identification of the  products
Biomimetic oxidations were analysed by treating the reaction mixtures with IM 
sodium hydroxide in methanol to hydrolyse carbinolamides to the corresponding 
amidesJ: Samples were divided into two fractions. One was analysed directly by gas
chromatography (for the N-methyl products) while the second was derivatised using 
MTBSTFA (N-methyl-N-tert-butyldimethylsilyltrifluoroacetamide) before analysis (for 
the N-dealkylated products). More detailed description of the GC analysis and sample 
preparation is reported in the Experimental section).
Typical gas chromatograms obtained after 60 minutes of TPPFe(III) catalysed 
oxidation of 10 mM solutions of the amides are reported in Figure 4.4 (for the direct GC 
analysis) and Figure 4.5 (for the GC analysis of the derivatised nor-lactams products). 
The compounds corresponding to the peak found in each chromatogram were identified 
by comparison of the retention times and mass spectra with those of synthetic standards. 
The identified products are reported in Tables 4.4 and 4.5.
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F igure 4 .4  Gas chromatograms of underivatised samples from the biomimetic 
oxidation of (a) N-methyl-2-pyrrolidinone, (b) N-methyl-2-piperidinone and (c) N- 
methylcaprolactam.
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 1 1
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F igure 4 .5  Gas chromatograms derivatised samples from the biomimetic oxidation of 
(a) N-m ethyl-2-pyrrolidinone, (b) N-methyl-2-piperidinone and (c) N- 
methylcaprolactam________________________________
Peak C om pounds
id en tified
Peak C om pounds
id en tified
Chromatogram a) 
Retention time: 
4.43 m inutes
N -m eth y l-2 -
p y rro lid in o n e
Chromatogram a) 
Retention time: 
2 .6 6  m inutes 1CHs
N-methylsuccinimide
Chromatogram b) 
Retention time; 
3.30 minutes
N -m e th y l-2 -
p iperid inone
Chromatogram b) 
Retention time: 
3.67 m inutes 1
CH3
N-methyl gl utari mide
Chromatogram c) 
Retention time: 
5.57 minutes
N -m ethy l
caprolactam
Chromatogram c) 
Retention time: 
6.29 m inutes
CH3
N-methyladipimide
Table 4 .3  Products of the biomimetic oxidation of N-methyI-2-pyrrolidinone, N- 
methyl-2-piperidinone and N-methylcaproIactam identified without derivatisation.
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The results can be summarised as follows. Biomimetic oxidation of all three
amides gives three products; the imide product of ring oxidation, the N-dealkylated
product, and the norimide product of both ring oxidation and dealkylation. Since the
formation of the latter product can occur by two routes, i.e. oxidation of both first
products 2 and 3 of Figure 4.3, the biomimetic oxidation of such compounds was
investigated further.
Peak C om pounds
iden tified
Peak C om pounds
identified
Chromatogram a) 
Retention time; 
8.87 m inutes 2 -pyrrolidinone
Chromatogram a) 
Retention time: 
9.56 m inutes
H
succinimide
Chromatogram b) 
Retention time: 
7.53 m inutes
Cl
H
0 -valerolactam
Chromatogram b) 
Retention time: 
1 0 .6 8  m inutes
n
H
glutarimide
Chromatogram c) 
Retention time: 
12.94 m inutes
o,
H
caprolactam
Chromatogram c) 
Retention time: 
13.32 m inutes
n O
H
adipimide
T able 4.4 Products of the biomimetic oxidation of N-methyl-2-pyrrolidinone, N- 
methyl-2-piperidinone and N-methyl caprolactam identified after derivatisation.
Biomimetic oxidations of N-methylsuccinimide, N-mcthylglularimide and N- 
methyladipimide, and of 2 -pyrrolidinone, 0 -valerolactam, were carried out and analysed 
by GC after derivatisation since the aim of this investigation was the identification of the
ion
 ________________________________________________________________  CHAPTER 4
norimine (product 4 of Figure 4.3). Typical gas chromatograms obtained after 60 minutes
are reported in Figures 4.6 and 4.7, while Tables 4.5 and 4.6 detail the identified
compounds. Product identification relied upon comparison of retention times and mass
spectra of the products with that of synthetic standards.
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F igure  4 .6  Gas chromatograms from the biomimetic oxidation of (a) N- 
methylsuccinimide, (b) N-methylglutarimide and (c) N-methyladipimide, obtained from 
MBTSTFA-derivatised samples.
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F igure 4 . 7  Gas chromatograms from biomimetic oxidation of (a) 2-pyrrolidinone, (b)
0-valerolactam and (c) adipimide, obtained from MBTSTFA-derivatised samples.
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Peak Com pounds identified
Chromatogram a) 
Retention time: 9.56 m inu tes succinim ide
Chromatogram b) 
Retention time: 10.68 m inu tes glutarim ide
Chromatogram c) 
Retention time: 13.32 m inu tes adipimide
Table 4 .5  Identified products from the biomimetic oxidation of N-methylsuccinlmide, 
N-methylglutarimide and N-methyladipimide.
Peak . Com pounds identified
Chromatogram a) 
Retention time: 8.87 m inu tes 2 -pyrroiid inone
Chromatogram a) 
Retention time: 9.56 m inutes succinim ide
Chromatogram b) 
Retention time: 7.53 m inutes 0 -valerolactam
Chromatogram c) 
Retention time: 12.94 m inu tes caprolactam
Table 4 .6  Identified products from the biomimetic oxidation of 2 -pyrrolidinone, ô- 
valerolactam and caprolactam._____________________ _________________ ___________
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It is interesting to note that formation of glutarimide and adipimide is observed
from the biomimetic oxidation of N-methylglutarimide and N-methyladipimide 
respectively whereas these compounds are not observed in the oxidation o f the 
corresponding 6 -valerolactam and caprolactam. In contrast, biomimetic oxidation of both 
N-methyl succinimide and 2-pyrrolidinone lead to the formation of succinimide.
Thus, biomimetic oxidation of N-methyl-2-pyrrolidinone leads to the formation 
of succinimide can potentially occur vw both N-demethylation of N-methylsuccinimide or 
ring oxidation of 2-pyrrolidinone. However, similar biomimetic oxidation of N-methyl-2 - 
piperidinone and N-methylcaprolactam yields glutarimide or adipimide only via the initial 
N-demethylation.
• Reaction kinetics
The time-courses of the biomimetic oxidation of 5 mM solutions of the amides 
were studied over an interval of 2 hours. These are presented in Figure 4.8 and refer to 
the main metabolite produced, i.e. the primary ring oxidation compounds. The reactions 
present a fairly linear rate of formation of products within the first 30 minutes followed 
by a gradual decrease over the remaining time of the reaction. This is probably due to the 
degradation of the catalyst. Indeed, side reactions such as catalyst auto-oxidation (as 
indicated by catalyst bleaching) and solvent oxidation are reported. 12 These are known to 
result in the observed emphatic 'tailing-off in the reaction progress. Thus, the time 
chosen for the determination of the initial rates of the reaction, vi, for all these biomimetic 
oxidations was the first 20 minutes. This reaction time provides a good compromise 
between the need to determine the products in the initial linear phase and the formation of 
a measurable quantity of metabolites.
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F igu re  4 .8  Time-course for the formation of the major product in the biomimetic 
oxidations of 5 mM N-methyl-2-pyrrolidinone, N-methyl-2-piperidinone and N- 
methylcaprolactam.____________________________
The initial rates for the biomimetic oxidation of these substrates were determined 
at various concentrations of the substrates (ranging between 0.02 and 10.0 mM) and 
these are reported in Tables 4.7-4.9. The reproducibility of these values was ±5 %.
[S ubstra te]
(mM)
N-
m ethylsuccinim ide
(mM/h/mmol cat.)
2 -pyrroIid inone
(mM/h/mmol cat)
succinim ide
(mM/h/mmol cat.)
0 .0 2 0.034 ± 0.002 0.003 ± 0.001 0.014 ± 0.003
0 .1 0 0.170 ± 0.012 0.013 ± 0.003 0.061 ± 0.005
1 .0 0 1.510 ±0.110 0.116 ± 0.006 0.260 ± 0 .0 2 1
3.00 3.630 ± 0.210 0.288 ± 0 .0 1 1 0.342 ± 0.041
5.00 5.020 ± 0.500 0.404 ± 0.021 0.365 ± 0.033
1 0 .0 7.100 ± 0.800 0.565 ± 0.026 0.384 ± 0.018
Table 4 .7  Initial rates, vi, of product formation for the biomimetic oxidation of N- 
methyl-2 -pyrrolidinone.
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[Substrate]
(mM)
N-
methylglutarimide
(mM/h/mmol cat.)
0-valerolactam
(mM/h/mmol cat)
glutarimide
(mM/h/mmol cat.)
0 .0 2 0.112 ±0.004 1.99 • 10-5 ± 1 • 10-6 0.074 ± 0.002
0 .1 0 0.544 ±0,104 9.86 • 10-5 ± 3-10-6 0.345 ± 0.008
1.0 4.187 ±0.260 8.79 • 10^ ± 1.9-10-5 1.900 ± 0.230
3.00 8.300 ±0.210 0.0021 ± 0.0005 3.087 ±0.315
5.00 10.335 ± 0.400 0.0029 ± 0.0003 3.466 ± 0.230
1 0 .0 12.659 ± 0.880 0.0042 ± 0.0006 3.820 ±0.181
Table 4 .8  Initial rates, Vi, of product formation for the biomimetic oxidation of N- 
methyl-2 -piperidinone.
[Substrate]
(mM)
N -m ethyl
adipimide
(mM/h/mmol cat.)
caprolactam
(mM/h/mmol cat.)
adipimide
(mM/h/mmol cat.)
0 .0 2 0.054 ± 0.006 0.0015 ± 0.001 0.059 ± 0.008
0 .1 0 0.268 ± 0 .0 1 2 0.015 ± 0.005 0.289 ± 0.026
1 .0 2.451 ± 0.210 0.075 ± 0.004 2.293 ±0.119
3.00 6.168 ± 0.331 0.216 ± 0 .0 1 1 4.717 ±0.T76
5.00 8.85 ± 0.521 0.344 ± 0.016 5.981 ± 0.233
1 0 .0 13.15 ±0.811 0.621 ± 0.033 7.485 ± 0.385
Table 4.9 Initial rates, vj, of product formation for the biomimetic oxidation of N- 
methylcaprolactam.
Based on the qualitative results reported earlier, the formation of succinimide in 
the biomimetic oxidation of N-methyl-2-pyrrol idi none could arise from further oxidation 
of the primary products. Thus, the evaluate of the total amount of initial ring oxidation 
with respect to N-demethylation rate of formation of succinimide from N-
CHAPTER 4
methylsuçcinimide and from 2-pyrroIidinone was determinated. The results are reported 
in Table 4.10.
vi of succinim ide
(mM/h/mmol cat)
[Substrate]
(mM)
F rom
N-
m ethylsuccin im ide
From
2 -pyrro lid iuone
Rate ratio
0.5 0.788 ± 0.090 0.454 ± 0.040 1.74
3.0 3.120 ±0.096 1.930 ± 0.040 1.62
5.0 4.740 ± 0.250 2.986 ± 0.099 1.59
1 0 .0 5.110 ± 0.066 3.260 ± 0.090 1.57
Table 4 .10 . Values of the initial ratio, v,, of the formation of succinimide for the 
biomimetic oxidation of N-methylsuccinimide and 2-pyrrolidinone
The plot Vi of N-m ethylglutarim ide versus N-methyl-2-piperidinone 
concentrations, illustrated in Figure 4.9, is curved at a substrate concentration of ca 5.0 
mM. This apparent limiting of the reaction rate can be rationalised in terms of a saturating 
“enzyme-type” catalysis. Analysis of the data can be achieved using the Michaelis-Menten 
method. Kinetic parameters for the oxidation reactions, reported in Table 4 . 1 1 , were 
obtained from the data of Tables 4.7, 4.8 and 4.9 by using the Hanes plot. The Hanes 
plot was chosen because of its better reliability and it does not magnify any errors in the 
data points at low Vi and low substrate concentrations.
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Figure 4 ,9  Initial rate, Vi, o f N-methylglutarimide formation versus substrate 
concentration in the biomimetic oxidation of N-methyl-2-piperidinone.
The kinetic parameters reported in Table 4.11 for ring oxidation include the 
formation of glutarimide and adipimide since these products almost entirely arise from the 
N-demethylation of the primary products N-methylglutarimide and N-methyladipimide. 
The parameters for ring oxidation and N-demethylation include a partitioning of the 
formation of succinimide in a ratio of 1.62.
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Com pound N -dem ethylation  
(Z- oxidation)
Ring oxidation 
(£- oxidation)
N -m ethyI-2 -
pyrro lid inone
Vm axî 1.17 ± 0.07 
(mM/h/mmol cat)
K m î 7.31 ± 0.16 (mM'l) 
V m ax/ Km: 0.16
Vmax: 12.33 ± 0.47 
(mM/h/mmoI cat)
Km: 7.Ô4 ± 0.12 (mM"*) 
Vmax/ Km: 1.75
N -m ethyl-2 -
piperidinone
Vm ax: 0.007 ± 0.0004
(mM/h/mmol cat)
K m  7.00 ± Ô.3 (mM"*)
. Vm ax/ Km: 0 .0 0 1
Vmax: 16.33 ± 0.90
(mM/h/mmol cat)
Km: 2.90 ± 0.15 (mM *) 
Vmax/ Km: 5.62
N -m ethylcaprolactam
Vm ax: 0.320 ± 0.016 
(mM/h/mmol cat)
K m : 4.15 ± 0.18 (mM"*) 
Vmax/ Km: 0.077
Vmax: 29.90 ± 1.89
(mM/h/mmol cat)
Km: 4.82 ± 0.21 (mM"*) 
Vmax/ Km: 6.19
Table 4 .1 1  Kinetic parameters Vmax. Km and Vmax/Km calculated for the biomimetic
oxidation of N -m ethyI-2-pyrrolidinone, N-m ethyl-2-piperidinone and N- 
methylcaprolactam.
The kinetic parameters obtained from these reactions indicate that, for all the 
amides a regioselectivity for the abstraction of the hydrogen atom from the E- carbon is 
preferred by a large factor. The ratio of the regiopreference in these biomimetic oxidations 
is summarised in Table 4.12. The data obtained are in excellent agreement with those 
obtained from the semi-empirical AM 1 calculations (Table 4.2).
TOO
S ubstra te
Ring oxidation (E)
vs
N-demethylation (Z)
N -m ethyl-2 -p y rro lid in o n e 10.9
N -m ethyI-2-p iperid inone 5620
N -m ethylcaprolactam 80 .4
Table 4 .1 2  Ratios of the ring oxidation versus N-demethylation for the biomimetic 
oxidation of N -m ethyl-2-pyrrolidinone, N-m ethyl-2-piperidinone and N- 
methylcaprolactam.
In conclusion, for the chemical catalysed oxidation of the three cyclic amides 
thermodynamic factors are the main, if not the only, driving force in determining the 
reaction profile.
4.4 M icrosomal oxidation
• Identification of the products
The three cyclic substrates were incubated with phenobarbital-induced rat liver 
microsomes in presence of a NADPH regenerating system. Product identification 
involved treating samples of the reaction mixture with 1.0 M aqueous sodium hydroxide 
(to hydrolyse any carbinolamides formed) then splitting the samples in two, one of which 
was analysed directly by GC while the other was derivatised by MTBSTFA before 
analysis.
Typical gas chromatograms, obtained after 30 minutes from samples with and without 
derivatisation, for the microsomal oxidations of 5 mM N-methyl-2-pyrrolidinone, N- 
methyl-2-piperidinone and N-methylcaprolactam are reported in Figures 4 .1 0 , 4 .1 1  and 
4.12, respectively. The products corresponding to each peak in the chromatograms were 
identified by comparison of their retention times and mass spectra with synthetic 
standards. Table 4.13 summarises the identified metabolites for the three amides 
analysed.
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F igu re  4 .1 0  GC analysis of the products of microsomal oxidation of 5 mM N-methyl
2-pyrrolidinone obtained from a) underivatised and b) MTBSTFA-derivatised samples.
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F igure  4 .1 1  GC analysis of the products of microsomal oxidation of 5 mM N-methyl 
2-pipcridinone obtained from a) underivatised and b) MTBSTFA-derivatised samples.
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F igure 4 .1 2  GC analysis of the products of microsomal oxidation of 5 mM N- 
methylcaprolactam obtained from a) underivatised and b) MTBSTFA-derivatised 
samples.
S ubstrate Peak C om pound
iden tified
Peak Com pound
iden tified
N -m ethyl-2-
pyrro lid inone
Chromatogram 
a) Figure 4.10 
4.43 m in.
N -m ethyl-2-
p y rro lid in o n e
Chromatogram 
b) Figure 4.10 
8.87 min.
2 -p y rro lid in o n e
N -m ethyl-2-
pyrrolid inone
Chromatogram 
a) Figure 4.10 
2 .6 6  m in.
N -m ethy l
succin im ide
Chromatogram 
b) Figure 4.10 
9.56 min.
Succin im ide
N -m ethyl-2-
piperldlnone
Chromatogram 
a) Figure 4.11 
3.16 m in.
N -m ethy l-2 -
p ip erid in o n e
Chromatogram 
b) Figure 4.11 
7.35 min.
0-VaIerolactam
N m ethyl-2 - 
piperid lnone
Chromatogram 
a) Figure 4,11 
3.52 m in.
N -m ethy l
g lu tarim ide
Chromatogram 
b) Figure 4.11 
1 0 .6 8  min.
G lutarim ide
N -m ethyl
caprolactam
Chromatogram 
a) Figure 4.12 
5.60 m in.
N -m ethy l
caprolactam
Chromatogram 
b) Figure 4.12 
12.94 min.
C aprolactam
N -m ethyl
caprolactam
Chromatogram 
a) Figure 4.12 
6.31 m in.
N -m ethyl
ad ip im ide
Chromatogram 
b) Figure 4.12 
13.32 min.
A dipim ide
Table 4.13 Identified metabolites from the microsomal oxidation of N-methyl-2- 
pyrrolidinone, N-methyl-2-piperidinone and N-methylcaprolactam.
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Control incubations confirmed that the products are metabolism dependent.
Figure 4.13 reports the gas chromatograms for 10 mM of a control incubation involving
N-methyl-2-piperidinone and microsomes but without the NADPH regenerating system.
3 - | gcr 3 , s .CO
1 1
2 - 2 -
I - 1 -
0 - b )L , , ,
0
I 1 1 ^ .
5 10 15 0
“ I —  1 1
5 10 15
minutes minutes
F igure 4 .13 . GC analysis of a control incubation for the microsomal oxidation of 10 
mM N-methyl-2-piperidinone: a) underivatised sample; b) MTBSTFA-derivatised 
sample.
The results indicate that microsomal metabolism of N-methyl-2-pyrrolidinone, 
N-methyl-2-piperidinone and N-methylcaproIactam leads to the formation of the same 
metabolites observed in the biomimetic oxidation of these compounds. No other 
substrate-derived products were identified under any different incubation condition. It is 
also worthy to note that ring oxidation of the substrates leads results in the'im ide 
formation while hydroxyl ring compounds were not identified in these reactions.
The presence of the secondary product of the metabolism for all these substrates, 
the norimide, requires an analysis as to which of the two potential metabolic pathways, 
illustrated in Figure 4.3 leads to these metabolite. Thus, microsomal incubations o f the 
primary metabolites 2 and 3 i o f Figure 4.3 were also carried out. Typical gas 
chromatograms of 5 mM incubations of these substrates are reported in Figures 4.14, 
4.15 and 4.16. As the norimide is the product of these reactions, gas chromatographic 
analysis was carried out only on derivatised samples.
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F igure 4 .1 4  GC analysis of the products of microsomal oxidation of 5 mM a) N- 
methylsuccinimide and b) 2-pyrrolidinone obtained from MTBSTFA-derivatised 
samples.
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F igure 4 .1 5  GC analysis of the products of microsomal oxidation of 5 mM a) N-
methylglutarimide and b) ô-valerolactam obtained from MTBSTFA-derivatised samples.
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F igure 4 .1 6  GC analysis of the products of microsomal oxidation of 5 mM a) N- 
methylcaprolactam and b) caprolactam obtained from MTBSTFA-derivatised samples.
As observed for the biomimetic oxidation of these compounds, glutarimide and 
adipimide are formed only from N-demethylation of N-methylglutarimide and N- 
methyladipimide respectively, whereas succinimide arises from both N-demethylation of 
N-methylsuccinimide and ring oxidation of 2-pyrrolidinone.
• Kinetic param eters
In a preliminary investigation, the rates of formation of the products of the 
microsomal oxidations of N-methyl -2-pyrrol idi none, N-methyl-2-piperidinone and N- 
methylcaprolactam were monitored over a 2 hours reaction period. Figure 4.17 shows the 
time-dependence of the formation of the main metabolites of the microsomal oxidations of 
3 mM solutions of the substrates.
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F ig u res  4 .17 . Time-course for the formation of 2-pyrrolidinone, ô-valerolactam and 
caprolactam from the microsomal oxidation of 3 mM N-methyl-2-pÿrrolidinone, N- 
methyl-2-piperidinone and N-methylcaprolactam.________________________________
The reactions present a linear phase over the first 20 minutes followed by a 
significant drop in catalytic activity. Thus, for all the reactions analysed the time chosen 
for the determination of the initial rates was 10 minutes. The initial rates, vj, for the 
formation of the metabolites of the microsomal oxidation of the three substrates at initialt
concentrations varying between 0.05 and 10 mM, determined by the GC method are 
given in Tables 4.14,4.15 and 4.16.
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[Substrate]
(mM)
N -m ethy l
succin im de
(mM/h/nmol P450)
2 -pyrro lid inone
(mM/h/nmol P450)
succin im ide
(mM/h/nmol P450)
0.05 0.119 ±0.008 0 .1 0 0  ±0.008 0.025 ± 0.002
0.5 0.927 ± 0.051 0.982 ±0.021 0 .2 0 1  ± 0 .0 2 1
3.0 5.755 ± 0.421 5.429 ± 0.308 1.151 ±0.090
5.0 9.019 ±0.816 8.512 ±0.564 1.971 ±0.142
1 0 .0 12.970 ± 0.790 14.824 ± 1.090 3.848 ±0.231
Table 4 .1 4  Initial ratio, vj, for the microsomal oxidation of N-methyl-2-pyrrolidinone.
[Substrate]
(mM)
N -m ethy l
g lu tarim ide
(mM/h/nmol P450)
ô-valerolactam
(mM/h/nmol P450)
glu tarim ide
(mM/h/nmol P450)
0.05 0.006 ± 0 .0 0 1 0.121 ±0.009 0.0003 ± 0.00002
0.5 0.059 ± 0.008 1.060 ± 0.033 0.003 ± 0.0008
3.0 0.312 ±0.016 6.356 + 0.219 0,016 ± 0,008
5.0 0.476 ± 0.032 7.398 ±0.561 0.026 ±0.006
1 0 .0 0.786 ± 0.012 10.264 ± 0.848 0.041 ± 0.001
Table 4 .1 5  Initial ratio, vj, for the microsomal oxidation of N-methyl-2-piperidinone.
[Substrate]
(mM)
N -m ethyl
adip im ide
(mM/h/nmol P450)
caprolactam
(mM/h/nmol P450)
adipim ide
(mM/h/nmol P450)
0.05 0.003 ± 0.0004 0.050 ± 0.006 4-10-5 ± 3 -  10-6
0.5 0 .0 2 1  ± 0 .0 0 2 0.506 ±0.018 0.0004 ± 0.00005
3.0 0.118 ±0.003 3.401 ±0.026 0.003 ± 0.0002
5.0 0.190 ± 0.006 5.100 ±0.019 0.0042 ± 0.0003
1 0 .0 0.389 ±0.011 11.300 ±0.056 0.009 ± 0.0006
Table 4 .1 6  Initial ratio, vi, for the microsomal oxidation of N-methylcaprolactam.
While for N-methyl-2-piperidinone and N-methylcaprolactam the formation of
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the norimide metabolite occurs only through one route, namely N-demethylation of the N- 
methylimide, for N-methyl-2-pyrrolidinone two metabolic routes are possible. Thus, the 
kinetic parameters for the formation of succinimide from N-methylsuccinimide and 2 - 
pyrrolidinone were also determined. Table 4.17 reports the values so obtained.
Vi of formation of Succinimide
(mM/h/nmol P450)
[Substrate]
(mM)
From
N -m ethyl
succinim ide
From
2-pyrrolidinone
Rate ratio
0.05 0.35 ± 0.021 0.066 ± 0.008 5.36
0.5 3.41 ± 0.260 0.66 ± 0.03 5.23
1.0 6.70 ± 0.360 1.31 ±0.23 5 .1 1
3.0 18.02 ± 0.940 3.82 ± 0.56 4.70
5.0 27.21 ± 1.320 6.20 ± 0.85 4.39
1 0 .0 44.06 ± 2.356 11.62 ±0.94 2.79
Table 4 .1 7  Initial rates, Vi, for succinimide formation in the microsomal oxidation of 
N-methylsuccinimide and 2-pyrrolidinone.
The Vi values were used to determine the kinetic parameters Vmax, Km and 
Vmax/Km for the microsomal oxidations, and these are reported in Table 4.18. As for the 
corresponding biomimetic reactions, the values are corrected for the known routes of 
formation of the norimide and expressed as ring oxidation and N-demethylation. Again, 
the kinetic parameters were calculated using the Hanes plot.
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Compound N-dem ethylation  
(Z- oxidation)
Ring oxidation 
(E- oxidation)
Z-/E-
N-methyl-2-
pyrrolidinone
^max- 57.37 ± 3.21
(mM/h/nmol P450)
Km: 0.029 ± 0.005 
(mM-l)
Vmax/Km:1999
Vmax: 61.35 ± 2.36
(mM/h/nmol P450)
Km: 0.025 ± 0.003 
(mM-l)
Vmax/ Km: 2399
Vmax: 0.93 
Vmax/Km: 0.83
N-methyl-2-
piperidinone
Vmax: 18.36 ± 1.56
(mM/h/nmol P450)
Km: 0.0077 ± 
O.OOOS (mM-l)
Vmax/ Km- 2436
Vmax: 2.36 ± 0.160
(mM/h/nmol P450)
Km: 0.0185 ±0.003 
(mM-l)
Vmax/ Km: 127
Vmax: 7.78 
Vmax/Km: 19.2
N-methyl
caprolactam
Vmax: 40.05 ± 3.12
(mM/h/nmol P450)
Km: 0.035 ± 0.006 
(mM-l)
Vmax/ Km: 1140
Vmax: 1.71 ±0.240
(mM/h/nmol P450)
Km: 0.040 ± 0.008 
(mM-l)
Vmax/ Km*. 42.8
Vmax: 23.45 
Vmax/Km: 26.82
Table 4 .1 8  Kinetic parameters calculated for the microsomal oxidation of N-methyl-2- 
pyrrolidinone, N-methyl-2-piperidinone and N-methylcaprolactam.
The results indicate that a regioselectivity for the Z- versus the E- alkyl group is 
present in the microsomal-dependent metabolism of these cyclic amides. In fact, in 
contrast to biomimctic oxidation microsomal metabolism of N methyl 2 pyrrolidinone 
displays a minor preference for the E- carbon with respect to the Z-. For the other two 
substrates the Z carbon atom is the preferred site of P450 metabolism, representing a 
total reversal of theoretical calculations and the observations from the biomimedc model. 
There appears to be relationship between the size of the ring and the preference for the Z- 
carbon, in contrast to the chemical model oxidations or semi-empirical AMI calculations.
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4.5 Conclusions
The results reported here demonstrate that all these substrates undergo 
biomimetlc and microsomal oxidation with the production of two primary metabolites, 
due to the oxidation of the E- and Z carbons, and a secondary metabolite formed by the 
subsequent oxidation of one or both of the primary metabolites. A major difference 
between the substrate employed is that for the 5-membered ring substrate N-methyl-2- 
pyrrolidinone, the formation of the norimide secondary metabolite arises from the 
oxidation of both primary metabolites, whilst the corresponding secondary metabolite 
from the 6 -and 7-membered ring substrates arises only from the oxidation of the N- 
demethylated primary intermediate.
An interesting difference for the microsomal metabolism of N-methyl-2- 
pyrrolidinone is also found between the presents results and those reported by Akesson 
and Jo n so n .l3  These authors have reported the formation of the 3-hydroxy-N- 
methylsuccinimide metabolite that was not found in the present study, while the N- 
demethylation product 2 -pyrrolidinone found in this study was not reported. 1 »^ 1  ^
Metabolism of N-methyl-2-pyrrolidinone studied in vivo is believed to lead to the 
formation of the main metabolite, 5-hydroxy-N-methyl-2-pyrrolidinone that is 
subsequently  transform ed into N-methylsuccinimide and 3-hydroxy-N- 
methylsuccinimide.13 The present results, obtained in vitro, suggest a quite different 
mechanism of oxidation. However, in the in vivo study of this compound, not all of the 
metabolites were identified, and 33 % of the administered dose of N-methyl-2- 
pyrrolidinone was not recovered. Other reports indicate in vivo formation of CO2 via 
and unidentified metabolic p a t h w a y . ^4 Thus, it is conceivable that in vivo, the N- 
demethylation of N-methyl-2-pyrrolidinone occurs through the formation of a 
carbinolamide that can, as is well k n o w n ,deg rade  to formaldehyde and subsequently 
CO2 .
Comparison of the analysis of the results obtained for the oxidation of these
n o
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three cyclic amides by the three different systems employed in this study reveals some
interesting observations. The energetically favoured hydrogen atom abstraction is from
the E- (ring) carbon. This predicted oxidation pattern is followed by the biomimetic
system whereas it is completely reversed by the microsomal system (Table 4.19).
Ring oxidation / N-demethylation M icrosomal
Z -selectivity
Compound M .O .
Calculation
Biom imetic
System
Microsomes
N-methyl-2-
pyrrolidinone
1 1 .9 1 0 .9 1.2 9 .0 8
N-methyl
-2-
piperidinone
16416 5 620 5620 1.1 • 105
N-methyl
caprolactam
8 6 .5 8 0 .4 0.037 2.17 • 103
Table 4 .1 9  Ratios of the E- (ring) versus Z- (N-methyl) oxidation obtained for the 
oxidations of N -m ethyl-2-pyrrolidinone, N-methyl-2-piperidinone and N- 
methylcaprolactam.
For microsomal system oxidations apparently there is no regioselectivity for the 
metabolism of the E- or Z alkyl groups in the five membered ring system, w here^ there 
is a marked increase in regioselectivity for the metabolism on the Z- carbon (N- 
demethylation) with increasing size o f the ring. However, for each compound 
comparison of the results from the biomimetic and microsomal reactions reveals that for 
all ring systems the microsomal reaction exhibits a marked preference for the Z- alkyl 
group.
Regioselectivity in P450-dependent reactions has been r e p o r t e d . ^ A n  
interesting case is the metabolism o f tertiary amines such as N-methyl-N,N- 
diisopropylamine.^ The aminium cation radical formed during the metabolism of this
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amine loses hydrogen exclusively from the N-methyl group. The regioselectivity of this 
reaction is postulated to be governed by steric factors, which restrict overlap of the p- 
orbital on the developing methine carbon radical of the N-isopropyl groups with the half- 
empty jt-orbital of the planar aminium radical. Regioselectivity of the P450-dependent 
metabolism of nicotine has been ascribed to the effects of the enzyme pockets.^ Iley and 
Constantino observed that in the microsomal-dependent metabolism of N-methyl-N- 
isopropylbenzamide N-demethylation is the preferred reaction despite being less favoured 
from a thermodynamic point of view.^^
A possible explanation of the results obtained in the present study could be that, 
in the microsomal oxidation of the three cyclic amides binding of the substrate to the 
active site of the enzyme occurs in such a way that the Z- N-methyl group is directed 
toward the haem plane. This would make the hydrogen atom more available for 
abstraction in a rate-limiting step of the reaction. The steric bulk of the substrate definitely 
seems to play an important role. Indeed, N-methylcaprolactam is the substrate with the 
bigger dimension and also the compound that shows the major Z- regiopreference. 
Certainly, the marked differences between the biomimetic and microsomal results point to 
a central role for the protein in the way the substrate is exposed to the haem. It is possible 
that these substrate-enzyme interactions are due to a hydrophobic pocket in the active site 
relatively close to the haem plane.
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CHAPTER 5 
Stereoselectivity in the oxidation of tertiary amides
The present chapter will describes the studies related to the stereoselectivity of 
the oxidation of tertiary amides using the following models:
• semi-empirical AMI molecular orbital calculations,
• P450 biomimetic system,
• rat liver microsomes.
5.1 Introduction
P450 enzymes exhibit stereoselectivity in a wide range of oxidation reactions. 
The oxidation of ir-bonded systems (olefins, acetylene and arenes) presents a marked 
enantioselectivity on depending of the P450 isoenzymes involved. For example 
polycyclic aromatic epoxides are produced with high enantioselectivity.L 2 ; 3 P450 is 
involved in the metabolism of arachidonic acid to a variety of oxygenated metabolites 
including epoxides and fatty acid alcohols,^; 5 different isoforms are reported to play a 
key role in the control of the stereoselectivity of the epoxidation.6; 7; 8
The P450-dependent oxidation of sulfur-containing compounds is also a-very 
common asymmetric transformation performed by these enzymes.^ In the oxidation of 
cyclic and acyclic sulfides catalysed by phenobarbital-induced rabbit liver P450 both the 
enantioselectivity and diastereoselectivity were modest. A preference for the R 
sulfoxidation product was observed in most cases, and in the presence of an electron 
withdrawing group oxidation at the methylene carbon occurred along with sulfoxidation 
leading to S-dealkylation.  ^^
Analysis of the P450-dependent metabolism of the amine nicotine indicated that 
phenobarbital-induced rat liver P450 presents a slightly but consistently lower metabolism
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The potential metabolic pathway for the oxidation of Rf+)- and ^(-)- N-methyl-
N-(l-phenylethyl)benzamide is shown in Figure 53. N-Dealkylation would be expected
be the more favoured route of oxidation, as to the presence of the benzylic ring enhances
hydrogen atom abstraction by stabilising the carbon-centred radical intermediate through
delocalisation.
a  ' Ç 0  ■
_  % -p-CHa
H 2  H . CHa
OX'O
•O H 'I
(7  HO
OH"
o ' t  • o
1
2 CH3
O I O
N-(l-phenylethyl)benzamlde
CH3
N-methyl benzamide acetophenone
Figure 5 .3 . Proposed pathw ay fo r the oxidation of N-methyl%N-(l 
phenylethyl)benzamide________________
The potential pathway for oxidation of R- and S- N-methyi-5-phenyl-2- 
pyrrolidinone is presented in Figure 5.4. This substrate is a structural analogue of the 
main nicotine metabolite, cotinine, the difference being that in cotinine the aryl ring is 3 ’- 
pyridyl rather than phenyl. Thus, the proposed pathway is based on the metabolism of 
c o t in in e ,a s s u m in g  that the different aryl rings do not elicit major metabolic 
differences. Thus, oxidation of N-methyl-5-phenyl-2-pyrrolidinone, is expected to 
involve either N-demethylation or N-dealkylation leading to the formation of products 2
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and 3, respectively. These could undergo further oxidation to give the product 4 . From 
the results obtained for N-methyl-2-pyrrolidinone (Chapter 4 ) formation of 4  is likely to 
arise from both oxidation routes.
CH2OH
N-methyi-2-pyrroUdinone
"OH"
HO,
H' CH:
(2)
N-methyl-4-oxo-4-phenyl
butanamide
H CH2
H +CH.O 
5-phenyl-2-pyrroUdinone
HO,
H 'CH2 OH
CH2O o
H H
4-oxo-4-phenyl
butanamide
F ig n re  5 .4  Potential pathway for the oxidation of N-methyl-5-phcnyl-2-pyrrolidinone.
The strategy adopted in this study followed that employed for the investigation 
of regioselectivity illustrated in Chapter 4. Namely» three models were used; AMI semi- 
empirical self-consistent field calculations, a biomimetic system and phenobarbital- 
induced rat liver microsomal P450. From the AMI calculations, a reaction model based 
on energetic considerations is made. This is subsequently tested using the biomimetic
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system. Finally, microsomal metabolism of the substrate probes was analysed. The
results from these three models were compared to clarify the main structural features of
these reactions.
5.2 AMI Molecular orbital calculations
Assuming oxidation of the substrates occurs via hydrogen atom abstraction 
from the a-carbon, the reaction involves formation of a carbon-centred radical. Semi- 
empirical AMI calculations were then made for the substrates and their carbon-centred 
radicals intermediates. Tables 5.1 and 5.2 report the results of the AMI calculations for 
R(+)- and S(-)-N methyl N (,1 phenylethyl)benzamidc, R- and S-N-methyl-5-phenyl-2- 
pyrrolidinone and their carbon centred intermediates, respectively. The enthalpies 
obtained allow a pathway for the oxidation to be predicted.
C om pound AHf (kj/m ol)
S .(-)-N -m ethyl-N -(l- 8 5 .1 1
phenylethyl)benzam ide
R (+ )-N -m eth y l-N -(l- 8 5 .0 8
phenylethyl)benzam ide
O
a  '£ .'0 151 .10
°  H,CH3
180.04
L/T -CH2 Ly
Table 5 .1  AHf values calculated by AM I for R(+)- and S(-)-N-methyl-N-(l- 
phenylethyl)benzamide and their corresponding radicals.
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Compound AHf (kJ/mol)
R-N-m ethyl-5-phenyl-2-
pyrrolidinone
- 42.76
S-N -m ethyl-5-phenyl-2-
pyrrolidinone
- 42.79
0 11.71
CH3
56 .9 3
CH2
5 6 .95
Table 5 .2  AHf values calculated by AMI for and S-N-methyl-5-phenyl-2- 
pyrrolidinone and their corresponding radicals.
As expected, no energetic differences are observed between the two enantiomers 
of either compound or their corresponding radicals. Thus implies that from a chemical 
viewpoint, there is no inherent preference for the oxidation of the R- or S- stereoisomers. 
However, there is a clear preference for formation of the N-alkyl centred-carbonj;entred 
radical compared with the N-methyl carbon centred radical. The ratio of the rate constants 
of these two potential reaction can be estimated from the differences between the AHf 
values of the radicals and the amide substrates. These ratios are given in Table 5.3.
Compound N-dealkylation/N-dem ethylation
R(+)- 110139
110150
Table 5 .3  Ratio of N-dealkylation versus N-demethylation estimated from the AHf 
values for in Table 5.2.
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Given that 4-oxo-4-phenylbutanamide can arise from oxidation of either 5-
phenyl-2-pyrrolidinoneorN-methyl-4-oxo-4-phenylbutanamide, the AHf values of these
substrates and their postulated carbon-centred radicals intermediates were also calculated
(Table 5.4). Clearly, ring oxidation is the less energy-demanding process.
Com pound AHf (kJ/mol)
5 -pheny]-2-pyrro lid inone - 65.79
- 4.91
CHa
N -m ethyl-4-oxo-4-
phenylbutanam ide
- 57.18
19 .82
T able 5.4 AHf values calculated by AMI for 5-phenyl-2-pyrrolidinone, N-methyl-4- 
oxo-phenylbutanamide and their postulated intermediates.
5.3 Biomimetic oxidation
• Identification of the p roducts from  R(+)- and S(-)-N-methyl-N-
(l-pheny le thy l)benzam ide
Model oxidation of the amides by TPPFeGU)/ rgr-butylhydroperoxide was 
followed by treatment of the samples with IM sodium hydroxide in methanol (to 
completely hydrolyse any labile carbinolamide products)^’ 24 analysis using HPLC.
Figure 5.5 displays a the typical HPLC profile. The compounds corresponding 
to the new peaks were identified by comparison of their retention time and UV spectra 
with those of synthetic standards (Table 5.5).
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I 20 
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Figure 5.5 HPLC of the reaction mixture from biomimetic system oxidation of a 5 
mM solution of R(+)-N-methyl-N-(l-phenylethy!) benzamide after a) 0  and b) 60 
minutes.
Peak found Compound identified
14.4 minutes N -m ethyl-N -(l-
phenyiethyi)benzamide
11.3 minutes N -(l-phenyIethyl)benzam ide
7.6 minutes acetophenone
3.7 minutes N-methylbenzamide
Table 5 .5  Products identified from the oxidation of a 5 mM solution of R(+)-N-methyl-
N-( I-phenylethyl)benzamide.
These results indicates that, as predicted, the biomimetic oxidation occurs as 
illustrated in Figure 5.3 both via N-dealkylation and N-demethylation. N- 
Methylbenzamide and acetophenone arise from the N-dealkylation reaction whereas N-( 1- 
phenylethyl)benzamide arises from the N-demethylation route. To assess the presence of 
stereoselectivity the kinetic characteristics of the reactions were examined.
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• Kinetic of the biomimetic oxidation o f R(+). and S.(-)-N-m ethyl-
N -(l-phenylethyl)benzam ide
The time-course, over a period of 2 hours, for the biomimetic oxidation of 5 
mM solution of N-methyl-(l-phenylethyI)benzamide is illustrated in Figure 5.6. The 
rather emphatic "tailing-off" in the reaction progress is almost certainly due to side 
reactions such as catalyst auto-oxidation and solvent oxidation.
f
I
400 
350- 
300- 
250- 
200 -  
150- 
100-  
5 0 -  
0
O
P""'
I I I 1 I I
20 40 60 80 100 120 140
Time (minntes)
N-methylbenzamide
N-( 1-phenylethyl) 
benzamide
Figure 5 .6  Time-course of the biomimetic oxidation of 5 mM R(-k)-N-methyl-N-( 1 - 
phenylethyl)benzamide.____________ ________________________
However, the reaction displays a linear phase within the first 20 minutes. Thus, 
the time chosen for the determination of the rate of formation of the oxidation products 
was 15 minutes, which is a convenient reaction time that permits the production of an 
accurate analytically determinable amount of products.
The initial rates of the biomimetic oxidation of R(4-)- and S(-)-N-methyl-N-(l- 
phenylethyl)benzamide, measured using substrate concentrations between 0 .5  and 1 0 .0  
mM are contained in Table 5.6.
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Vj (pM/h/mmol catalyst)
[Substrate]
(mM)
N-( 1 -pheny lethy l) 
benzam ide
N -m ethyl
benzam ide
acetophenone
R(+)- 0.5 82.10 ± 6 .1 220.67 ± 12.9 214.4 ± 10.2
R(+)- 1 .0 . 125.47 ± 9.6 387.25 ± 19.0 390.6 ± 16.3
R(+)- 2.0 170.51 ±11.8 622.05 ± 33.5 616.5 ± 28.0
R(+)- 3.0 193.68 ± 14.3 779.60 ± 28.1 781.5 ± 33 .4
R(+). 5.0 217.32 ± 15.2 977.72 ± 36.1 974.6 ± 15.5
R(+)- 10.0 237.5 ± 18.1 1207.95 ± 46.8 1215.3 ± 69.8
S(-)- 0.5 79.30 ±4.1 210.74 ± 13.5 216.6 ± 11.9
S.(-)- 1 .0 129.03 ± 19.0 396.51 ± 29.3 400.0 ± 18.5
S(-)- 2 .0 167.80 ± 26.5 608.12 ±26.9 610.5 ±37.1
S(-)- 3.0 199.73 ± 26.9 771.90 ± 15.0 780.4 ± 28.9
S(-)- 5.0 209.90 ± 35.6 984.65 ± 36.1 988.4 ± 35.5
S(-)- 1 0 .0 240.70 ± 15.2 1213.11 ±51.0 1201.7 ± 80.0
Table 5.6 Initial rates, Vi, of the biomimetic oxidation of R(+)- and S(-)-N-methyl-N-( l- 
phenylethyl)benzamide.
The plot of Vj versus substrate concentration, illustrated in Figure 5.7, obtained 
using the data in Table 5.6, is curved and can be rationalised in terms of saturating 
‘‘enzyme-type” catalysis. Analysis of the data using the Michaelis-Menten method yields 
the kinetic parameters Vmax, Km and Vmax/Km reported in Table 5.7. The data in Table
5.6 and Table 5.7 reveal that the rates of formation of N-methylbenzamide and 
acetophenone are equivalent given that they are the products of the same dealkylation 
reaction.
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Figure 5 .7  Hot of the initial rate, Vj, versus [substrate] for the biomimetic oxidation of 
R(+)-N-methyl-N-(l-phenylethyl)benzamide.___________________________________
SUBSTRATE N-demethylation N-dealkylation
E (+ )- Vmax* ± 8
(pM/h/mmol catalyst)
Km: 1.12 ± 0.14 (mM) 
Vmax/Km: 237
Vmax: 1580 ± 30
(pM/h/mmol catalyst)
Km: 3.08 ± 0.45 (mM) 
Vmax/Km: 512
&(-)- Vmax: 261 ± 11
(pM/h/mmol catalyst)
Km: 1 14 ± 0.18 (mM) 
Vmax/Km: 228
Vmax: 1595 ± 46
(pM/h/mmol catalyst)
Km: 3.14 ± 0.31 (mM) 
Vmax/ Km: 507
Table 5 .7  Kinetic parameters for the biomimetic oxidation of R(+)~ and S(-)-N-methyl- 
N-( 1-phenylethyl)benzamide.
The calculate kinetic parameters are essentially identical for both dealkylation 
and déméthylation of the two amides isomers. Though dealkylation is the favoured 
reaction, the ratios of N-dealkylation /N-demethylation (Table 5.8) markedly differ from
153
CHAPTER 5
those calculated by AMI. The most likely reason for this is the presence of a bulky N- 
alkyl group that can protect the hydrogen.
S ubstra te N -dealkylation/N -dem ethylation
R (+ )- 2 .1 6
S (-)- 2 . 2 2
Table 5.8 Ratio of N-dealkylation to N-demethylation in the biomimetic oxidation of N- 
methyl-N-(l-phenylethyl)benzamide.
• Identifîcation o f the p roducts from  R and S- N-methyl-5- 
phenyl-2 -p y rro lid in o n e
Figure 5.8 is a typical HPLC trace, obtained from the oxidation of S- isomer 
(the HPLC profile obtained from the oxidation of the R- isomer was essentially identical). 
The products of the reaction were identified by comparison of their retention time and UV 
spectra with that of synthetic standard. The products obtained from these biomimetic 
oxidations are illustrated in Table 5.9.
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Figure 5.8 HPLC of the products of biomimetic oxidation of 5 mM N-methyl-5-
phenyl-2-pyrrolidinone, after a) 0 and b) 1 hour._________________
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Peak Compound Identified
15.0 m inutes N -m ethyl-5-phenyl-2-pyrro lid inone
1 0 .1  m i n u t e s 5-P heny l-2 -pyrro lid inone
7.1 m inutes N -m ethyI-4-0 X 0 - 4 -  
phenylbutanam ide
5.6 m inutes 4-oxo-4-phenylbutanam ide
Table 5 .9  Products identified from the biomimetic oxidation of R- and S- N-methyl-5- 
phenyl-2 -pyrrolidinone.
The products are consistent with the pathway illustrated in Figure 5.4; no other 
products were identified under any condition. The 4-oxo-4-phenylbutanamide product 
can arise from two pathways. To clarify which of these is most important, the biomimetic 
oxidation of 5 mM 5-phenyl-2-pyirolidinone and N-methyl-4-oxo-4-phenylbutanamide 
was also studied. Figure 5.9 illustrates typical HPLC chromatograms from biomimetic 
oxidation of these compounds after 60 minutes. Table 5.10 lists the products identified. It 
is evident that both primary products undergo further oxidation to 4 -oxo-4 - 
phenylbutanamide.
w 3 -| 
2 -
I ’l
S 2 -
1 - lO1 1 -. olO1
0 - _ L_..J1—  „ 1 -
0
1 1 1 
5 10 15 Q 
minutes
a )
1
5
b )
1 1 
10 15
minutes
F igure 5 .9  HPLC analysis of the biomimetic oxidation of a) 5 mM 5-phenyl-2- 
pyrrolidinone and b) N-methyl-4-oxo-4-phenylbutanamide, after 60 minutes.
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Peak Compound Identified
Chromatogram a) 10.1 minutes 5-phenyl-2-pyrrolidinone
Chromatogram a) 5,6 minutes 4-oxo-phenyIbutanamide
Chromatogram b) 7.1 minutes N -m ethyl 4 -O X O -4 -  
phenylbutanamide
Chromatogram b) 5.6 minutes 4-oxo-4-phenylbutanamide
Table 5 .1 1  Products identified from the biomimetic oxidation of 5-phenyl-2- 
pyrrolidinone and N-methyl-4-oxo-4-phenylbutanamide.
• Kinetic of the biomimetic oxidation of R- and N-methyI-5- 
phenyl-2-pyrrolidinone
The time-course of the biomimetic oxidation of 5 mM N-methyl-5-phenyl-2- 
pyrrolidinone was monitored over two hours. The results obtained. Figure 5.10, displays 
an initial linear phase over the first 2 0  minutes, follows by a decrease of the reaction rate 
ascribed to catalyst auto-oxidation. Initial rates were detennihed after 20 minutes.
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Figure 5 . 1 0  Time-course of the biomimetic oxidation of R- 5 mM N-methyl-5-
phenyl-2-pyrrolidinone.___________________________________________ ________
156
 _____________________________________________________________________   CHAPTER S
The initial rates determined using substrate concentrations between 0.5 and 10.0
mM, are detailed in Table 5.11. Clearly there is no stereoselectivity in the biomimetic
oxidation of this substrate.
To evaluate the kinetic parameters for these oxidations, the initial rates for 
oxidation of N-methyl-4-oxo-4-phenylbutanamide and 5-phenyl-2-pyrrolidinone were 
determined (Table 5.12. Significantly, formation of 4-oxo-4-pheny I butanamide from 5- 
phenyl-2-pyrrolidinone is the preferred reaction, consistent with the MO calculations 
(Table 5.4).
Vi (mM/h/mmol catalyst)
[Substrate]
(mM)
5-pheny l-2 -
p y rro lid in o n e
N -m ethyl-4-oxo-
4 -
phenylbutanam ide
4 - O X O - 4 -
phenylbutanam ide
R 0.5 0.98 ± 0.009 2.78± 0.10 0.03 ± 0.001
R 1 .0 1.84 ± 0.09 4.96 ±0.30 0.05 ± 0.002
R- 2.0 3.28 ± 0.16 8.16 ±0.35 0.10 ±0.004
R 3.0 4.43 ± 0 3 5 10.40 ± 0.61 0.17 ±0.004
R 5.0 6.16 ± 0.70 1334 ± 1.10 0.23 ± 0.010
R 1 0 .0 8.70 ±0 .86 16.91 ± 1.18 0.402 ± 0.02
S- 0.5 0.96 ±0 .07 2.74 ± 0.11 0.03 ± 0.001
S- 1.0 1.81 ± 0 .1 1 4.89 ± 0.21 0.05 ± 0.002
S- 2.0 3.23 ±0.18 8.03 ± 1.05 0.10 ± 0.030
S- 3.0 4.38 ± 0.31 10.23 ±1.09 0.14 ± 0.020
S- 5.0 6.11 ±0.51 13.08 ± 1.11 0.23 ± 0.04
S- 1 0 .0 8 .6 8  ± 0.32 16.5 ± 1.23 0.39 ± 0.05
Table 5 .11 . Initial rates, Vj, of the biomimetic oxidation of R- and S-N-methyl-5-
phenyl-2 -pyrrolidinone.
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Vi (m M /h/m ihol catalyst)
[Substrate]
(mM)
5-pheny l-2 -
p y rro lid in o n e
N -m ethyl-4-oxo-
phenylbutanam id
e
R atio
0.5 2.76 ±0.11 0.06 ± 0.009 46.0
1 .0 4.27 ± 0.21 0 .1 2  ± 0 .0 1 0 35.6
2 .0 5.87 ± 0.20 0 .2 2  ± 0 .0 2 0 26.7
3.0 6.71 ± 0.42 0.31 ± 0.010 2 1 .6
5.0 7.58 ± 0.33 0.47 ± 0.030 16.1
1 0 . 0 8.39 ± 0.36 0.76 ± 0.022 1 1 .0
Table 5 .1 2  Initial rates, vj, for the formation of 4—oxo-4—phenyl butanamide from the 
biomimetic-dependentoxidation of N-methyl-4-oxo-4-phenylbutanamide and 5 -phenyl- 
2 -pyrrolidinone.
The kinetic parameters for the oxidation of R- and S-N-methyl-5-phenyl-2- 
pyrrolidinone (Table 5.13) were calculated from the data of Table 5.12 by partitioning the 
formation of 4-oxo-4-pheny I butanamide in a ratio of 26/1 from 5phenyl-2-pyrrolidinone 
and N-methyl^oxo-4-phenylbutanamide.
Substrate N -dem ethylation Ring oxidation
R-
Vmayî 15.2 ± 1.5
(pM/Hr/mmol. cat)
K m : 6.84 ± 0.52 (pM) 
V m ax/K m ' 2 .2 2
Vmax: 23.1 ± 2.8
(pM/Hr/mmol. cat)
Km:3.66 ± 0.32 (pM) 
Vmax/Km: 6.31
s -
Vmax* 15.3 ± 1 .2
(pM/Hr/mmol. cat) 
K m : 7.08 ± 0.33 (pM) 
V m ax/K m : 2.16
Vmax: 22.7 ± T.12
(pM/Hr/mmol. cat)
Km: 3.60 ± 0.28 (pM) 
Vmax/Km: 6.30
Table 5 .13 . Kinetic parameters for the biomimetic oxidation of R- and S-N-methyl-5- 
phenyl-2 -pyrrolidinone.
The results show preferential ring oxidation, as predicted from the semi- 
empirical AMI calculations. However, 3 to 1 ratio for ring oxidation 'versus N- 
demethylation (Table 5.14), is significantly smaller of that predicted by the semi-empirical
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calculations. As observed for the N-methyl-N-(l-phenylethyl)benzamides the steric bulk 
of the N-alkyl substituent must mask the large energetic preference for dealkylation.
S ubstra te Ring oxidation/N -dem ethylation
R 2 .8 2
S - 2 .8 9
Table 5 .1 4  Ratios of N-demethylation to ring oxidation from the biomimetic oxidation 
of R- and S- N-methyl-5-phenyl-2-pyrrolidinone.
5.4. M icrosomal O xidation
• Identihcation of the p roducts from  R(+)- and ^ (-)-N -m eth y l-N - 
(l-pheny le thy l)benzam ide
Microsomal incubations of 5 mM substrates were analysed by HPLC after 60 
minutes. Product identification was achieved by comparison of the diode array UV 
spectra with those of synthetic standards. Qualitatively, the HPLC profiles for the two 
isomers were similar Figure 5.12 is a typical HPLC chromatogram obtained for the 
microsomal incubation of 5 mM R(-h)-N-methyl-N-(l-phenylethyl)benzamide. Table 5.14 
details the compound identified.
I
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 1----- 1----- 1 1
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I
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o
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F igure 5 ,1 2  HPLC chromatograms of the a) 0 and b) 60, microsomal oxidation of 5 
mM R(+)-N-methyl-N-( l-phenylethyl)benzamide after minutes.____________________
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Peak Compound Identified
14.4 minutes N - methyl- ( 1 - pheny le thy 1) benzamide
11.2 minutes N- ( 1 -pheny letby l)benzamide
7.6 minutes acetophenone
3.7 minutes N-methylbenzamide
Table 5 .1 4  Compounds identified from the microsomal oxidation of R(+)-N-methyl-N- 
( 1-phenylethyl)benzamide.
The identified products are the only compounds detected in the microsomal 
metabolism of either isomer under any experimental condition. Microsomal oxidation thus 
presents a similar pattern of reaction to the bioniimetic system.
• Kinetic of the microsomal oxidation of R(+)- and ^(-)-N -m ethyl- 
N -(l-phenylethyl)benzam ide
Figure 5.13 illustrates the time-dependent formation of the major metabolite, N- 
methylbenzamide, from the microsomal oxidation of both isomers. A linear phase is 
observed over the first 20 minutes. Thus, initial rates were determined after 15 minutes 
incubation.
300
250- . O
200 -
n 150 -
—I-------- 1---------1-------- 1---------- 1-------1—
0 20 40 60 80 100 120 140
Time (minutes)
N-methylbenzamide 
from S(-)
N-methylbenzamide 
from R(+)
Figure 5 .1 3  Time-course for the formation of N-methylbenzamide during the 
microsomal oxidation of 5 mM R(+)- and ^(-)-N-methyl-N-(l-phenylethyl)benzamide.
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The initial rates for the microsomal oxidation of R(+)- and S(-)N-mcthyl-N-(l-
phenylethyl)benzamide were measured using substrate concentrations between 0 .5  and 
10.0 mM (Table 5.15). The initial rates were used to calculate the kinetic parameters 
Vmax. Km and Vmax/ Km using the Hanes plot. The results, expressed as N- 
dealkylation ver5W5 N-demethylation, are reported in Table 5.16.
V| (pM /h/nmol P450)
[Substrate]
(mM)
N -( l-
pheny le thy l)
benzam ide
N -m ethyl
benzam ide
acetophenone
R(+)- 0.5 51.0 ± 8.5 30.0 ± 1.8 33.0 ± 3.2
R(+)- LO 87.5 ± 7.5 52.2 ± 3.2 50.2 ± 3.0
R(+)- 3.0 167.6 ± 8 .8 103.8 ± 11.0 105.5 ± 10.0
R(+)- 5.0 205.2 ± 14.0 129.2 ± 11.0 130.6 ± 12.0
R (+ )-10 .0 246.6 ± 11.0 158.5 ±21.0 160.0 ± 2 1 .0
§.(-)- 0.5 53:2 ± 2.4 15.2 ± 0.8 14.1 ± 0 .5
S(-)- 1.0 90.2 ± 3.8 27.5 ± 1.2 29.0 ± 2.0
§.(-)- 3.0 168.2 ± 1 1 .0 59.6 ± 3.2 58.0 ± 2.1
S(-)- 5.0 203.3 ± 13.5 77.7 ± 3.5 79.0 ± 5.2
S ( - ) - 1 0 .0 241.0 ± 16.0 100.7 ± 6.5 103.0 + 8.0
Table 5.15 Initial rates, v,, for the microsomal oxidation of R(+)- and S(-)-N-methyl- 
N-( 1 -phenyl ethyl )benzamide.
Substrate N -dem ethylation N -dealkylation
E (+ )- Vmax* 309 ± 30
(pM/h/nmol P450) 
K m : 2.53 ± 0.11 (mM) 
Vmax/Km: 1 2 2
Vmax: 205 ±_16 
(pM/h/nmol P450) 
Km: 2.93 ± 0.08 (mM) 
Vmax/Km: 70
§.(-)- Vmax: 296 ± 20 
(pM/h/nmol P450) 
K m : 2.28± 0.07 (mM) 
Vm ax/Km : 130
Vmax: 143 ± 21 
(pM/h/nmol P450) 
Km: 4.20 ± 0.31 (mM) 
Vmax/Km: 34
Table 5.16 Kinetic parameters for the microsomal oxidation of R(+)- and S(-)-N- 
methyl-N-( 1-pheny Iethyl)benzamide.
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The results demonstrate that N-demethylation exhibits no stereoselectivity
whereas N-dealkylation displays a slight stereoselective preference (oa. 2 : 1) for R(+)-
isomer. Obviously, the ratios of N-demethylation to N-dealkylation for the two isomers
(Table 5.17) reflect the observed stereoselectivity.
S ubstra te N -dem etbylation/N -dealkylation
R (+ )- 1.74
S (-)- 3 .82
Table 5 .1 7  Ratios of N-demethylation to N-dealkylation in the microsomal oxidation of 
R(+)- and §.(-)-N-methyl-(l-phenylethyl)benzamide.
• Products of the microsomal oxidation of R- and S.-N-methyl-5- 
phenyl-2-pÿrrolidinone
Identification of the products was achieved by comparison of the retention times 
and UV spectra of each HPLC peak with those obtained from synthetic standards (Table 
5.18). A typical HPLC chromatogram obtained from the microsomal oxidation of 5 mM 
R-N-methyl-5-phenyl-2-pyrrolidinone is shown in Figure 5.14.
a )
2 -
0 5 10 15 20
nunutes
I
2 -
0  — JlT------ 1------1------ 1
0 5 10 15 20
b ) minutes
Figure 5 . 14  HPLC chromatogram of the microsomal oxidation of 5 mM R-N-methyl-
5-phenyl-2-pyrrolidinone after a) 0 and b) 60 minutes.__________________ _________
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Peak Compound identified
14.9 m inutes N -m ethyl-5-phenyl-2-pyrro lid inone
1 0 .1  m inutes 5-phehyl-2-pyrro lid inone
7.00 m inutes N -m ethyl-4-oxo-4-
phenylbutanam ide
5.6 m inutes 4-oxo-4-phenylbutanam ide
Table 5 .1 8  Compounds identified from the microsomal oxidation of R-N-methyl-^ 
phenyl-2 -pyrrolidinone.
Since 4-oxo-4-pheny I butanamide is a product of these reactions, the microsomal 
metabolism of the two primary metabolites 5-phenyl-2-pyrrolidinone and N-methyl-4- 
oxo-4-phenylbutanamide was studied. Figure 5.15 reports the typical HPLC 
chromatograms from microsomal oxidation of 5 mM solutions of a) 5-phenyl-2- 
pyrrolidinone and b) N-methyl-4-oxo-4-phenylbutanamide. The identified products are 
listed in Table 5.19.
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F igure 5 .1 5  HPLC chromatogram of the microsomal oxidation of a) 5-phenyl-2- 
pyrrolidinone and b) N-methyl-4-oxo-4-phenylbutanamide obtained after 60 minutes.
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Peak Compound identified
Chromatogram a) 10.1 minutes 5-phenyl-2-pyrrolidinone
Chromatogram a) 5.6 minutes 4-oxo-phenylbutanamide
Chromatogram b) 7.0 minutes N -m ethyl-4-oxo-4-
phenylbutanamide
Chromatogram b) 5.6 minutes 4-oxo-4-phenylbutanamide
Table 5 .1 9  Compounds identified from the microsomal oxidation of 5-phenyl-2- 
pyrrolidinone and N-methyl-4-oxo-4-phenylbutanamide.
• Kinetic of the microsomal oxidation of R- and S.-N-methyl-5- 
phenyl-2-pyrrolidinone
The time-course of the microsomal metabolism of 5 mM solutions of the R- and 
S- isomers of N-methyl-5-phenyl-2-pyrrolidinone (Figure 5.16) reveals a initial linear 
phase within the first 15 minutes. Thus, the initial rates of the microsomal oxidation of 
the two isomers were determined during the first 10  minutes using substrates 
concentrations between 0.5 and 10.0 mM. The data are contained in Table 5.20.
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Figure 5 .1 6  Time-course of the microsomal metabolism of R- and S-N-methyl-5- 
phenyl-2 -pyrrolidinone.______________________________________________________
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Since the formation of the secondary metabolite, 4-oxo-4-phenylbutanamide can
arise from both primary products, the initial rates of the microsomal oxidation of N-
methyl-4-oxo-4-phenylbutanamide and 5-phenyl-2-pyrrolidinone were also determined
(Table 5.21).
Vj (pM/h/nmoi P450)
[Substrate] (mM) 5-phenyl-2-
pyrrolidinone
N-methyi-4-oxo-
4-
phenylbutanamide
4-oxo-4-p h en yl
butanamide
R- 0.5 301 ± 12 161 ± 9 9 7 ± 6
R 1.0 529 ±33 313 ±27 165 ± 11
R 3.0 1065 ±23 806 ±51 300 ±21
R 5.0 1334 ± 50 1144 ± 30 357 ± 33
R 10.0 1648 ± 38 1636 ±65 414 ± 2 5
S- 0.5 254 ± 12 598 ±80 282± 12
S- 1.0 541 ± 38 1106 ±35 426 ±21
S- 3.0 918 ± 80 2389 ±55 645 ± 36
5.0 1153±91 3058 ± 65 720 ± 59
S- 10.0 1425 ± 101 3843 ±85 788 ± 6 2
Table 5 .2 0  Values of the initial rate of the microsomal oxidation of R- and S-N-methyl- 
5-phenyl-2-pyrrolidinone.
Vj (pM/h/nmol P450) -
[Substrate]
(mM)
From
5-phenyl-2-
pyrrolidinone
From
N-m ethyl-4-oxo-4-
phenylbutanamide
Ratio
0 .5 15.8 ± 1.2 164±23 10.4
1 .0 28.3 ± 1.6 288 ±31 1 0 .2
5 .0 76.6 ± 3.2 736 ±51 9.6
10 .0 97.5 ± 2.6 914 ±36 9.4
Table 5 .21 . Initial rates for the of formation of 4-oxo-4-phenylbutanamide from 
microsomal oxidation of 5-phenyl-2-pyrroIidinone and N-methyl-4-oxo-4- 
phenylbutanamide.
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Clearly 4-oxo-4-pheny!butanamide is formed preferentially from N-methyl-4 - 
oxo-4-phenylbutanamide rather than Sphenyl-2-pyrrolidinone in a ratio 9.9/1. This is a 
complete reversal of the selectivity predicted from the M.O. calculations and observed 
with the biomimetic system. Thus, the rates for initial ring oxidation and N-demethylation 
were corrected on the basis of these results, allowing calculation of the kinetic parameters 
of the reaction (Table 5.22). The extent of ring oxidation and N-demethylation is reported 
in Table 5.23.
The kinetic parameters reveals that there is no stereochemical preference present 
in the N-demethylation reaction. In contrast, the ^.-isomer is oxidised in position 5 ’- 
approximately 4 times more efficiently. Given that the alkyl group has no effect on 
déméthylation, but that the stereochemistry of the alkyl group affects its own 
dealkylation, there must be a substrate-enzyme interaction in very close proximity to the 
haem active site. It is probable that an interaction between the bulky phenyl substituent of 
the substrate and a hydrophobic pocket of the enzyme active site can account for these 
observations.
Substrate N -dem ethyiation Ring oxidation
R-
Vmax: 2201 ± 300
(pM/Hr/nmol. P450) 
K m : 3.03 ± 0.4 (mM) 
Vm ax/Km: 726
Vmax: 3194 ± 188
(pM/Hr/nmol. P450) 
Km: 5.90 ± 0.2 (mM) 
Vmax/Km: 540
S-
Vmax: 1948 ± 2 3 1
(pM/Hr/nmol. P450) 
K m : 2.95 ± 0.6 (mM) 
Vmax/Km: 662
Vmax: 5!W0 ± 250
(pM/Hr/nmol. P450) 
Km: 2.96 ± 0.3 (mM) 
Vmax/Km: 1990
Table 5 .21. Kinetic parameters for the microsomal oxidation of R- and S- N-methyl-5- 
phenyl-2 -pyrrolidinone.
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S ubstra te N-demethylation/Ring oxidation
R- 1.34
s -
0.33
Table 5.23 Ratios of N-demethylation to ring oxidation for the microsomal oxidation of 
R- and S- N-methyl-5-phenyl-2-pyrrolidinone.
5.5 Conclusion
Qualitatively both molecular orbital calculations and the catalytic by biomimetic 
system are revealed to be useful tools in predicting the metabolic fate of the substrates 
used in this study. Not surprisingly however, some features of the P450-mediated 
oxidations were quite different from those predicted. Thermodynamically, and indeed 
chemically, N-dealkylation and ring oxidations are more favoured, whereas in 
microsomal metabolism N-demethylation competes effectively with N-dealkylation. As 
observed in Chapter 4, kinetic factors seem to be the main driving force of these 
microsomal reactions. It is also plausible that the steric bulk of the N-alkyl substituents 
somehow hinders the N-alkyl hydrogen atom in a such a way as to make it less available 
to the haem plane of the P450. Furthermore, a stereoselectivity, not predicted from 
energetic considerations and not observed in the biomimetic oxidations, is noted for these 
microsomal reactions. This stereopreference in the P450 reactions is most likely to be due 
to interactions between the protein in the active site of the enzyme and the bulky 
substituent of the substrates. The small, but significant, preference for N-dealkylation of 
R(+)- N-methyl-(l-phenylethyl)benzamide becomes more pronounced for ring oxidation 
of the conformationally rigid ^ -N-methyl-5-phenyl-2-pyrrolidinone. The difference of the 
extent of stereoselectivity between the two substrates may be due to the fact that N- 
methyl-(l-phenylethyl)benzamide possess relatively free rotation along the C-N bond 
which may result in only a small difference in the spatial conformations of the substrates 
with regard to their relative orientations to the haem plane of the enzyme. The active site 
of P450 is believed to be very non-polar, based on structural analogy with the well-
167
     CHAPTER S
known P450cam*^ Moreover, the rate of rotation in amides increases with a decrease in
the polarity of the solvent.-^ Therefore, it seems unlikely that amide rotation in the active
site is a process slow enough to present any stereoselectivity. Thus, an explanation for
the observed stereoselectivity for N-dealkylation may lie with a hydrophobic interaction
between the non-polar substituent of the substrate and a hydrophobic moiety of the
protein in the enzyme active site. These would slow down rotation about the amide C-N
bond resulting in a stabilisation of two different conformational orientations toward the
haem plane. However, given the results obtained, these interactions appear to be very
small. With the fixed conformation, cyclic substrates, the stereoselectivity for N-
dealkylation (ring oxidation) is more evident. A model to explain the stereopreference for
the metabolism of the structurally similar substrate nicotine by P450 proposed that
interaction between the pyridyl ring and a protein residue is responsible of the
stereochemical course of the r e a c t i o n .  ^ 8  it i s  curious, therefore, that no evidence has been
reported of stereoselectivity in the metabolism of nicotine metabolite cotinine,26; 27 ^
compound with almost identical molecular structure to the cyclic substrate used in this
study (cotinine possess a 3 ’- pyridyl ring instead of the phenyl group).
The conclusions that can be drawn from the experimental data are that 
interactions between the non-polar moiety of the substrate and a hydrophobic pocket of 
the enzyme active site impose a steric constraint on the substrate in such a way as to 
determine a preferential orientation of the hydrogen atom with respect the haem plane. 
The S-. isomer of N-methyl-5-phenyl-2-pyirolidinone presents a relative position of the 
ring that maximises this steric effect. Steric effects are unimportant for N-demethylation. 
presumably because access to the N-methyl hydrogen atoms is not significantly different 
between two isomers.
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CHAPTER 6
Microsomal metabolism of N,N-dimethyIformamide (DMF) and N,N-
dimethylacetamide (DMAC)
The present chapter will describes the following studies on the interactions
between microsomal cytochrome P450 and DMF and DMAC:
• attempts to trap intermolecularly and intramolecularly the carbon-centred
radical intermediates
• effects of the oxidation of DMF and DMAC on the metabolising enzyme
• attempts of identification the reactive species produced during the oxidation of
DMF and DMAC
6.1 Introduction
N,N-Dimethylformamide (DMF) and N,N-dimethylacetamide (DMAC), are 
organic solvents widely used in a large variety of industrial process, among them the 
manufacture of synthetic fibres, leather, films and surface coatings. Consequently, a 
significant quantity of metabolic and toxicological data for these compounds are available.
Two reported major effects in workers exposed to DMF are gastric irritation and 
hepatotoxicity.l The toxicity of DMF in animals has been cogently reviewed.^ DMF has 
been implicated as the cause of alcohol incompatibly reactions in exposed workers and 
is suspected of being carcinogenic.^:^ However, the results of extensive studies of 
workers exposed to DMF over many years suggest that the carcinogenic risk associated 
with occupational exposure is very low.^:l^
DMAC is reported to present low acute toxicity 2 and animal exposure to high 
concentrations of the solvent presents liver damage as the first indication of toxicological
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change.2 ; H;l2 in humans, alteration of liver function has been observed at relatively low
chronic exposure. 13
For both chemicals it is believed that hepatotoxicity is related, to their P450- 
mediated metabolism, a process that involves the formation of reactive species 
responsible for the toxic effects.^^:l3;l6 The main route of P450 mediated metabolism is 
reported to be the oxidation of the carbon a -  to nitrogen to give the corresponding N- 
hydroxylmethyl-N-methylamide.1^18 On the basis of kinetic isotope effects 16;19;20 it is 
thought that P450 oxidation of these compound occurs via hydrogen atom abstraction 
leading to the formation of a carbon centred-radical intermediate.
The metabolic fate in vivo and in vitro of DMF has been reviewed by Gescher. 1^  
The proposed metabolic pathway leading from DMF to toxic intermediates is illustrated in 
Figure 6.1.
Oxidation can occur either at the a-carbon or at the carbonyl moiety. Oxidation 
of the carbonyl moiety is believed to be responsible for the formation, in vivo, of 
glutathione derived products, which are considered the main factors responsible for the 
toxicity of DMF (as reported for N-methyl formamide (NMF)).2l-26 Oxidation of the a - 
carbon leads to N-demethylation of DMF resulting in the formation of NMF, which can 
undergo further metabolism to toxic species. However, the formation of the thiol 
derivatives of DMF is not reported during the in vitro m etabolism .Indeed,"the a -  
carbon oxidation reaction has a higher affinity for the enzyme, which results in an 
inhibition in the formation of the thiol derivatives in the in vitro metabolism of NMF. 
Moreover, high concentrations of DMF seem to inhibit its bioconversion into a reactive 
thiol intermediate. Despite the efforts to clarify the full metabolic features responsible 
for the toxicological response of DMF many aspects of this metabolic bioconversion are 
still unknown.
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Figure 6 .1 Proposed metabolic pathways leading toxic intermediates from DMF.
It is reported that the P450 isoform primarily responsible for the metabolism of 
DMF is ethanol-induced P450 2 E l,l^»26 and that the affinity of DMF for the enzyme is 
10 fold higher than that of HMMF and 20 fold higher than that of NMF.^^ Moreover, in 
rats DMF is more toxic than NMF or HMMF, and the precise diagnosis of DMF toxicity 
is more accurate when analysed over a prolonged period.^^ In rats DMF is metabolised to 
HMMF and subsequently to NMF. The time-course of NMF formation fits with a 
possible role for such a chemical as a precursor to the reactive intermediates responsible
1 7 1
__________________________________________________   CHAPTKR 6
of the DMF toxicity.27 However, there are differences in the degree of hepatotoxicity
after administration of DMF and NMF.
DMAC is reported to be metabolised by P450 to N-hydroxymethyl-N- 
methylacetamide m vitro and in rats, while in humans only the N-demethylated product
was identified.2;i5
A comparative study on the in.vitro metabolism of DMAC and DMF, using 
phenobarbital-induced rat liver microsomes reports the production of N-demethylated 
metabolites from both substrates and that DMAC seems to be more readily metabolised
than DMF. 17;28
Despite extensive investigation into the metabolic fate of DMF, and to a lesser 
extent DMAC, few studies have reported the effects that the metabolism o f these 
substrates have on the metabolising enzymes. The only indication so far reported in the 
literature is the study of Imazu and c o lla b o ra to rs ,2 9 ;3 0  where in an in vivo study using a 
high concentration of DMF (0.5 ml/kg body weight) for prolonged period (1 week), a 
decrease in the content of P450 and microsomal haem was observed. The authors 
suggested three hypotheses to explain these observations:
• enzyme destruction,
• inhibition of the synthesis of protohaem and/or apoprotein, and '
• massive cellular damage or damages of the membranes.
The third possibility seems unlikely because membrane bound cytochrome bs 
and NADPH cytochrome c reductase are unaffected by the DMF administration.
Inactivation of P450 during the metabolism of tertiary amides has not been 
reported so far. An indirect indication o f P450 inactivation comes from the kinetic 
analysis of the microsomal metabolism of N,N-dimethylbenzamide, where an initial high 
rate metabolism is followed by a second phase of slower activity. This bilinear trend,
17/1
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can be explained either by enzyme inactivation or by the presence of two P450 isoforms 
of which one exhibits an high metabolic rate and saturation at low substrate 
concentrations. The authors favoured this second possibility because it was felt there was 
no rational explanation for the formation of reactive species in the metabolism of this
s u b s t r a t e .  4^; 19;20
Given the observations reported in Chapters 2 and 3 regarding the formation of 
free radicals during the oxidation of tertiary amides together with the reported in vivo 
effects of the metabolism of DMF on P450, an investigation into the in vitro effects of 
DMF and DMAC on P450 was therefore undertaken. The rationale underpinning this 
approach is that carbon-centred radical intermediates are reactive species able to attack any 
available biological target. Due to the low half-life of these radicals it is possible that the 
metabolising enzyme becomes the more relevant target of these reactive intermediates. 
Given that the synthesis of protohaem and of P450 is not present in microsomes, if loss 
of P450 and microsomal haem is found then the only available hypothesis left to explain 
the in vivo observation 29;301§ the destruction of the enzyme. Further, the choice DMAC 
as substrate is due to its close structural analogy with DMF and because it can block any 
potential metabolism at the carbonyl moiety of the amide. Thus, if loss of P450 is also 
observed for this substrate, then it provides additional structural information as to the 
reactive species responsible for its biological action.
The initial part of the study involves semi-empirical AMI calculations of the 
heats of formation of the substrates and of their postulated radical intermediates, to 
predict, from a thermodynamic point of view, the most likely metabolic pathway of these 
substrates. Subsequently, identification of the reactive intermediate was undertaken using 
inter-and intra-molecular trapping techniques on the assumption that carbon-centred 
radicals are formed during the reaction. Finally, the effects of the metabolism of the 
substrates on ethanol-induced rat liver P450 were analysed.
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6.2 AM I M olecular o rb ita l calculations
The heats of formation of DMF, DMAC, their corresponding radical cations and 
carbon-centred radical intermediates, calculated by AMI method^ are contained in Table 
6 . 1.
The data obtained identify formation of the carbon-centred radical intermediate 
obtained by abstraction of the hydrogen atom from the a-carbon to be favoured over the 
abstraction of the formyl hydrogen atom. On the assumption that AHf approximates to Ea 
then abstraction of the a-carbon hydrogen atom is favoured by a factor of 1260.
Comparison of the AHf values for the formation of the carbon^centred radical 
intermediates from DMF and DMAC indicates that there are no significant differences; the 
oxidation of DMF is slightly favoured, by a factors of 1.3.
C om pound AHf (kJ/mol)
DMF - 128.82
JCHg
38.07
.C .^.CH 3
CHs
55.85
0
CHs
729.48
DMAC - 147.61
0
CHs'
• CH2
20.33
0
CH3
672.9
Table 6.1 Heats of formation (AHf) of DMF, DMAC and their postulated radical 
intermediates.
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6.3 Microsomal metabolism of DM F and DMAC 
•Identification of the  p roducts
Ethanol-induced rat hepatic microsomes were incubated in the presence of 10 
mM substrate for 30 minutes. Figures 6.2 and 6.3 display typical gas chromatograms 
from the incubations of DMF and DMAC after 30 minutes, respectively. The products of 
the reaction were identified by comparison of their mass spectra with that recorded for 
pure standards (Table 6.2)
œ
3
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0 2 4 6  8  10
a ) minutes
I
3-1
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0 - J
0
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2 4 6  8  10
b ) minutes
F igure 6 .2  Typical gas chromatogram of a s ^ p le  obtained from microsomal incubation 
of 10 mM DMF, at reaction time a) 0 and b) 30 minutes.
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Figure 6 .3  Typical gas chromatogram of a sample obtained from microsomal incubation
of 10 mM DMAC, at reaction time a) 0 and b) 30 minutes. ___________ _
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Peak Compound identified
Retention Time: 2.58 minutes 
Figure 6.2 chromatogram h)
N,N-dimethylformamide
Retention Time: 1.98 minutes 
Figure 6.2 chromatogram h)
N-methylformamide
Retention Time: 4.07 minutes 
Figure 6.3 chromatogram h)
N,N-dimethylacetamide
Retention Time: 2.19 minutes 
Figure 6.3 chromatogram h)
N-methylacetamide
Tahle 6 .2  Products identified from microsomal incubations of DMF and DMAC.
No other products were observed under any reaction condition, in agreement 
with the literature 1^  that the only detected metabolite of these substrates in vitro is the N- 
demethylated amide.
• Quantitative analysis of the microsomal metaholism of DMF and
DMAC
Initial rates for the microsomal oxidation of DMF and DMAC, measured after 5 
minutes reaction, are reported in Tables 6.3 and 6.4 respectively, while Table 6.5 
summarises the derived kinetic parameters calculated for these reactions.
[Substrate]
(mM)
Vi N-methylformamide
(pM/min/nmol P450)
0 .5 0.89 ± 0.06
1 .0 1.21 ± 0.07
3 .0 1.62 ± 0.03
5 .0 1.74 ±0.06
10 .0 1.84 ±0.10
Table 6 .3  Initial rates vj, for the microsomal oxidation of DMF.
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[S ubstrate]
(mM)
Vj N-methylacetamide
(pM/min/nmol P450)
0 .5 2.42 ±0.12
1 . 0 3.04 ±0.21
3 .0 3.66 ± 0.25
5 .0 3.82 ±0.16
1 0 . 0 3.94 ± 0.24
Table 6 .4  Initial rates Vi, for the microsomal oxidation of DMAC.
DMF DMAC
Vmax (pM/nmol P450) 1.95 ±0.12 4.08 ± 0.21
Km (mM-l) 0.60 ± 0.03 0.34 ± 0.04
Vmax/Km 3.25 1 2 .0 0
Table 6 . 5 Kinetic parameters for the microsomal oxidation of DMF and DMAC.
DMAC is more readily metabolised than DMF; comparison of the Vmax/Km 
values reveals a difference in reactivity of ca. 3.5.
6.4 Trapping of the reactive interm ediates in the metabolism o f DM F and 
DMAC
6.4.1 In tram olecular trapp ing  using an N-alkynyl probe substrate
To identity the nature of the carbon-centred radical intermediate formed during 
the metabolism of these substrates, a probe substrate with a structure able to trap the 
radical intramolecularly was synthesised. Based on the results in Chapter 2, the chosen 
probe substrate is N-(3-butynyl)-N-methylformamide (Figure 6.4).
CHs
N-(3-butynyl)-N-methylformamide
Figure 6 .4  NMF analogue for intramolecular trapping of the carbon-centred radical 
produced during P450-dependent metabolism.__________________________________
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Three potential carbon-centred radical intermediates can be formed during the 
metabolism of this substrate (Figure 6.5). Hydrogen atom abstraction from the two 
carbon atoms a -  to nitrogen leads to the formation of radicals 2 and 3 whereas 
abstraction of the formyl atom leads to the formyl radical 4. Intermediate 3 will undergo 
hydroxylation to form the N-dealkylated product N-methylformamide. The intermediates 
2 and 4 can undergo intramolecular rearrangement via endo and exo pathways to yield the 
cyclic compounds 5, 6 , 7 and 8 . Moreover, radical intermediate 2 can also undergo 
hydroxylation and dealkylation to form N-(3-butynyl)formamide.
CH3 3
F igure 6 .5  Potential pathway for the microsomal oxidation of N-(3-butynyl)-N- 
methylformamide.__________________________________________________
Microsomal incubation of a 10 mM solution of N-(3-butynyl)-N- 
methylformamide, followed by treatment of the reaction mixture with 1 M sodium 
hydroxide (to completely hydrolyse the base labile carbinolamide), extraction with ethyl 
acetate and analysis by gas chromatography, resulted in the typical gas chromatogram 
illustrated in Figure 6 .6 . The reaction products were identified by comparison of their
180
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retention times and mass spectra with those obtained for the equivalent synthetic 
standards; the results are summarised in Table 6 .6 .
3 - j 3-,
1
O '
2 - 2 - ino
%
1 - a )  1 -
CO 
1 1
b )
0 - 0 - _l J _
0
1 1 1 
2 4 6
■ 1 ■■ 1 
8  10  0
minutes
1 1 
2 4
I
6
1 1 
8  10
minutes
F igure 6 . 6  Typical gas chromatogram of ethyl acetate extracts obtained frorri 
microsomal incubation of 10 mM N-(3-butynyl)-N-methylformamide, at reaction time a) 
0 and b) 30 minutes, b).
Peak Compound identified
Retention tim e: 1.41 m inutes N-methyl form am ide
Retention tim e: 3.28 m inutes
HA/V o
N-(3-butynyi) form am ideRetention time: 5.05 m inutes
Retention tim e: 6.92 m inutes N-methyl-N-(3-butynyi) fo rm am ide
Table 6 . 6  Metabolites identified from the microsomal oxidation of N-(3-biitynyl)-N- 
methylformamide.__________________________________________________________
These results are consistent with the formation of the carbon-centred radical 
intermediates 2 and 3 of Figure 6.5 via hydrogen atom abstraction from the two a-carbon 
atoms. Thus, the mechanism of the microsomal oxidation of N-(3-butynyl)-N- 
methylformamide is that proposed in Figure 6.7. As well as hydroxyl group insertion, the 
radical intermediate 2  undergoes intramolecular cyclisation resulting in the formation of 
the six-membered product. Despite the reported preference for the formation of five- 
membered ring systems in radicals cyclization reactions, ^1'^^ only the exo cyclization 
product was observed. It is worthy to note that no cyclic products were found that could
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be ascribed to the formation of the formyl radical 4 of Figure 6.5. Thus, in these in vitro
conditions, the abstraction of the carbonyl hydrogen does not occur. Nevertheless,
stnictiiral differences between the N-alkenyl formamide and DMF and DMAC may play a
relevant role in the mechanism of the P450 oxidations.
CH
OH
CH
Figure 6 .7  Pathway of the m icrosom al oxidation of N-(3-butynyl)-N- 
methylformamide.___________________________________________________________
• Kinetic of the  P450-dependent oxidation of N-(3-butynyl)-N- 
m ethylform am ide
Initial rates for the form ation of products from N-(3-butynyl)-N- 
methylformamide were determined using substrate concentrations between 0.5 and 10
CHAPTKR 6
mM (Table 6 .8 ). The kinetic parameters (Table 6 .8 ) were calculated as described 
previously.
Vi (pM/h/nmol P450)
[substra te]
(mM)
Total
m etabolism
N -d ea lk . N -dem eth. Cyclization D em eth ./
cy c liza t.
0 .5 0.17 ±0.008 0.07 ± 0.003 0.07 ± 0.002 0.014 ± 
0 .0 0 2
4.11
1 . 0 0.34 ± 0.010 0.14 ±0.010 0.13 ±0.010 0.03 ± 0.003 4.33
3 .0 1 .0  ± 0 .0 2 0 0.41 ±0.010 0.38 ± 0.014 0.08 ± 0.009 4.75
5 .0 1.62 ± 0.090 0 .6 8  ± 0 .0 2 0 0.63 ± 0.020 0.13 ±0.010 4.84
1 0 . 0 3.08 ±0.10 1.30 ± 0.090 1.22 ±0.140 0.25 ± 0.060 4.88
Vmax
(p,M/nmol
P450)
38.61 ± 0.91 19.5 ± 0.60 18.5 ± 0.83 2.31 ±0.11
114.3 ±3.1 136.0 ± 8.0 141.0 ±5 .0 83.0 ± 3.5
V max/l^m 0.34 0.140 0.131 0.028
Table 6 . 8  Initial rates vi and kinetic parameters for the microsomal oxidation of N-(3- 
butynyl)-N-methylformamide.
The kinetic parameters calculated for the total metabolism of microsomal 
oxidation were then cornpared with those for the microsomal oxidation of DMF and 
DMAC (Table 6.9).
DM F DMAC N -(3-bu tyny l)-N -
m ethylform am ide
Vmax 
(pM/nmol. P450)
1.95 ±0.12 4.08 ± 0.21 38.61 ± 6.91
Km
(mM-l)
0.60 ± 0.03 0.34 ± 0.04 114.3± 3.1
Vmax/Km 3.25 1 2 .0 0 0.34
Table 6.9 Comparison of the kinetic parameters for the total microsomal metabolism of 
DMF, DMAC and N-(3-butynyl)-N-methylformamide.
The results obtained indicate that the microsomal metabolism of N-methyl-N-(3- 
butynyl) formamide occurs less efficiently than that of DMF and DMAC. Despite these 
quantitative differences it is rational to argue that not major qualitative difference are 
presents in the metabolism of these three substrates.
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6.4.2 ESR spin trapp ing  s tudy  of the microsomal oxidation of DM F and  
DMAC
Since the spin trapping agent PBN was found to be very efficient in the 
stabilisation of the radicals formed during the microsomal oxidation of benzamides, the 
metabolism of DMF and DMAC were carried out in the presence of PBN.
The ESR. spectra obtained from chloroform/methanol extracts of microsomal 
incubations of solutions of 10 mM DMF or DMF after 30 minutes are illustrated in Figure 
6 .8  and 6.9. The metabolism-dependent signal is a triplet of doublets, for which the 
hyperfine splitting constants are summarised in Table 6.10.
a)
b)
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F igure 6 . 8  ESR spectra of extracts from microsomal oxidation of 10 mM DMF carried 
Out in the presence of 3 mM PBN: a) complete microsomal monooxygenase system and 3 
mM PBN, b) microsomes, 10 mM DMF and 3 mM PBN (without NADPH regenerating 
system) c) NADPH regenerating system and 3 mM PBN d) 10 mM DMF, 3 mM PBN 
and NADPH regenerating system e) and full system incubation.____________________
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F igure 6 .9  ESR spectra of extracts from microsomal oxidation of 10 mM DMAC 
carried out in the presence of 3 mM PBN: a) complete microsomal monooxygenase 
system and 3 mM PBN, b) microsomes, 10 mM DMAC and 3 mM PBN (without 
NADPH regenerating system) c) NADPH regenerating system and 3 mM PBN d) 10 mM 
DMAC, 3 mM PBN and NADPH regenerating system e) and full system incubation.
Substrate HN (G) afiH (G)
DMF 6.85 14.70
DMAC 7.35 15.68
Table 6 .1 0  Hyperfine splitting constants from the ESR. spectra obtained from 
microsomal oxidation of DMF and DMAC.
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The results demonstrate that during the microsomal oxidation a trappable radical
intermediate is formed. The formation of these radicals is metabolism dependent. The
postulated carbon-centred radicals formed during these reactions are illustrated in Figure
6 . 10.
O O
.CHa . J  CHs I  CHa
H3C----
\  \  \
■ CHg CH3 • CH2
B
F igure 6 .1 0  Postulated radicals formed during the microsomal oxidation of DMF and 
DMAC.
To characterise these radicals more fully, they were synthesised by the methods 
shown in equation 6.A and 6.B.
0  O OBujSnH/ r
kkgSiCI ii) PBN
Ph o
o
?  - u  OBujSnH/AIBN n .CH3 J CH
cHa ii) P B N  n ^ bu*
.0
The ESR. spectra recorded for these radicals in chloroform/methanol are illustrated in 
Figure 6.11, while their measured hyperfine splitting constants are summarised in Table 
6 . 11.
186
CHAPTER 6
a)
b)
32C3 asca
H / G
120
c)
d)
'32C0 H/G aaco
H/G
e)
Figure 6 .1 1  ESR. spectra of the PBN adducts of the radicals of Figure 6.10: spectrum 
1, from radical A; spectrum 2, from radical B and spectrum 3, from radical C.
. »N
(G )
o
jl
13.6Ô
\
CHa
OII 6.80 1 4 .SO
\
CH3 -PBN
0II 7.46 15.75-
\
CH3 -PBN
Table & .11 Hyperfine splitting constants of the ESR. spectra obtained from the PBN 
adducts of the radicals shown in Figure 6.10.
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The results indicates that the radical intermediate formed during the microsomal
metabolism of DMF and DMAC is the carbon-centred radical generated by hydrogen atom
abstraction from the a-carbon. Indeed, the ESR spectrum of the PBN adduct of the
carbonyl-centred radical is clearly different from that recorded from the microsomal
incubation of DMF, lacking the doublet hyperfine splitting normally observed because of
coupling to the hydrogen atom. Presumably, this is because the presence of the carbonyl
group allows the radical to enolise:
eu'
M02N Ph
On the base of the in vivo effects of the metabolism of DMF on the metabolising 
e n z y m e s ,29;30 it is arguable that a reactive intermediate is formed that destroy the enzyme 
system. The following part of the present study is intended to clarify the in vitro effect of 
metabolism of DMF and DMAC on microsomal P450.
6.5 The effect of in vitro metabolism of DMF and DMAC on P450
6.5.1 Inactivation of P450
The P450 content was measured at the end of the microsomal incubations of 
DMF and DMAC by the reduced differential spectra of the P450-CO complex as 
described by Omura and Sato.^
Figure 6.11 reports the time-dependence of the inactivation of microsomal P450 
after incubations with 5 mM DMF and DMAC.
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#—  Control + DMF 5 mM 
-o—  Control + DMAC 5 mM
Time (minutes)
Figure 6 .1 2  Time-course of P450 inactivation during the microsomal oxidation of 5 
mMDMF and DMAC. Control incubations are constituted by microsomes and NADPH 
regenerating systems.________________________________________________________
The results clearly demonstrate time-dependent loss of P450 during the 
microsomal metabolism of DMF and DMAC. Moreover, DMF is more efficient in this 
enzyme inactivation reaction. To quantify differences between the two substrates on the 
loss of P450, dose-dependent study of this reaction was performed. Table 6.12 reports 
the dose-dependent loss of P450 after 15 minute incubations with either DMF or DMAC.
[P450] (nmoles/ml) Loss %
Incubation DMF DMAC DMF DMAC
Control 1.80 ± 0.03 1.80 ± 0.03 0.00 0.00
+ Sub. 0.5 mM 1.60 ± 0.03 1.66 ± 0.03 11.2* 7.8*
+ Sub. 1.0 mM 1.46 ± 0.02 1.53 ± 0.04 18.9 ** 15.0*
+ Sub. 5.0 mM 1.35 ± 0.03 1.44 ± 0.03 25.0 ** 20.0 **
+ Sub. 10.0 
mM
1.32 ± 0.04 1.40 ± 0.02 26.7 ** 22.3 **
+ Sub.20.0 
mM
1.30 ± 0.0^ 1.38 ± 0.04 27.8 ** 24.4**
* P < 0.01, ** P < 0.001 Student’s t test.
Table 6 .1 2  Dose-dependent loss of P450 after 15 minute incubations of DMF and 
DMAC. The control incubations omitted substrate.
Dose-dependent inactivation of P450 during the oxidation of the substrates is 
present; at low concentration of amides the relationship between substrate concentration 
and enzyme inactivation is roughly linear.
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The results indicate that during the microsomal oxidation of DMF and DMAC a
reactive species is form that is able to attack the enzyme.
6.5.2 Loss o f m icrosom al haem
From the point of view of the enzyme, there are two potential targets for the 
reactive species generated during the reactions: one is the apoprotein, the other is the 
prosthetic haem group. The latter target seems to be the more likely as it is more readily 
available being in close proximity to the generated reactive species. A large number of 
reports indicate that covalent modification of the P450 haem group is one of the 
mechanisms of metabolism-based suicide inactivation of the enzyme.^^"^ Thus the effect 
of DMF and DMAC metabolism on the content of the microsomal haem was analysed. 
Microsomal haem content was measured by the pyridine/haemochromogen methods.^^ 
The time- and dose-dependent loss of microsomal haem determined during the oxidation 
of 5 mM solutions Of DMF and DMAC are reported in Figure 6.13 and Table 6.13, 
respectively.
I
-o
2 -I
30
Tim e (minutes)
Control
Control + DMF 5 mM 
Control + DMAC 5 mM
F igure  6 .1 3  Time-course of the loss of microsomal haem during the oxidation of 5 mM 
DMF and DMAC. Control Incubations are constituted by microsomes and NADPH 
regenerating systenis
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[ Haem] (nmoles/ml) Loss %
Incubations DMF DMAC DMF DMAC
C ontrol 2.64 ± 0.05 2.64 ± 0.05 0.00 0.00
+Sub. 0.5 
mM
2.40 ± 0.03 2.52 ± 0.03 9.10 * 4.6 NS
+Sub. 1.0 
mM
2.26 ± 0.02 2.38 ± 0.02 14.4 ** 9.9 *
+Sub. 5.0 
mM
2.11 ±0.03 2.26 ± 0.01 20.1 ** 14.4 **
+Sub. 10 mM 2.03 ± 0.02 2.14 ±0.03 23.1 ** 18.9 **
+Sub. 20 mM 2.01 ± 0.03 2.10 ± 0.02 23.9 ** 20.5 **
NS not significant, * P < 0.01, ** P < 0.001, Student’s t test.
Table 6 .1 3  Dose-dependent loss of microsomal haem after 15 minutes incubation of 
DMF and DMAC. The control incubations were constituted by microsomes and NADPH 
regenerating system.
A clear time- and dose-dependent loss of microsomal haem is present; as for the 
inactivation of P450, the full metabolic system is required indicating that such loss is 
metabolism-dependent. Comparison of these data with those for the inactivation of P450 
reveals that the amount of haem lost corresponds to the amount of P450 inactivated 
during these oxidations. The discrepancy between the percentage values for the loss of 
haem and the inactivation of P450 can be ascribed to the analytical method used for the 
determination of the haem, which measures total microsomal haem. Given the presence in 
the microsomes of heamoproteins other than P450, and of the presence of P450 isoforms 
not involved in the metabolism of the substrates, the content of haem determined is higher 
than that which is “enzymatically active” in these reactions.
Thus, it is possible to conclude that the prosthetic haem group of the P450 is the 
target of the reactive species generated during the oxidation of the substrates; modification 
of the haem results in the inactivation of the enzyme.
1 0 1
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The nature of the modification of the P450 haem occurring during the 
microsomal metabolism of DMF and DMAC was further investigated. The content of the 
microsomal haem at the end of the reactions was quantified by two different analytical 
methods: fluorimetric measurement of protoporphyrin IX, and HPLC analysis.
After 15 minutes microsomal incubations of DMF and DMAC the content of 
protoporphyrin IX was measured by the method of Morrison.48 Using the same 
incubation, the haem was also quantified by the pyridine/haemochromogen method. The 
results are reported in Tables 6.14 and 6.15.
Protoporphyrin IX Haem
Incubation [Proto. IX]
(nmoles/ml)
Loss % [Haem]
(nmoles/ml)
Loss %
Control 2.55 ±0.11 0.00 2.64 ± 0.05 0.00
+ DMF 
0.5 mM
2.51 ± 0.09 1.60 NS 2.40 ± 0.03 9.10*
+ DMF 
1.0 mM
2.48 ±0 .12 2.80 NS 2.26 ± 0.02 14.4 **
+ DMF 
5.0 mM
2.50 ±0 .13 2.00 NS 2.11 ±0.03 20.1 **
+ DMF 
10.0 mM
2.49 ± 0.20 2.40 NS 2.03 ± 0.02 23.1 **
+ DMF 
20.0 mM
2.47 ± 0 .1 4 3.20 NS 2.01 ± 0.03 23.9 **
NS not significant, * P <  0.01, ** P <  0.001, Student’s t test.
Table 6 .1 4  Determination of the content of microsomal protoporphyrin IX and haem 
after 15 minute incubations using DMF. The control incubations were constituted by 
microsomes and NADPH regenerating system.
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P ro toporphyrin  IX Haem
Incubation [Proto . IX]
(nmoles/ml)
Loss % [Haem]
(nmoles/ml)
Loss %
C ontrol 2.55 ±0.11 0.00 2.64 ± 0.05 0.00
+ DMAC 
0.5 mM
2.53 ±0.10 0.80 S 2.52 ± 0.03 4.6 NS
+ DMAC 
1.0 mM
2.50 ± 0.09 2.00 NS 2.38 ± 0.02 9.9 *
+ DMAC 
5.0 mM
2.46 ±0.21 3.60 NS 2.26 ± 0.01 14.4 **
+ DMAC 
10.0 mM
2,44 ± 0.23 4.40 NS 2.14 ±0.03 18.9 **
+ DMAC 
20.0 mM
2.48 ±0.18 2.80 NS 2.10 ±0.02 20.5 **
NS not significant, * P < 0.01, ** P < 0.001, Student’s t test.
Table 6 .15 . Determination of the content of microsomal protoporphyrin IX and haem 
after 15 minute incubations using DMAC. The control incubations were constituted by 
microsomes and NADPH regenerating system.
It is interesting to note that the metabolism-dependent loss of microsomal haem 
does not correspond to a loss of protoporphyrin IX. This observation can be rationalised 
by the two analytical methods used. It is probable that the modification occurring in the 
haem group does not permit the formation of the pyridine-haemochromogen complex 
resulting in an measurable loss of the haem. In contrast, the failure to determine a loss of 
protoporphyrin IX is probably due to the fact that the haem modification does not result in 
the loss of the tetrapyrrolic structure.
6.5.2.1 Analysis of the m odified microsomal haem
Ethanol-induced rat liver microsomes were incubated in presence of DMF or 
DMAC. After 30 minutes the content of microsomal haem was analysed by HPLC. 
Typical HPLC chromatograms obtained with 10 mM DMF and DMAC are illustrated in 
Figure 6.14.
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The peak with retention time 3.10 minutes, present in each chromatogram, was 
identified as unmodified haem by comparison of its UV/VIS spectra with that of a pure 
standard. The peaks with retention time 4.48 minutes of chromatogram b) and! 6.12 
minutes of chromatogram d) correspond to a modified haem occurring during the 
metabolism of the substrate, as indicated by their absence at time 0 minutes. The UV/VIS 
spectra, recorded by a diode array detector, of these metabolism-dependent modified 
haems are similar of that of pure haem, as illustrated in Figure 6. 15, indicating the haem 
nature of these compounds.
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F igure 6 .1 4  HPLC chromatograms of samples obtained from 30 minute microsomal 
incubations of 10 mM DMF and DMAC: a): microsomal oxidation system and 10 mM 
DMF at reaction time 0 minutes, b) microsomal oxidation system and 10 mM DMF at 
reaction time 30 minutes, c) microsomal oxidation system and 10 mM DMAC at reaction 
time 0 minutes, and d) microsomal oxidation system and 10 mM DMAC at reaction time 
30 minutes
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a)
b)
c)
F igure 6 .1 5  UV/VIS spectra of the DMF and DMAC metabolism-dependent haem 
modified products and of pure haem standard: a) compound with retention time 4.48 
minutes of chromatogram b) of Figure 6.14, b) compound with retention time 6.12 
minutes of chromatogram d) of Figure 6.14, and c) pure haem.____________________
Attempts to purify and characterise the modified haem products proved 
unsuccessful. However, a series of indirect observation into the nature of these 
compounds were obtained.
It seems plausible to assume that the a- carbon-centred radical species are 
responsible of the observed Inactivation of the metabolising enzyme. So, these radicals
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were chemically generated, by the methods outlined in reaction 6.A and 6.B (but omitting 
PBN), in the presence of haem. The products of these reactions were analysed by HPLC. 
The results obtained are illustrated in Figure 6.16.
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Figure 6 .1 6  HPLC chromatograms of the reaction between the chemically generated 
carbon-centred radicals and haem: a) from DMF, b) from DMAC. , ___________
The peak with a retention time of 3.10 minutes, present in both chromatograms, 
corresponds to the unchanged haem. The reaction of the DMF and DMAC derived 
carbon-centred radicals with haem gives rise to three modified haem products for each 
reaction. The product from the DMF reaction with a retention time of 4.48 minutes, and 
that from the DMAC reaction with a reaction time of 6.43 minutes, present identical 
UV/VIS spectra (Figure 6.17) to those produced in the microsomal incubation of DMF 
and DMAC.
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a) b)
c) d)
F igure 6 .17  Comparison of the UV/VIS spectra of the modified haem compounds 
obtained from the reaction between the DMF and DMAC chemically generated carbon- 
centred radicals and haem (spectra a) and b)), with the corresponding haem modified 
products formed in the microsomal oxidations of DMF and DMAC (spectra c) and.d)).
That reaction of the chemically generated radicals with haem produces three 
modified haem products, whereas the microsomal reactions produces only one modified 
haem product, is probably due to the availability, in the chemical reaction all the 
potentially attachable sites for the radical in the haem. In microsomal reactions, the 
apoprotein “protects” some of the haem sites from attack. In fact, a regioselectivity is 
reported for the modification of haem in many metabolism-based inactivations o f  
P450.^^î^ Covalent modification of the haem can arise by the attack of radical species at 
three different point of the haem molecule (Figure
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Figure 6 .1 8  Potential sites for covalent modification of haem by radical species.
The addition to the nitrogen atom of the haem of the carbon-centred radical 
generated from DMF and DMAC (route C) generates an aminal functionality:
O,
N-CH2—N
VCH3
Addition to the haem by routes A and B, involving C-C bond formation, should 
generate relatively stable compounds. Thus, the samples obtained from microsomal 
incubation of DMF and DMAC were then analysed by HPLC both before and after 
treatment with IM hydrochloric acid. The samples obtained from the reactions between 
the chemically generated radicals of DMF or DMAC and haem were similarly analysed. 
The results are illustrated in Figures 6.19 and 6.20, respectively.
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F i g u r e  6 . 1 9 .  HPLC a n a l y s i s  o f  t h e  s a m p l e s  o b t a i n e d  f r o m  m i c r o s o m a l  i n c u b a t i o n s  o f  
DMF a n d  DMAC, b e f o r e  a n d  a f t e r  IM h y d r o c h l o r i c  a c i d  t r e a t m e n t :  a )  m i c r o s o m e s  a n d  
DMF w i t h o u t  a c i d  t r e a t m e n t ,  b )  m i c r o s o m e s  a n d  DMF a f t e r  a c i d  t r e a t m e n t ,  c )  
m i c r o s o m e s  a n d  DMAC w i t h o u t  acid treatment, d) m i c r o s o m e s  a n d  DMAC a f t e r  a c i d  
t r e a t m e n t .
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Figure 6 .2 0  HPLC analysis of the samples obtained from the reaction between the 
DMF and DMAC chemically generated carbon centred radical and haem, before and after 
IM hydrochloric acid treatment: a) DMF radical and haem without acid treatment, b) DMF 
radical and haem after acid treatment, c) DMAC radical and haem without acid treatment 
d) DMAC radical and haem after acid treatment.  _________________________
The acid treatment of the modified haem obtained from the reaction of the 
chemically generated DMF and DMAC radicals with haem results in the disappearance of 
the peak with retention time ca. 2.5 minutes for both DMF and DMAC radical. Similar 
acid treatment of the sample obtained from microsomal incubations does not result in any 
modification of the HPLC chromatograms. These results suggest that the 2.5 minutes 
peaks correspond to haem modified at one or more nitrogen atom of the tetrapyrrolic ring. 
Thus, the modified haem originating from the microsomal oxidation of DMF and DMAC 
is probably the result of radical addition at the vinyl or meso positions._________ ______
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6.5,3 Effect of PBN, glutathione (GSH), CO and vitamin C on the
inactivation of P450 and loss of haem
The final part of this study of the metabolism-based Inactivation of P450 during 
the microsomal oxidation of DMF and DMAC involved the effects of the enzyme inhibitor 
CO and of various radical trapping agents.
Microsomal oxidations of DMF and DMAC were performed in the presence and 
absence of saturating concentrations of CO. The P450 content was quantified at the end 
of the reaction period by the method of Omura and Sato .^  Table 6.16 summarises the 
results obtained after 15 minutes incubation of 10 mM DMF and DMAC.
Incubation [P450] (nmoles/ml) Loss %
C ontrol 1.85 ± 0.03 0.00
+ DMF 1.29 ± 0.04 30.3 *
+ DMF + CO 1.81 ±0.08 2.2 NS
+ DMAC 1.40 ± 0.02 24.4*
+ DMAC + CO 1.86 ± 0.05 0.00
NS not significant, * P < 0.001, Student’s t test.
Table 6 .1 6  Effect of a saturating concentration of CO on the metabolism-dependent 
inactivation of P450 incubations of 10 mM DMF and DMAC for 15 minutes. Control 
incubations are constituted by microsomes and NADPH regenerating system.
Not surprisely, the presence of a saturating concentration of CO completely 
inhibits the inactivation of the enzyme, due the well known inhibitory effect of CO on the 
P450 metabolism. The results confirm that the metabolic transformation of the substrates 
is required for the inactivation of the enzyme.
The effects of radical trapping agents on the loss of microsomal haem during 
substrate oxidation was then investigated. Microsomal incubations of 10 mM DMF and 
DMAC were performed for 15 minutes in the presence and absence of 5 mM PBN, 10 
mM GSH and 10 mM vitamin C. The results are summarised in Table 6.17.
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Incubation [H aem ]
(nmoles/ml)
Loss %
C ontrol 2.67 ± 0.03 0.00
+ DMF 2.10 ±0.05 21.4 **
+ DMF + PBN 2.44 ± 0.04 8.6 *
+ DMF + GSH 2.11 ±0.06 21.0 **
+ DMF + Vitamin C 2.09 ± 0.03 21.7 **
+ DMAC 2.28 ± 0.02 14.6 **
+ DMAC + PBN 2.50 ± 0.03 6.4*
+ DMAC + GSH 2.26 ± 0.04 15.4*
+ DMAC + Vitamin C 2.29 ± 0.04 14.2*
* P < 0.01, ** P < 0.001, Student’s t test.
Table 6 .1 7  Effects of 5 mM PBN, 10 mM GSH and 10 mM vitamin C on the loss of 
microsomal haem after 15 minute incubations of 10 mM DMF and DMAC. Control is 
constituted by microsomes and NADPH regenerating system. Incubation in presence of 
PBN, GSH and vitamin C but in absence of substrate does not result in any change of the 
microsomal haem content.
Neither GSH nor vitamin C are effective in preventing the loss of microsomal 
haem. Incubations involving different concentrations of GSH and vitamin C do not result 
in any protection of haem loss occurring. However, the presence of PBN results in a 
protection of the loss of haem by about 50 %. Since it is reported that PBN interacts with 
P450,50 it is possible that inhibition of the substrate metabolism is responsible for the 
decrease in inactivation of the haem. This possibility can be ruled out on the basis of the 
data in Chapter 3 on the effect of PBN on the metabolism of N,N-dimethyl benzamide. 
The inability of GSH and vitamin C to prevent haem loss is probably due to their 
increased hydrophilicity compared with PBN and consequent reduced access to the active 
site of the enzyme.
6.6 Conclusions
It has been widely reported that the in vivo and in vitro metabolism of DMF and 
DMAC occurs via P450-mediated hydroxylation of the carbon a- to nitrogen leading to 
the formation of an N-hydroxylmethyl-N-methylamide.^^»^^ The in vivo metabolism of 
DMF also occurs via oxidation of the carbonyl moiety of the substrate, resulting in the
2 0 2
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formation of thiocarbamates that are believed to be major species responsible of the
metabolism-dependent toxicity of this compound. However, such a metabolic route has
not been reported in vitro. The P450 isoenzyme involved in the oxidation of DMF and
DMAC is reported to be the ethanol-induced P4 5 0 2 El.^^î26 From the data obtained in the
present study, it appears that the metabolism of DMAC is approximately 4 times greater
than that of DMF. No oxidation of the carbonyl moiety of DMF was observed under any
of the experimental conditions used during this study. This result is not too surprising, as
it has been reported that N-methyl oxidation of DMF is 20 times more efficient than
oxidation of the carbonyl group.^4;16;27
By using a substrate probe, structurally related to DMF, capable of trapping 
intramolecularly a carbon-centred radical, and by using PBN as a spin trap, the formation 
of a carbon-centred radical intermediate during the oxidation of DMF and DMAC has 
been demonstrated. The intermediates were identified as the radicals centred on the a -  
carbon (Figure 6.21).
.CHg (W .CHa
H '  N '
. W  .CHz
Figure 6 .2 1  Carbon-centred radical intermediates identified during the microsomal 
oxidation of DMF and DMAC.
It is concluded that microsomal oxidation of DMF and DMAC occurs via 
hydrogen atom abstraction from the a-carbon leading to the formation of a carbon-centred 
radical intermediate. This intermediate can undergo either hydroxyl group insertion from 
the P450 haem-activated oxygen complex to give an N-hydroxylmethyl-N-methylamide 
product, or it can attack the haem leading to inactivation of the enzyme. Indeed, 
microsomal oxidations of DMF and DMAC results in metabolism-dependent inactivation 
of P450, that is completely inhibited by the presence of a saturating concentration of CO. 
The target of the radical species is the haem prosthetic group of the enzyme. P450
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inactivation is due to a modification of the haem moiety without destruction of its 
protoporphyrin IX tetrapyrrolic structure. Reactions of chemically generated carbon- 
centred radicals with haem results in the formation of identical haem modified products. 
The presence of the spin trapping agent, PBN, in the microsomal incubation of the 
substrates significantly protects against the loss of haem. The hydrophilic radical trapping 
agents, GSH and ascorbic acid, completely fail to prevent the haem modification during 
these microsomal oxidations. The structure of the modified haem products formed during 
the microsomal oxidations of DMF and DMAC remains to be investigated. The evidence 
available from the current study implies a compound that retains its tetrapyrrolic structure 
and which is modified at the vinyl or meso positions rather than at a pyrrole N-atom. 
Further investigation is needed to isolate and characterise these P450-derived DMF- and 
DMAC-dependent haem products.
On the basis of these results a scheme for the metabolism of DMF and DMAC is 
proposed in Figure 6.22.
\
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Figure 6 .2 2  Proposed mechanism for the P450-dependent metabolism of DMF and 
DMAC.
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CHAPTER 7
Metabolism-dependent inactivation of microsomal P450 by tertiary amides
The present chapter will describe the studies related to the effects of the P450- 
dependent metabolism of tertiary amides on the enzyme itself.
7.1 Introduction
It has been reported that the time-course of the microsomal metabolism of tertiary 
amides presents a bilinear progress characterised by an initial short-lived (< 5 minutes) 
burst followed by a longer linear phase with lower rate of oxidation.^ Similar bilinear 
progress curves have been observed also for the oxidation of halobenzenes by 
phenobarbital-induced rat liver microsomes.^»^ The origin of this effect can be attributed 
to two mechanisms
• enzyme inactivation, or
• the presence of a minor but kinetically significant isoenzyme of the P450.
The latter hypothesis was proposed to occur during the microsomal metabolism 
of N,N-dimethylbenzamide. 1 This hypothesis was based on the supposition that there is 
no obvious way to generate a particularly reactive metabolite from N,N-dialkyl^ides.^ 
However, the data reported in Chapter 6 indicate that, during the microsomal oxidation of 
N,N-dimethylformamide and N,N-dimethylacetamide, P450 undergoes inactivation. The 
results imply that the metabolism-based inactivation of the enzyme is due to the covalent 
modification of its prosthetic haem group by the carbon-centred radical intermediates 
formed during the reaction.
Here the effects of the microsomal metabolism of other N,N-dialkylamides on 
P450 are examined. The substrates used were N,N-dimethylbenzamide (DMB) and N- 
benzyl-N-methylbenzamide (BMB) (Figure 7.1). Given that the N-benzyl group is much
208
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more reactive than N-methyl,* and that the benzylic- carbon-centred radical intermediate 
should be more stable due to resonance stabilisation, it might be expected that the 
inactivation of P450 by this substrate should be more marked.
N,N-dimethylbenzainide (DMB) N-benzyl-N-methylbenzamide (BMB)
Figure 7 .1  Substrates used in the present study.
7.2 Inactivation of P450
Following incubation of phenobarbital-induced rat liver microsomes with the 
appropiate substrate, the P450 content was measured from the reduced spectrum of the 
P450-CO complex, as described by Omura and S ato .^  Initially, the concentration of the 
enzyme was monitored over 2 hour microsomal incubations of 5 mM DMB and BMB 
(Figure 7.2).
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Figure 7.2 Time-course for the inactivation of P450 during the microsomal oxidation of
5 mM N,N-dimethylbenzamide and N-benzyl-N-methylbenzamide.__________________
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more reactive than N-methyl,^ and that the benzylic- carbon-centred radical intermediate 
should be more stable due to resonance stabilisation, it might be expected that the 
inactivation of P450 by this substrate should be more marked.
N,N-dimethylbenzamide (DMB) N-benzyl-N-methylbenzamide (BMB)
Figure 7 .1  Substrates used in the present study.
7.2 Inactivation of P450
Following incubation of phenobarbital-induced rat liver microsomes with the 
appropiate substrate, the P450 content was measured from the reduced spectrum of the 
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Microsomal metabolism of DMB and BMB results in time-dependent inactivation 
of P450. The inactivation of the enzyme occurs within the first 5 minutes of the reaction, 
subsequently reaching a plateau where not significant further loss is observed.
Subsequently, to quantify the metabolism-dependent inactivation of P450, a 
dose-dependence analysis was performed by incubating phenobarbital-induced rat liver 
microsomes for 15 minutes in presence of a range of substrate concentrations between 
0.5 and 20 mM. The results (Table 7.1) show a dose-dependent inactivation of P450 that 
progresses linearly up to a substrate concentration of 10 mM; thereafter, an increase in the 
concentration of the amides beyond 10 mM produces smaller increase in the extent of 
enzyme inactivation. More especially, enzyme inactivation by BMB is greater by a factor 
of ca. 2.
[P450] (nm oles/m l) Loss %
Incubations DMB BM B DMB BMB
C ontrol 1.67 ± 0.08 1.67 ± 0.08 0.00 0.00
+ Sub. 0.5 
mM
1.60 ± 0.06 1.49 ± 0 .05 4.2 * 10.8 **
+ Sub. 1.0 
niM
1.50 ± 0.04 1.30 ± 0.03 10.2 ** 22.2 ***
+ Sub. 5.0 
mM
1.39 ± 0 .03 1.10 ± 0 .0 4 16.8 *** 34.2 ***
+ Sub. 10 
mM
1.36 ±0 .05 1.07 ± 0 .06 18.6 *** 36.0 ***
+ Sub. 20 
mM
1.35 ± 0 .0 6 1.08 ± 0.04 19.2 *** 35.4 ***
* P < 0.05, ** P < 0.01, *** P <  0.001, Student’s t test.
Table  7 .1  Dose-dependent inactivation of P450 during 15 minute microsomal 
incubations of DMB and BMB.
The greater extent of inactivation of P450 by BMB, compared to that by DMB, 
can be ascribed to a higher degree of metabolism of BMB. Indeed, for the para-chlovo 
analogue of BMB, N-dealkylation is preferred to N-demethylation.^ To examine whether
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the higher production of carbon-centred radical intermediates» is related to the different 
extent of P450 inactivation, the rate and the time-course of the microsomal metabolism of 
the substrates was then analysed. The results obtained are reported in Table 7.2 and
v\ (um oles/m in/nm oles P450) j
Substrate Total metabolism N -dem ethylation N -dealkylation
DMB 51.6± 2.5 25.8 ± 1.9
BMB 70.0 ± 3 .6 15 ± 1.2 55 ± 2.3
Tabie 7 .2  Rate of microsomal metabolism of DMB and BMB.
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Figure 7 .3  Time course for the microsomal metabolism of 5 mM DMB and BMB.
Both inactivation of enzyme and rate of substrate metabolism exhibit an initial 
burst in the first five minutes of the reactions. Possibly, the initial high rate of metabolism 
results in an inactivation of the enzyme which effects the overall rate of metabolism of the 
substrate. Alternatively, the substrate may have high affinity for an isoform of P450 that 
is particularly sensitive of metabolism-based inacti vation.
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7.3 Loss of microsomal haem
Following, microsomal incubations of DMB and BMB, the haem content was 
measured by the pyridine/haemochromogen method^ and by the fluorimetric 
determination of the protoporphyrin IX,^ as described in the experimental section. The 
concentration of haem was monitored for microsomal incubations of 5 mM DMB or MBB 
over two hours. Subsequently, the effect of different concentrations of substrate on the 
microsomal haem content was analysed after incubation for 15 minutes. The results are 
illustrated in Figure 7.4 and summarised in Tables 7.3 and 7.4, respectively.
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Figure 7.4 Time-course for the loss of microsomal haem during the oxidation of 5 mM 
N,N-dimethylbenzamide and N-benzyl-N-methylbenzamide._________________________
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[H aem ] (nmoles/ml) [P rotoporphyrin IX]
Incubations (nm oles/m l) Loss % (nm oles/m l) Loss %
Control 2.00 ± 0.05 0.00 1.95 ± 0.06 0.00
+ Sub. 0.5 
mM
1.90 ± 0 .03 5.00 * 1.91 ± 0.10 2.10 NS
+ Sub. 1.0 
mM
1.81 ± 0.05 9.5 * 1.90 ±0.09 2.6 NS
+ Sub. 5.0 
mM
1.72 ± 0.03 14.0 ** 1.98 ± 0.08
+ Sub. 10 
mM
1.70 ± 0 .0 6 15.0 ** 1.88 ±0.11 3.6 NS
+ Sub. 20 
mM
1.68 ± 0.04 16.0 ** 2.00 ± 0.06
NS = not significant, * P < 0.01, ** ?  < 0.001, Student’s t test.
Table 7 .3  Dose-dependent loss of microsomal haem during a 15 minute microsomal 
incubation of DMB.
[H aem ] (nmoles/ml) [Protoporphyrin  IX]
(nmoles/ml)
Incubations (nm oles/m l) Loss % (nm oles/m l) Loss %
Control 2.00 ± 0.05 0.00 1.95 ± 0.06 0.00
+ Sub. 0.5 
mM
1.74 ± 0 .0 4 13.0 * 1.90 ±0.12 2.60 NS
+ Sub. 1.0 
mM
1.66 ± 0.03 17.0 * 1.88 ±0.11 3.6 NS
+ Sub. 5.0 
mM
1.50 ± 0 .06 25.0 * 1.90 ±0.09 2.60 NS
+ Sub. 10 
mM
1.48 ±0 .07 26.0 * 2.01 ± 0.13
+ Sub. 20 
mM
1.47 ±0 .05 26.5 * 1.87 ±0.12 4.2 NS
NS = not significant, * P < 0.001, Student’s t test.
Table. 7.4. Dose-dependent loss of microsomal haem during a 15 minute microsomal 
incubation of BMB.
The loss of microsomal haem is time-and dose-dependent and presents an 
equimolar equivalence with the inactivation of P450. Moreover, as observed for the
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inactivation of P450, the effects of the BMB-dependent loss of haem is approximately
twice that due to the metabolism of DMB. This is probably due to the major rate of the
microsomal metabolism of this substrate which results in a higher formation of reactive
species. Moreover, as observed for the inactivation of P450 by DMF and DMAC
(Chapter 6), the loss of microsomal haem is observed when the haemochromogen
pyridine method is used, while no significant loss was observed when measuring the
content of microsomal protoporphyrin IX fluorimetrically. These results can be
interpreted as indicating a modification of haem, during substrate metabolism, that does
not result in the loss of its tetrapyrrolic structure.
7.4. Effects of CO, PBN, GSH and ascorbic acid on the inactivation of 
P450 and microsomal haem loss bv DMB and MBB
The content of P450 was measured after 15 minute microsomal incubations of 5 
mM DMB and BMB carried out both in presence and absence of a saturating 
concentration of CO. The results obtained (Table 7.5) indicate that inactivation of P450 
does not occur if microsomal incubation is performed in the presence of CO.
[P 450] (nmoles/ml) Loss %
Incubation DMB BMB DMB BMB
C ontrol 1.70 ± 0 .08 1.70 ± 0 .08 0.00 0.00
+ CO 1.67 ± 0.07 1.65 ± 0.07 1.8 NS 0.00
+ Substrate 1.47 ± 0.03 1.25 ± 0.04 13.6 * 22.5 *
+ Substrate 
+ CO
1.67 ± 0.05 1.68 ± 0.06 1.8 NS 1.2 NS
* P < 0.001, NS = not significant Student’s t test.
Table 7 .5  Effect of a saturating concentration of CO on the inactivation of P450 during 
15 minute microsomal incubations of 5 mM DMB and BMB.
Microsomal incubations of 5 mM substrate carried out in presence of PBN, 
GSH and ascorbic acid and analysed after 15 minutes, give rise to the results in Table 
7.6.
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[Haem] (nmoles/ml) Loss %
Incubation DMB BMB DMB BMB
Control 2.00 ± 0.05 2.00 ± 0.05 0.00 0.00
+ Substrate 1.75 ± 0 .02 1.57 ± 0.03 12.5 ** 21.5 **
+ Substrate 
+ 1 mM PBN
1.83 ± 0.03 1.79 ±0 .04 8.5 * 10.5 *
+ Substrate 
+ 10 mM 
GSH
1.72 ± 0 .04 1.55 ± 0.04 14.0 ** 22.5 **
+ Substrate 
+ Ascorbic 
acid 10 mM
1.73 ± 0 .06 1.56 ±0 .08 13.5 ** 22.0 **
NS = not significant, * P < 0.01, ** P < 0.001, Student’s / test.
Table 7 .6  Effect of the presence of PBN, GSH and ascorbic acid on the loss of 
microsomal haem during 15 minute microsomal incubations of 5 mM DMB and BMB.
The results demonstrate that the presence of the spin trapping agent PBN results 
in a significant protection of the loss of microsomal haem during the DMB and BMB 
oxidations. That prevention by PBN is not complete probably can be rationalised by 
competitive reaction of the carbon-centred radical with PBN and haem itself.
In conclusion, the reactive species responsible for the observed loss of
microsomal haem during the metabolism of DMB and BMB are the carbon-centred radical
intermediates generated by the P450-dependent hydrogen atom abstraction from the 
carbon a -  to nitrogen.
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7.5 Conclusions
The results obtained in the present study show significant metabolism-based 
time-and dose-dependent inactivation of P450 during the microsomal oxidation of DMB 
and BMB. The time-dependence of the enzyme inactivation displays a bilinear progress 
with 90% occurring within the first 10 minutes of the reaction. Microsomal metabolism of 
DMB and MBB present a bilinear progress, with a burst in the first five minutes of the 
reaction. Comparison of the progress of substrate metabolism with that for P450 
inactivation indicates a common initial burst. These results are in agreement with the 
proposal suggested by Hall and Hanzlik^ of the inactivation of a minor but kinetically 
significant isoenzyme of P450. Inactivation of the enzyme is due to covalent modification 
of its prosthetic haem group by the carbon-centred radicals generated during the 
oxidation. Carbon-centred radical intermediates have been identified during the 
microsomal metabolism of DMB and BMB by PBN spin trapping (Chapter 3). Moreover, 
the presence of PBN in the microsomal incubations of the substrates results in a 
significant reduction in the loss of haem, consistent with radical intermediates being 
responsible for the m odification o f  the prosthetic group of the enzyme.
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E x p erim en ta l 
8 .1  In s tru m en ta tio n
NMR spectra were recorded using Perkin Elmer R12B (^H), and Jeol EX 90Q 
Fourier and Jeol 400 FT spectrometers (^H and ^^C). UV-VIS spectra were recorded 
using a Kontron Uvikon 810P spectrophotometer, and infra-red spectra were recorded 
using a Nicolet 205 FTIR spectrophotometer. Gas chromatography was performed using 
a Perkin Elmer chromatograph equipped with a BP5 20 m x 0.5 mm ID column and FID 
detector. GC/MS were performed using a Hewlett-Packard 5809-A chromatograph 
equipped with a BP5 20m x 0.5 mm column connected to a mass Lab 25-250 mass 
spectrometer. HPLC was carried out using a Varian 5000 chromatograph equipped with a 
25 cm X 5 mm Cig Jones chromatography analytical column, with a Cecil 2112 variable 
wavelength detector and a Waters integrator. Diode array HPLC was performed using a 
Varian 9060 polychrom diode array detector. ESR spectra were recorded using a Varian 1 
109 X band spectrometer. Melting points were recorded using a Pye model 290 melting 
point apparatus. Elemental analysis were carried out by Medac Ltd., Brunei University, 
Uxbridge, England using a Perkin Elmer 240 C elemental analyser model 3400 data 
station.
8 .2 . Solvents and  reag en ts  
8 .2.1  S ubstra tes  and  reag en ts
N,N-Dimethylbenzamide, N-methylbenzamide, N-benzylbenzamide, N,N- 
dimethylaniline, N-methylaniline, N-benzoylpiperidine, N-/crr-butyl-a-phenylnitrone, N- 
m e thy lpyrro lid inone , N -m e th y lp ip e r id in o n e ,  N -m e thy lcap ro lac tam , N- 
methylsuccinimide, glutarimide, 0-valerolactam, 2-pyrrolidinone, e-caprolactam, 
succinimide, N,N-dimethylformamide, N,N-dimethylacetamide, N-methylformamide, N-
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methylacetamide, haemin, pyridine, diisopropylamine, acetylsalicilic acid, ethyl
chloroformate, dimethylamine, monomethylamine, triethylamine, chloroacetonitriie, 
paraformaldehyde, chlorotrimethylsilane, acryloyl chloride, 3-hydroxydihydrofuran, 3- 
(aminomethyl)pyridine, lithium diisopropylamide, molybdenum trioxide, 25% (w/v) 
hydrogen peroxide, hexamethylphosphorictriamide, n-butyllithium, S-cotinine, 4-bromo- 
1-butene, potassium phthalimide, hydrazine monohydrate, benzoyl chloride, N- 
benzoylpiperidinone, benzyl bromide, N,N-dimethylcarbamyl chloride, 4-toluenesulfonyl 
ch lo r id e ,  m e th y l t r ip h e n y lp h o s p h o r iu m  io d id e ,  2-carboxybenzaldehyde, 
azobis(cyclohexane-carbonitrile) (AIBN), tributyltin hydride, glutaric anhydride, 
adipamide, adipoyl chloride, pyroglutamic acid, benzene, phosphorus pentoxide, 
methanesulfonic acid, S-(-)-l -phenyl ethyl isoci an te, acetophenone, 3-benzoyl propionic 
acid, S(-)-a-methylbenzylamine, R(+)-a-methylbenzylamine, iodomethane, pyridine, 
(S)-2,2,2-trifluoro-l-(9-anthryl)ethanol and 4-piperidinone hydrochloride were 
purchased from Aldrich. NADP", glucose-6-phosphate, glucose-6-phosphate 
dehydrogenase, haemin, tetraphenylporphirinatoiron (111) chloride, and terî- 
butylhydroperoxide were purchased from Sigma.
8 .2 .2  Solvents
Benzene BDH Analar grade dried by sodium and distilled onto molecular sieves. 
Ethanol was 97%, dried by a 12 hour reflux over magnesium and distilled when required. 
Ether and hexane used for microcolumn chromatography were BDH sodium dried and 
Rathbum glass distilled respectively. Both were sodium dried and distilled when 
required. Acetonitrile was BDH Analar and was dried by calcium hydride and distilled 
accordingly. Dichloromethane used for the biomimetic studies, was distilled onto 
molecular sieves and stored at 5° C in the dark. Tetrahydrofuran was distilled from 
calcium hydride prior used. All solvents used for HPLC were Rathbum HPLC grade and 
were used without further purification.
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8 .3 S ynthesis
N -C yanom ethyl-N -m ethylaniline: N-methylaniline (0.05 mol, 5.36 g) and 
potassium carbonate (0.05 mol, 6.0 g) were dissolved in dry acetonitrile (50 cm-^). To 
this solution was added chloroacetonitriie (0.055 mol, 3.82 g). The mixture was refluxed 
for 2 h, then left at room temperature, under stirring, for a further 24 h. At the end of the 
reaction, the solution was filtered and the solvent removed under reduced pressure. The 
solid residue was resuspended in diethyl ether (50 cm^), the organic phase washed with 
water ( 2 x 1 5  cm^) and dried (MgSO^). The solvent was removed in vacuo  to give the 
desired product. Bmax/cm'*: 3080, 3040, 2200, 1600, 1580, 1500, 1400, 1300, 1220. 
Ô H (CDCI3): 2.75(3H, s), 3 .9(2H , s),7.1 (5H, m). m/z (%); 146 (30) (M+), 120(15), 
106 (100), 91 (35), 77 (25). C9 H 10N2 requires: C; 73.97 %; H: 6.85 %; N; 19.18 % 
Found: C: 74.14 %; H: 7.00 %; N: 19.34 %.
N -C yanom ethyl-N -m ethylbenzam ide: N-methylbenzamide (0.01 mol, 
1.34 g) and paraformaldehyde (0.5 g) were dissolved in chlorotrimethylsilane (30 cm^); 
the solution was refluxed for 2 h, the solid filtered off, and the solvent removed under 
reduced pressure. The solid residue was dissolved in dry tetrahydrofuran (50 cm^) and to 
this solution was added sodium cyanide (0.01 mol, 0.5 g). The mixture was refluxed for 
3 h, then left at room temperature for further 24 h. The mixture was filtered and the 
solvent removed under reduced pressure. The solid residue was resuspended in diethyl 
ether (50 cm^), the organic phase was washed with water (2 x 15 cm^) and dried 
(MgSO^). The solvent was removed in vacuo to give the desired product. Umax/cm"^: 
1680, 1500, 1300. ÔH(CDCl3 ): 3.14 (3H, s), 4.1 (2H, s), 7.35 (5H, m). m/z (%): 174 
(20), 148 (10), 135 (90), 105 (100), 77 (100). C 10H 10N2 O requires: C: 68.96 %; H: 
5.75 %; N: 16.09 %. Found: C: 69.15 %; H: 5.81 %; N: 16.25 %.
N ,N -D im ethyl-2-hydroxybenzam ide: Acetylsalicylic acid (0.1 mol, 18.0 
g), triethylamine (0.1 mol, 10.1 g) and ethyl chloroformate (0.1 mol, 10.85 g), were 
dissolved in dry tetrahydrofuran (50 cm^). The solution was cooled to -10 °C, and a large
2 2 0
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excess of dimethylamine was added. The reaction mixture was brought at room
temperature and left, under stirring, for 1 h. The solid was filtered off, the solvent
removed under reduced pressure and the solid residue resuspended in 2.0 M sodium
hydroxide solution (50 cm^). The solution was refluxed for 1 h and after cooling the pH
was brought to 7 by addition of concentrated hydrochloric acid. The solution was
extracted with dichloromethane (50 cm^), washed with 1 M hydrochloric acid (1 x 20
cm^), saturated sodium bicarbonate (2  x 10  cm^), water (2  x 10  cm^) and dried
(MgSO^). The solvent was removed to give the desired product, m.p.: 112-116 ®C.
3450, 1680, 1600, 1520, 1500, 1400. Ô h (CDCI3): 3.12 (6 H, s), 7.1 ( 4  H, 
m), 8 .1.(IH, br). m/z (%): 165 (55), 151 (15), 121 ( 1 0 0 ), 93 (25 ), 44 (60). C9H 11NO2 
requires: C: 65.45 %; H: 6 .6 6 %; N: 8.48 % Found: C: 65.73 %; H: 6.21 %; N: 8.21 %.
N>Methyl-2-hydroxybenzainide: A similar procedure to the synthesis of 
N,N-dimethyl-2 -hydroxybenzamide was adopted, substituting methylamine for 
dimethylamine. m.p.: 130-133 °C. "Umax/cm"^ : 3450, 3300, 1650, 1600, 1500, 1480, 
1380. Ô h(CDC13): 2.9 (3H, d. J=5 Hz). 6.4 (IH. br.), 7.0 (4 H, m). 9.3 (IH , br.). 
m/z (%): 152 (50), 137 (10), 121 (100), 93 (25). CgHgNOo requires: C: 63.16 %; H: 
5.92 %; N: 9.21 %. Found: C: 63.52 %; H: 6.10 %; N: 9.40 %.
3-M ethyl-4-oxobenz-l,3-oxazinane: N-Methyl-2-hydroxybenzamide (2.0 
mmol, 0.3 g), concentrated hydrochloric acid (0.05 cm^) and paraformaldehyde (20 mg) 
were dissolved in dry acetonitrile (30 cm^). The solution was refluxed for 2 h, cooled, 
filtered and the solvent removed under reduced pressure. The solid residue was 
resuspended in dichloromethane (20 cm^), washed with water (2 x 10 cm^ ) dried 
(MgS0 4 ), and the solvent was removed in vacuo to give the desired product. D max/cm ' 
3080, 1680, 1600, 1520, 1500, 1400, 1350. ô H (CDCI3): 3.00 (3H, s), 5.1 (2H, s), 
7.30 (4H, m). m/z (%): 163 (30), 148 (10), 120 (40), 93 (100). C10H9NO2 requires: C:
68.57 %; H: 5.14 %; N: 8.00 %. Found: C: 68.72 %; H: 5.31 %; N: 8.11 %.
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N-Methylacrylamide: To an ice cold solution of acryloyl chloride (0.1 mol,
9.05 g) in dry diethyl ether (100 cm^) was added, under stirring, dry methylamine in 
large excess. The solution was maintained at room temperature for 30 minutes, the solid 
filtered off, and the solvent removed under reduced pressure to give a solid residue that 
was resuspended in dichloromethane (50 cm^), washed with brine (2 x 10 cm^), water (2 
X  10 cm^) and dried (MgSO^). The solvent was removed to give the desired product as 
pale yellow liquid. Umax/cm'^: 3380, 1700, 1620, 1580. ô H (CDCI3): 3.14 (3H, s), 4 .2  
(IH, br.), 5.42-5.72 (IH , m), 6.14-6.65 (2H, m). m/z (%): 85 (40) (M+‘), 58 (60) 
(M+*- CH2=CH), 55 (100) (M+" - NHMe). C4H7NO requires: C: 56.47 %; H: 8.23 %; 
N: 16.47 %. Found: C: 56.20 %; H: 8.00 %; N: 16.70 %.
N-Pyridylmethylacrylamide: The procedure for N-methylacrylamide was 
adopted using 3-(aminomethyl)pyridine in place of methylamine. Dmax/cm'^: 3400, 1690, 
1600. ÔH(CDCI3): 3.4 (2 H, d) 4.4 (IH , d), 5.6 (IH, m), 6 .0  (2 H, m), 6 .7  (IH , br),
7.2 (IH , m), 7.6 (IH, m), 8.4 (2 H, m). m/z (%): 162 (30) (M+*), 135 (45) (M+* 
■C^ H2=CH), 107 (80) (NHCH2Pyr), 55 (100) (M"*"*- NHCHiPyr). C9H 10N2O requires: 
C: 66.67%; H: 6.17 %; N: 17.28 %. Found: C: 66.90 %; H: 5.98 %; N: 16.96 %.
N-M ethyl-N-3-pyridylmethylacrylamide: N-(3-pyridylmethyl)acrylamide 
(0.05 mol, 8.1  g) was dissolved in dry tetrahydrofuran (50 cm^). Under a N2 atmosphere 
and at -10 °C, a lithium diisopropylamide (0.045 mol, 22.5 cm^) 2.0 M solution in 
hepthane/tetrahydrofuran was added. The mixture was left under stirring at room 
temperature for 15 minutes, then iodomethane (0.06 mol, 8.5 g) was added dropwise. 
The mixture was kept at room temperature under stirring for 1 h, then the solvent 
removed and the solid residue was resuspended in dichloromethane (50 cm^). The 
solution was washed with water (2  x 10  cm^) and dried (MgSO^). After concentration the 
crude product was p u rified  by silica  gel chromatography using 9 :1  
dichloromethane/methanol eluent.'Umax/cm‘ :^ 3010, 1690, 1600. ô H (CDCI3 ): 3.0 (3H, 
s), 4.66 (2H, s), 5.7-5.77 (IH , m), 6.4-6.71 (2H, m), 7.2-7.8 (4H, m). m/z (%): 176 
(25) (M+‘), 148 (60) (M+* - CH2=CH), 121 (50) (M+- - CHi^CHCO), 79 (15) (Pyr),
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55 (100) (CH2=CHCH). C 10H 12N2O requires: C: 68.18 %; H: 6.82 %; N: 15.90 %.
Found: C: 68.40 %; H: 7.04 %; N: 16.21 %.
N ,N -D im eth y l a c ry la m id e :  T he m ethod  fo r sy n thesis ing  N- 
methylacrylamide was followed substituting dimethylamine for methylamine. 1 )max/cm'^: 
1710, 1640, 1580. ÔH (CDCI3 ): 3.10 ( 6  H, s), 5.52-5.8 (IH , m), 6.04-6.52 (2H, m). 
m/z (%): 99 (30) (M+‘), 72 (60) (M+* - CH2=CH), 55 ( 100) (M+- - MeNMe). C5H9NO 
requires: C: 60.61 %; H: 9.1 %; N: 14.14 %. Found: C: 61.0 %; H: 9.3 %; N: 14.62 %.
5-S -3’-H ydroxycotin inel‘.2: Molybdenum trioxide (33  mmol, 5.0 g) and a
25 % (w/v) hydrogen peroxide of hydrogen peroxide (25 cm^) were stirred and 
maintained at a temperature of 40 °C for 3.5 h. After cooling the reaction mixture was 
filte red , and the y e llo w  so lu tio n  w as coo led  dow n to 1 0 ° C. 
Hexamethylphosphorictriamide (0.035 mol, 6 . 2  g) was added and the crystalline 
precipitate collected. Recrystallization from hot methanol (40° C maximum temperature) 
gaveMoOs* H2O' HMPA as yellow needles. This (8.65 mmol, 3 g) was dissolved in dry 
tetrahydrofuran (40 cm^), cooled to 2 0 ° C, and pyridine (8.65 mmol, 0.68 g) was added 
dropwise. The yellow crystalline precipitate was collected, washed with water (10 cm^), 
diethyl ether (100 cm^) and dried under vacuum to give M0 O3 ' (Pyridine)* HMPA, that 
was stored in the dark at 0 ° C until used.
Diisopropylamine (11.36 mmol, 1.15 g) was dissolved in. dry tetrahydrofuran 
(35 cm^) and cooled to -78° C. A 2.0 M solution of /i-butyllithium in n-hexane was added 
(11.36 mmol, 5.68 cm^), the temperature was brought up to 0° C fur 10  minutes, then 
recooled to -78° C. A solution of (S)-cotinine (5.6 mmol, 1.0 g) in dry tetrahydrofuran 
(20 cm^) was added. A fte r  10 rn inutes, under a strong flow  o f N2 , 
MoOs* (Pyridine)* HMPA (11.36 mmol, 4.93 g), dissolved in dry tetrahydrofuran ( 1 0  
cm3), was added. The solution was brought to 0° C for 10  minutes, then to 10° C for an 
additional 15 minutes, alter which the reaction was quenched by addition of saturated 
sodium sulfite (80 cm^). The organic phase was separated and the remaining aqueous
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phase extracted with 1:1 dichloromethane/2-propanol (3 x 75 cm^). The extracts were
pooled the solvent removed to give a deep blue solid. This was dried by azeotropic
distillation, first with dichloromethane (400 cm^) followed by chloroform (400 cm^).
m.p.: 74-78° C.DmaVcm-^: 3420.3100, 1698, 1150, 1190, 1050, 1030. Ô h  (CDCI3 ):
2.0 (2H, m, J= 2.5 Hz), 2.78 (3H, s), 2.98 (IH, m, J= 2.5 Hz), 4.5 (IH, m, J= 2.5),
5.5 (IH, br.), 7.4 (2H, m, J= 2.5 Hz), 8.0 (2H, m, J= 2.5 Hz), m/z (%): 192 (10), 174
(30), 135 (30), 114 (25), 106 (100). C 10H 12N2O2 requires: C: 62.5 %; H: 6.25%; N:
14.58 %. Found: C: 62.70 %; H: 6.40 %; N: 14.80 %.
(*) N - M e t h y l - 3 - h y d r o x y - 2 - p y r r o l i d i n o n e b 2 ;  a  similar procedure to that 
used to synthesise 3'-hydroxycotinine was used, substituting N-methyl-2-Pyrrolidinone 
(11.3 mmol, 1.12 g) in place of cotinine b.p.: 106-110° C. Dmax/cm" :^ 3400, 1700, 
1640, 1520. Ôh(CDC13):2 .0  (2H, m, J= 2.5 Hz), 2.85 (3H, s), 3.1 (2H, q, J= 2.5),
4.3 (IH, t, J= 2.5), 4.85 (IH , br.). m/z (%): 115 (20), 100 (25), 98 (100), 47 (60). 
C5H9NO2 requires: C: 52.17 %; H: 7.82 %; N: 12.17 %. Found: C: 52.30 %; H: 7 .9 9  
%; N: 12.33 %.
N-Chloromethyl-N-methylacrylainide: N-Methyl acrylamide (0 .0 2  mol,
1.7 g), was dissolved in trimethylsylilchloride (50 cm^). To this solution was added 
paraformaldehyde (2 .0  g) before refluxing for 2  h. After cooling the solvent was removed 
and the solid residue purified by chromatography using 9:1 dichloromethane/methanol as 
the mobile phase. 'Umax/cm' :^ 1670, 1590, 1410, 1280, 1260. ô h (CDCI3): 3.00 (3H, 
s), 5.3 (2H, s), 5.6-5.80 (IH, m), 6.00-6.25 (2H, m). m/z (%): 135 (5) 133 (18) (M+"), 
84 (40) (M+- - CH2CI), 55 (100), 27 (10).
N,N-Dim ethyI-2-vinylbenzam ide: Methyltriphenylphosphonium iodide 
(50 mmol, 17.8 g) and diisopropylamine (100 mmol, 10.1 g) were dissolved in dry 
tetrahydrofuran (1 0 0  cm^) in a No atmosphere and cooled to -10° C. A solution 2.5 M of 
butyllithium in/i-hexane (100 mmol, 6.4 g) was added dropwise when a deep orange 
coloured solution was observed. The mixture was left stirring under a N2 atmosphere at
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0°Cfor 15 minutes. To this solution was added 2-carboxybenzaldehyde (50 mmol, 7 .5  
g). The mixture was left at room temperature for 1 h. The solvent was removed and the 
solid residue was resuspended in dichloromethane (1 0 0  cm^). and extracted with 
saturated sodium bicarbonate (2 x 50 cm^). The aqueous extracts were acidified with 
concentrated hydrochloric acid and extracted with dichloromethane (100 cm^). The 
organic phase was dried (MgSO^) and the solvent removed to give the crude vinyl 
carboxylic acid (20 mmol, 2.98 g). The crude product and triethylamine (20 mmol, 2.8 
cm3) were dissolved in dry tetrahydrofuran (50 cm^), cooled to -10° C for 20 minutes, 
then ethylchloroformate (20 mmol, 1.73 cm^) dissolved in dry tetrahydrofuran (10 cm^) 
was added dropwise. The solution was maintained under stirring at -10 °C for 30 
minutes, then excess dry dimethylamine was added. The reaction was brought to room 
temperature and left stirring for 1 h. The solid was filtered off and the solvent removed to 
give a solid residue which was resuspended in dichloromethane (50 cm^), washed with 
0.1 N hydrochloric acid (2 x 10 cm^), aqueous saturated sodium bicarbonate (2 x 10 
cm^) and dried (MgSO#). Evaporation of the solvent gave the desired product 'Umax/cm' 
3100, 1720, 1650. ô h  (CDCI3 ): 2.85 (3H, s), 3.12 (3 H, s), 5.2-5.6 (2 H, m), 5.84 
(IH, d, J=2.5 Hz), 6.44-6.88 (2H, m), 7.16-7.56 (2H, m). m/z (%): 175 (50) (M+-), 
160 (25) (M+- -Me), 148(10) (M+ -CH=CH2), 131 (100) (M+ - MeNMe), 103 (80) (M+
- MeNMeCO), 77 (75). C 11H 13NO requires: C: 75.42 %; H: 7.43 %; N: 8.00 %. Found: 
C: 75.21 %; H: 7.60 %; N: 7.81 %.
N-(3-Batenyl)phthalim ide: 4-Bromo-l-butene (0.133 mol, 17.0 g), 
potassium phthalimide (0.141 mol, 26.17 g) and potassium iodide (4.8 mmol, 0.8 g) 
were dissolved in dry dimethylformamide (200 cm^). The solution was heated at 130° C 
for 2 hours under a N] atmosphere then poured onto crushed ice (200 g). Extraction with 
diethyl ether (4 x 2 0 0  cm^) was followed by washing with 1 M sodium hydroxide (200 
cm3),water (2 x 100 cm^), and 0.5 M hydrochloric acid (200 cm^). The organic layer 
was dried (MgSO^) and the solvent removed to leave the product as a yellow oil which 
solidified on standing and was recrystallized from diethyl ether/hexane to give the pure
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product as a white crystalline solid, m.p.: 50-51° C .'Umax/cm’’: 1700, 1 6 8 0  1 6 2 0 , 1480,
1460. 0 H(CDCl3 ): 2.45 (2H. m, J =5.0 Hz), 3.77 (2H, t, J= 5.0 Hz), 5.05 (2H, m, J=
5.0 Hz), 5.70 (IH, m, J= 5.0 Hz), 7.70-7.85 (4H, m, J= 5.0 Hz), m/z (%): 210 (15), 
174 (10), 146 (30), 132 (100), 105 (30), 97 (20). C 12H 11NO2 requires: C: 71.64 %; H: 
5.47 %; N: 6.96 %. Found: C: 71.80 %; H: 5.63 %; N: 7.09 %.
3-Butenylamine hydrochloride: N-(3-Butenyl)phthalimide (0.05 mmol,
10.05 g) was dissolved in ethanol (200 cm^) and refluxed in the presence of hydrazine 
monohydrate (0.05 mol, 2.5 g) for 3 h. After cooling, water (100 cm^) and 1 M 
hydrochloric acid (to pH 4.0) were added. Filtration of the white precipitate gave a clear 
yellow solution which was concentrated to leave the product as a yellow hygroscopic 
solid. Dma-x/cm' :^ 3350, 1400, 1000. ô h(CDC13): 2.39 (2H, m, J =5.0 Hz), 2.84 (2H, 
t, J= 5.0 Hz), 5.12 (2H, m, J= 5.0 Hz), 5.82 (IH, m, J= 5.0 Hz), 8.3 (3H, br.). m/z 
(%): 72 (80), 55 (55), 30 (100).
N-(3-Batenyl)benzam lde: 3-Butenylamine hydrochloride (0.10 mol, 11.8 g) 
was dissolved in dry tetrahydrofuran (200 cm^) in the presence of a large excess of 
triethylamine. To this solution tetrahydrofuran (50 cm^) containing benzoyl chloride 
(0.11 mol, 12.7 g) was added dropwise, the mixture was maintained basic by adding 
further triethylamine. The reaction mixture was refluxed overnight, after cooling the white 
precipitate was filtered off, the solvent removed and the solid residue purified by silica gel 
chromatography, using diethyl ether as eluent. Umax/cm" :^ 3320, 3050, 1650, 1580, 
1500, 1480, 1350. 0 h(C D C 13): 2.1 (2H, m, J= 3.5 Hz), 3.3 (2H, q, J= 3.55), 5,0 
(2H, q, J= 3.5 Hz), 5.6 (IH , m, J= 3.5 Hz), 6.8 (IH, br.), 7.5 (5H, m, J= 3.5 Hz), 
m/z (%): 175 (10), 134 (50), 105 (100), 77 (55), 39 (25). C11H13NO requires: C: 75.42 
%; H: 7.43 %; N: 8.00 %. Found: C: 75.60 %; H: 7.58 %; N: 8.10 %.
N-(3-Butenyl)-N-m ethylbenzam ide: N-(3-butenyl)benzamide (0.02 mol,
3.5 g) was dissolved in dry tetrahydrofuran (50 cm^) under a N2 atmosphere. To this 
solution, at 0° C, lithium diisopropylamide was added (0.022 mol, 11 cm^ of a 2.0 M
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solution in tetrahydrofuran), after 15 minutes at room temperature, iodomethane (0.022
mol, 3.12 g) was added dropwise and the mixture left for a further I h. The solvent was 
removed, the solid residue resuspended in dichloromethane (50 cm^), washed with water 
(2 X 20 cm^), dried (MgSO^) and concentrated. The crude product was purified by 
column chromatography using 8 :2  dichloromethane/methanol as mobile phase. Umax/cm’ 
•: 3010, 1650, 1510, 1500, 1480, 1380. Ô h(CDCI3): 2 .1  (2 H. m, J= 3.5 Hz), 3 .1  (3 H, 
s), 3.3 (2H, m, J= 3.5), 5,0 (2H, m, J= 3.5 Hz), 5.6 (IH, m, J= 3.5 Hz), 7.5 (5H, m). 
m/z(%): 189(8), 148(60) 135 ( 10). 105 ( 1 0 0 ), 77 (60), 39 (10). C 12H 15NO requires: 
C: 76.19 %; H: 7.94 %; N: 7.41 %. Found: C: 76.34 %; H: 8.01 %; N: 7.33 %.
N -Benzyl-N-(3-butenyl)benzam ide: N-(3-butenyl)benzamide (0 .0 2  mol,
3.5 g) was dissolved in of dry tetrahydrofuran (50 cm^) under a No atmosphere; to this 
solution , at 0° C, lithium diisopropylamide was added (0.022 mol, 11 cm^ of a 2.0 M 
solution in tetrahydrofuran). After 15 minutes at room temperature, dry tetrahydrofuran 
(10 cm3) containing benzyl bromide (0.022 mol, 3.76 g) and potassium iodide (2.4 
mmol, 0.4 g) was added dropwise and the mixture left under stirring for a further 1 h. 
The solvent was removed, the solid residue resuspended in dichloromethane (50 cm^), 
washed with water (2  x 20 cm^), dried (MgSO^) and concentrated. The product was 
purified by column chromatography using 8 :2  dichloromethane/methanol as mobile 
phase. DmaVcm'^: 3010, 1700, 1660, 1600, 1500, 1480, 1440, 1370, 1300, 1240. Ôh 
(CDCI3 ): 2 .1  (2H, m, J= 5 Hz), 3.3 (2H, m, J= 5), 3.6 (2H, s ), 5,0 (2H, m, J= 5 Hz),
5.6 (IH, m, J= 5 Hz), 7.5 (lOH, m). m/z (%): 265 (10), 224 (45) 210 (8 ), 174 (5), 105 
(100), 91 (45), 77 (50). CigHiçNO requires: C: 81.50 %; H: 7.17 %; N: 5.28 %. 
Found: C: 81.78 %; H: 7.21 %; N: 5.33 %.
3'-Butynyl-(4'-toluene) salfonate: 3-Butyn-l-ol (0.1 mol, 7.01 g) and 
triethylamine (0.11 mol, 11.1 g) were dissolved in dry tetrahydrofuran (100 cm^). To 
this, a solution of dry tetrahydrofuran (50 cm^) containing 4 -toiuensulfonyl chloride (0 .1  
mol, 19.1 g) was added dropwise and the reaction mixture refluxed for 2 h. After 
cooling, a white precipitate was filtered off and the solvent removed to give a dark oil
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which was resuspended in diethyl ether (50 cm^)  ^ washed with 1 M hydrochloric acid (2
X 2 0  cm3), saturated sodium bicarbonate (2  x 2 0  cm^), water (2  x 2 0  cm^) and dried
(MgS0 4 ), The solvent was removed to give the desired product. "Umax/cm"^ : 3400, 3000,
2920, 1580, 1380, 1180. ô H(CDCI3 ): 2.1 (IH, t, J= 2.0 Hz), 2.4 (3H, s), 2.7 (2H, m,
J= 7 Hz), 4.12 (2H, t, J= 7.0), 7.4 (2H, d, Ji= 7, J2 = 9), 7.8 (2H, d, Ji= 9, J2= 9).
m/z(%): 224 (25), 209 (5), 185 (15), 171 (10), 155 (100), 91 (100), 69 (40), 39 (15).
C11H 12SO3 requires: C: 58.89 %; H: 5.37 %. Found: C: 59.05 %; H: 5.45.
N-(3-Butynyl)phthalim ide: 3-Butynyl-4-toluensulfonate (0.067 mol, 14.2 
g), potassium iodide (3.6 mmol, 0.6 g) and potassium phthalimide (0.074 mol, 13.65 g) 
were dissolved in dry dimethylformamide (2 0 0  cm^) and refluxed for 24 h under a N2 
atmosphere. After cooling, the solution was poured onto crushed ice (2 0 0  g). Extraction 
with diethyl ether (4 x 200 cm^) was followed by washing with 1 M sodium hydroxide 
(2 0 0  cm3), water (2 X 100 cm ^), and 0.5 M hydrochloric acid (200 cm^). The organic 
layer was dried (MgSO^) and the solvent was removed to leave the product which was 
recrystallized from diethyl ether/hexane as a white crystalline solid. "Umax/cm"^ : 3300, 
3050, 1780, 1700, 1500, 1450, 1400. ô H (CDCI3): 2 .1  (IH, t, J= 5.0), 2 .6  (2H, t d, 
Jl= 7.0, J2= 7.0), 4.0 (2H, t, J= 7.0), 7.7 (4H, m). m/z (%): 199 (35), 160 (100), 132 
(35), 105 (30), 77 (35), 39 ( 1 0 ). C 12H9NO2 requires: C: 72.36 %; H: 4.52 %; N: 7.03 
%. Found: C: 72.51 %; H: 4.62 %; N: 7.20 %
3-Botynylamine hydrochloride: N-(3-Butynyl)phthalimide (0.05 mmol, 
^•95 g) was dissolved in ethanol (2 0 0  cm^) and refluxed in the presence of hydrazine 
monohydrate (0.05 mol, 2.5 g) for 3 h. After cooling, water (100 cm^) and 1 M 
hydrochloric acid (to pH 4.0) were added. Filtration of the white precipitate gave a clear 
yellow solution which was concentrated to leave the product as a yellow hygroscopic 
solid Umax/cm" :^ 3350, 1700, 1500, 1380. 0 h(CDC13): 2.0 (IH, m), 2.6 (2H, q, J =5 
Hz), 3.04 (2H, t, J= 5 Hz), 7.5 (3H, br.). m/z (%): 70 (80), 53 (45), 39 (100).
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N -(3-B utynyl)benzam ide: N-(3-Butynyl)aminehydrochloride (0 .1 0  mol, 
10.55 g) was dissolved in dry tetrahydrofuran (200 cm^) in the presence of a large 
excess of triethylamine. To this solution tetrahydrofuran (50 cm^) containing benzoyl 
chloride (0.11 mol, 12.7 g) was added dropwise! The pH of the mixture was monitored 
and maintained at 10 throughout by adding further triethylamine. The reaction mixture 
was refluxed overnight, cooled the white precipitate filtered off, the solvent removed and 
the solid residue purified by chromatography using diethyl ether as mobile phase. 
'Uma.x/cm-^ : 3350, 3300, 3150, 1710, 1650, 1550, 1500, 1460. 0h(CDC13): 1.9 (IH , t, 
J= 2.0 Hz), 2.3 (2H, m, J%=5 Hz, J2 = 5  Hz), 3.2 (2H, m, J= 5 Hz), 6 .8  (IH , br.), 7.6 
(5H, m). m/z (%): 173 (20), 149 (15), 134 (50), 105 (100), 77 (90), 6 8  (50), 39 (25). 
C iiH iiN O  requires: C: 76.30 %; H: 6 3 6  %; N: 8.09 %. Found:C: 76.58 %; H: 6.41 %; 
N: 8.00 %.
N -(3-B atynyl)-N -m ethylbenzam ide: N-(3-Butynyl)benzamide (0 .0 2  mol, 
3.46 g) was dissolved in of dry tetrahydrofuran (50 cm^) under a No atmosphere. To this 
solution , at 0° C, lithium diisopropylamide was added (0.022 mol, 11 cm^ of a 2.0 M 
solution in tetrahydrofuran) After 15 minutes at room temperature iodomethane (0.022 
mol, 3.12 g) was added dropwise, the mixture stirred for further 1 h, the solvent 
removed and, the solid residue resuspended in dichloromethane (50 cm^), washed with 
water (2 x 20 cm^), dried (MgSO^) and concentrated. The crude product was purified by 
column chromatography using 8 :2  dichloromethane/methanol as mobile phase. ITmax/cm" 
h 3050, 1650, 1580, 1550, 1520, 1500, 1480, 1400, 1350, 1300, 1280. ô H (CDCI3):
1.9 (IH, I, J= 2.0 Hz), 2.3 (2H, m, Ji=2 Hz, J2= 5 Hz), 2.92 (3 H, s), 3 .2  (2H, q, J= 5 
Hz), 7.6 (5H, m). m/z (%): 187 (10), 148 (55), 134 (20), 105 (100), 77 (70), 39 (12). 
C 12H 13NO requires: C: 77.00 %; H: 6.95 %; N: 7.49 %. Found: C: 77.22 %; H: 7 .0 1  
%; N: 7.38 %.
N -B utenyi-N -chlorom ethylbenzam ide: N-(3-Butenyl)benzamide (0 .0 2  
mol, 3.5 g), was dissolved in trimethylsylil chloride (50 cm^). To this solution was 
added paraformaldehyde (2.0 g). the solution was refluxed for 2  h. After cooling the
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solvent was removed and the solid residue purified by silica gel chromatography using
dichloromethane as mobile phase. Umax/cm'^: 3010, 1650, 1510, 1500, 1480, 1380. ô H
(CDCI3): 2.1 (2H, m, J= 5 Hz), 3.3 (2H, m, J= 5), 5,0 (2H, m, J= 5 Hz), 5.30 (2H, s),
5.6 (IH, m. J= 5 Hz), 7.28 (5H, s). m/z (%): 225(15) (M+*), 173 (40) (M+* - CHoCl),
105 (44), 77 (100).
N-(3-Butynyl)-N-chloroinethylbenzam ide: N-(3-Butynyl)benzamide
(0.02 mol, 3.45 g), was dissolved in trimethylsylilchloride (50 cm^), to this solution was 
then added paraformaldehyde (2.0 g). The solution was refluxed for 2 h. After cooling 
the solvent was removed and the solid residue was purified by silica gel using 
dichloromethane as mobile phase, m.p. 88-91 °C. "Umax/cm"^ : 3050, 1650, 1580, 1550, 
1520, 1500, 1480, 1400, 1350, 1300, 1280. Ô h (CDCI3): 1.9 (IH, t, J= 2  Hz), 2 .3  
(2H, m, Ji=2 Hz, J2= 5 Hz), 3.2 (2H, m, J= 5 Hz), 5.30 (2H, s), 7.28 (5H, s). m/z 
(%): 223 (10) (M+- ), 171 (55) (M+- - CH2CI), 105 (35), 77 (100).
N -B enzoy l-l,2 ,5 ,6 -te trahydropyrid ine : Benzoyl chloride (0.05 mol; 7 .0  
g) was dissolved in 10% aqueous NaOH (30 cm^). To this solution was added 1,2,5,6- 
tetrahydropyridine (0.045 mol, 3.73 g). The reaction mixture was stirred vigorously for 
30 minutes. The products were extracted using dichloromethane (2 x 30 cm^), the organic 
phase was, washed with water (2 x 20 cm^), dried (MgS0 4 ) and concentrated. The 
resulting oil was then purified by silica gel chromatography using diethyl ether as eluent. 
'Umax/cm"^ : 3010, 2450, 2400, 1650, 1500, 1480. Ô h  (CDCI3): 2 .1  (2 H, m), 3 .2  (2 H, 
m), 3.4 (2H, m), 5.8 (2H, m), 7.0 (5H, m). m/z (%): 187 (15), 105 (100), 79 (40), 77 
(70). C12H13NO requires: C: 77.00 %; H: 6.95 %; N: 7.49 %. Found: C: 77.40 %; H: 
6.80 %; N: 7.55 %.
N -B enzoyl-3-m cthylpyrrolid ihe: 3-Methyl-2-pyirolidinonc(125 mol; 1.26 
g) was dissolved in dry tetrahydrofuran (25 cm^). The solution was cooled to 0“ C and 
borane methylsulphide ( 125 mmol) was added dropwise. After vigorous reaction ceased, 
the resulting mixture was brought to gentle reflux and maintained at that temperature for 3
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h. The reaction mixture was cooled to 0“ C, methanol (20 cm^) was added and the
solution was stirred well for further 1 h. Anhydrous hydrogen chloride was added to the
mixture to obtain a pH < 2, and the resulting mixture was gently rcfluxed for 1 h. After
cooling, methanol (1 0 0  cm^) was added and the solvents removed by reduced pressure.
The residue obtained was made basic ( HoO; NaOH pellets, pH > 12) and extracted with
diethyl ether (3 x 100 cm^), dried (MgSO^) and the solvent was removed to give pure 3 -
methyl pyrrolidine.
3-Methylpyrrolidinone (0.045 mol; 3.82 g) was added to a 10% NaOH solution 
(30 cm^) containing benzoyl chloride (0.05 mol; 7.0 g). The reaction mixture was stirred 
vigorously for 30 minutes, extracted by dichloromethane (2x50 cm^), the organic phase 
was washed with water (2  x 2 0  cm^), dried (MgS0 4 ) and the solvent was removed to
giveN -benzoyl-3-m ethylpyrrolidine.ljm a.x/cm "^: 3000 , 1630, 1580,1400. Ôh (CDCI3): 
1.2 (3H , d, J=5 H z), 1.3 ( I H ,  m), 2 .0  (2H , m), 3 .0  (2H , m), 3.2 (2H , m), 7 .0  (5H , 
m). m /z (%): 189 (20), 174 (30), 105 (100), 84  (50), 7 7  (80). C 12H 15NO requires: C: 
76.16 %; H: 6.95 %; N: 7 .48  %. Found: C: 76 .5  %; H: 6 .70 %; N: 7 .75 %.
N -Benzoyl-3-inethylenepyrrolidine: N-Benzylpyrrolidin-3 -one (0 .0 2  
mol; 3.5 g) was dissolved in dry dichloromethane (30 cm^). To this solution, was added 
with stirring a dichlorom ethane ( 1 0  cm^) solution containing 5,10,15,20- 
tetraphenylporphine iron(III)ch loride (TPP) (3.0 mmol, 2.1 g) and tert- 
butylhydroperoxide (0.2 mol; 18 g). The reaction mixture was maintained at room 
temperature for 48 hours, every 4 hours a dichloromethane solution (10 cm^) containing 
/CTt-butylhydroperoxide (0.2 mol) was added. The solvent was removed and the solid 
residue subjected to chromatography on silica gel using diethyl ether/ hexane 8 :2  as the 
mobile phase to obtain N-benzoy 1-pyrrolidin-3-one.
Methyltriphenylphosphonium bromide (4.07 mmol; 1 .45  g) was dissolved in 
dry tetrahydrofuran (30 cm^). The solution was cooled to -15” C and, under N2 , a 2.5 M 
butyllithium solution in hexane was added dropwise (4.07 mmol; 1.53 cm^). The mixture
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was maintained at -15“ C under stirring until the colour changed to orange, then a dry
tetrahydrofuran solution (2 0  cm^) containing N-benzoylpyrrolidin-3 -one (3 .9  mmol; 0.70
g) was added. The reaction mixture was maintained at -15“ C for 30 minutes, brought to
room temperature and left for a further 2 h. Upon completion of the reaction, ammonium
chloride was added (0.1 mol; 5.2 g), the solvent removed, the solid residue resuspended
in dichloromethane (1 0 0  cm^) and the organic phase washed with water ( 2  x 2 0  cm^),
dried (MgS0 4 ) and, after concentration subjected to cromatography on silica gel using
diethyl ether/hexane 7:3 as eluent. *u max/cm'^: 3000, 1680, 1520, 1470. Ôh (CDCI3):
2.0 (2H, t, J= 5 Hz), 3.2 (2H, m), 3.4 (2H, m), 5.0 (2H, d, J= 5 Hz), 7.1 (5H, m). m/z
(%): 187 (25), 173 (35), 105 ( 100), 82 (40), 77  (70). C 12H 13NO requires: C: 77.00 %;
H: 6.95 %; N: 7.49 %. Found: C: 77.60 %; H: 7.05 %; N: 7.61 %.
N -Benzoyl-3-forinylpyrrolidine: in dry tetrahydrofuran (30 cm^), 
Methoxymethyltriphenylphosphonium bromide (5.23 mmol; 2:23 g) was dissolved. The 
solution was cooled to -15 C and, under No, a 2.5 M butyllithiun solution in hexane 
(5.23 mmol; 2.1 cm^) was added dropwise. The mixture was maintained at -15“ C until 
the colour changed to orange, then a dry tetrahydrofuran solution (20 cm^) containing N- 
benzoylpyrrolidin-3-one (5.0 mmol; 0.90 g) was added. The reaction mixture was 
maintained at -15“ C for 30 minutes, brought to room temperature and left for a further 2  
h. Ammonium chloride was added (0 .1  mol; 5.2 g), and the solution extracted with 
chloroform (2 x 50 cm^), the organic phase evaporated, the solid residue resuspehded in 
0.1 N hydrochloric acid (50 cm^) and refluxed for 30 minutes. After cooling, the acid 
solution was extracted with chloroform (2 x 50 cm3), the organic phase washed with 
water (2  x 2 0  cm^), dried (MgS0 4 ) and, after concentration, subjected to cromatography 
on silica gel using diethyl ether/ hexane 8 :2  as eluent. "Umax/cm"^ : 3020, 1725, 1700, 
1610, 1500. ÔH(CDCl3): 2.1 (2H, t, 5 Hz), 2.4 (IH, m), 3.0 (2H, m), 3.2 (2H, t, 
J= 5 Hz), 7.1 (5H, m), 9.1 (IH , s). M/z (%): 203 (20), 174 (30), 105 (100), 98 (40), 77 
(70). C12H13NO2 requires: C: 70.93 %; H: 6.40 %; N: 6.89 %. Found: C: 70.20 %; H: 
6.15 % ;N: 7.01 %.
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N -H ydroxym ethyl-N -m ethylbenzam ide: was synthesised following the 
method reported by Constantino etal.^
N -C hlorom ethyl-N -m ethylbenzam ide: was synthesised following the 
method reported by Moreira etal.^
N -B enzoyl-N -/er/-butyl-N -hydroxy-N -m ethyl-l-phenyl-l,2-
diam inoethane (PBN-DMB addnct): N-Chloromethyl-N-methyi benzamide (0.01 
mol, 1.83 g) and PBN ( 0.01 mol, 1.77 g), were dissolved in dry acetonitrile (20 cm^) 
and refluxed. An a c e to n itr ile  so lu tion  (5 cm^) co n ta in in g  1,1- 
azobis(cyclohexanecarbonitrile) (0.001 mol, 0.24 g) and tributyltin hydride (0.001 mol, 
0.29 g) was added dropwise within 30 minutes. The mixture was refluxed for a further 
30 minutes. After cooling, the solvent was removed and the residue purified by silica gel 
chromatography using diethyl ether as mobile phase. Umax/cm' :^ 3450, 1630, 1580, 
1540, 1500, 1460, 1400, 1380. 0 h(CD C 13): 1.91 (9H, s), 3.0 (3H, s), 3.6 (2H, d, J= 
5 Hz), 4.8 (IH, t, J=5 Hz), 7.4 (lOH, m), 8.1 (IH, br). m/z (%): 325 (10), 310 (10), 
268 (20), 238 (40), 205 (20), 191 ( 10), 105 ( 100), 77 (80).
N -M ethylglotarim ide: Glutaric anhydride (0.175 mol, 20 g) was added to an 
aqueous solution of methylamine (40 %, 0.967 mol). The solution was stirred and 
refluxed for 4 hours, cooled, the water removed under reduced pressure and the organic 
residue distilled under vacuum (15 mmHg). The fraction containing the product was 
subsequently purified by chromatography on silica gel using ethyl acetate/«-hexane 5:2 as 
eluent. B.p.: 224° C. Dmax/cm'^- 1705. 1670. ÔH(CDCl3 ): 2.04 (2H, q, J= 7. Hz), 2.76 
(4H, t, J= 7 Hz), 3.14 (3H, s). m/z (%): 127 (75) (M+- ), 98 (25) (M+*- Me-N), 70 (35) 
(M+‘- Me-NCO), 42 (100). C6H9NO2 requires C: 56.69 %; H: 7.08 %; N: 11.02 % 
found: C: 56.58 %; H: 7.14 %; N: 10.9 %.
Adipimide: Adipamide (0.14 mol; 20 g) was heated to 250-260° C, resulting in 
a copious evolution of ammonia. When gas evolution subsided the pressure was reduced 
to 60-100 mm Hg and about 1 g of water was removed. Further reduction of pressure to
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12-17 mm Hg resulted in distillation of 10.4 g of a clear syrup boiling at 160-170° C. A
third fraction, b.p. 180° C solidified in the receiver. Redistillation of the middle fraction
though a 25 cm packed column gave three liquid fractions after removed; 1 ° b.p. 145-150°
C (7.5 mmHg); 2°, b.p. 154-160° C (7.5 mmHg) and 3, b.p. 156-168“ C ( 4  mmHg).
Cooling fraction 2  gave a crystalline deposit which was filtered and recrystallized from
benzene-petroleum ether to give 0.25 g of adipimide. m.p. 98°C. 'Uma.Vcm'  ^ :3400, 1690,
1640. Ôh(CDC13): 2.3 (4H, q, J= 7. Hz), 2.76 (4H, t, J= 7  Hz), 6.5 (H, br.). m/z (%):
127 (2 0 ) (M+0, 84 (25) (M+‘- HNCO), 6 8  (80), 54 (80), 42 ( 100) CgH^NOo requires
C: 56.69 %; H: 7.08 %; N: 11.02 %. Found: C: 57.0 %; H: 7.21 %; N: 11.2 %.
N -M ethyladipim ide: To a solution of adipoyl chloride (0.16 mol; 30 g) in dry 
ether at -78 C was added, under stirring, a large excess of methylamine. The solution 
was left at - 78° C for 10  minutes, and the temperature then raised to 25° C for 30 
minutes. The solid was filtered off and the solvent was removed. The solid residue was 
heated at 250-260° C, resulting in a copious evolution of methylamine. When gas 
evolution subside the pressure was reduced to 60-100 mmHg and about 2 g of water 
were removed. Further reduction of pressure to 12-17 mmHg resulted in distillation of
15.0 g of a clear yellow syrup boiling at 150-165° C. A third fraction, b.p. 195 °C 
solidified in the receiver. Fraction 2 was redistilled though a 25 cm packed column to give 
a fraction : 1° b.p. 130-135 °C (7.5 mm); 2 °, b.p. 140-150 °C (7 .5  mm) and 3°, b.p. 155- 
160 °C (4 mm) that solidified on cooling, m.p 8 8 ° C. Dma.x/cm' :^ 1705, 1670. ô h  
(CDCb): 2.04 (4H, q, J= 7. Hz), 2.76 (4H, t, J= 7 Hz), 3.14 (3H, s). m/z (%): 141 
(65) (M+-), 112 (25) (M+*- Me-N), 84 (25) (M+‘- Me-NCO), 55 (100) C7H11NO2 
requires: C: 59.57 %; H: 7.80 %; N: 9.93 %. Found: C: 59.8 %; H: 7.90 %; N: 10.1 %.
R(+)- o r  S (-)-N -(l-Phenylethyl)benzam ide: To an aqueous solution of 
10 % w/w sodium hydroxide (45 cm^) were added benzoyl chloride (0.06 mol; 8.5 g) 
and R(+)- or S(-)-a-methyl benzylamine (0.05 mol; 6 .6  g). The solution was maintained 
at pH 10, stirred vigorously, diluted with water (100 cm^), and the product filtered, 
washed with water and finally reciystallized from hot methanol. Umax/cm" :^ 3 3 7 5 , 1640.
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ÔH(CDC13): 1.52 (3H, d, J= 7.2 Hz), 5.4 (IH, br.), 6 .4  (IH, br.) 7.05 (5H, s), 7.15
(5H, s). m/z (%): 225 (30) (M+-). 2 1 0  ( 10) (M+- - Me), 120(10), 105 ( 1 0 0), 7 7  (40). 
C15H 15NO requires Ci 80.0 %; H: 6.67 %; N: 6.22 %. Found for R(+)-: C: 80.05 %; H: 
6.72 %; N: 6.37 %. and for S(-)-: C:80.2 %; H: 6.60 %; N: 6.40 %.
R(+)- o r S(-)-N-M ethyl-(l-phenylethyl)benzam ide: N(+)- or S(-)-N- 
(l-Phenylethyl)benzamide (0.013 mol; 2.92 g) was dissolved in tetrabydrofuran (30 
cm3) and to this was added, under a No atmosphere and with stirring, a solution of 
butyllithium in /i-hexane (0.06 mol; 5 cm^). After 10 minutes, a solution of iodomethane 
(0.11 mol) in tetrabydrofuran (5 cm^) was added, and stirring continued for 45 minutes. 
Ethanol (5 cm^) was added to terminate the reaction. The solvents were removed and the 
suspended in ethyl acetate (30 cm^). The organic phase was washed with water (2 x 10 
cm^) dried (MgS0 4 ) and concentrated to give the crude product which was purified by 
column chromatography on silica gel (eluent: ethyl acetate/n-hexane 3:1). m.p 56° C. 
"Umax/cm-^  3090, 3060, 1640. 0 H(CDCl3 ): 1.52 (3H, d, J= 7.2 Hz), 2.64 (3 H, s), 5 .4  
(IH, q, J=7 Hz), 7.05 (5H, s), 7.15 (5H, s). m/z (%): 239 (30) M+-), 224 (10) (M+- - 
Me), 105 (100), 77 (45). C 16H 17NO requires C: 80.30 %; H: 7.16 %; N: 5.85 %. 
Found for R(+)-: C: 80.1 %; H: 7.2 %; N: 5.7 %. and for S(-)-: C:80.3 %; H7.2 %; N:
5.8 %.
5-PhenyI-2-pyrrolidinone (racem ic m ixture):^ A well stirred mixture of 
pyroglutamic acid (0.039 mol; 5 g), benzene (0.040 mol, 3.12 g) and P2O5/CH3 SO3H 
(1/10 w/w, 35 g) was heated at 100 °C for 60 minutes. After cooling the solution was 
added to water (2 0 0  cm^), then extracted with dichloromethane (3 x 30 cm3) and dried 
(MgSO^). After evaporation of the solvent, the solid was recrystallized from ether/ethanol 
1:1. m.p. 107 °C. Umax/cm"  ^ • 3450, 1710, 1670, 1580. Ô H (CDCI3): 2.76 (4H, m), 4.6 
(IH, t, J= 7 Hz), 6.7 (IH, br.), 7.05 (5H, s). m/z (%): 161 (100) (M+"), 107 (60) (M+"
- NCO), 84 (45) (M+* -Ph), 77 (45) (Ph "*"). CioHnNO requires; C; 74.53 %; H: 6.83 
%; N: 8.69 %. Found: C: 74.80 %; H: 6.95 %; N: 9.00 %
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N-[(S)-N’-(l-PhenyI)ethyl)carbamoyl]-5-phenyl-2-pyrroIidinoneA
solution of racemic SphenyI-2-pyrroIidinone( 10.1 mmol; 1.70 g) and (S)-l-phenylethyl 
isocyanate (11.0 mmol; 1.62 g) in toluene (10 cm^) was refluxed for 24 h. After cooling 
to room temperature the reaction mixture was washed quickly with water, dried (MgS0 4 ) 
and concentrated. The solid residue was dissolved in dichloromethane (5 cm^) and 
filtered. The mixture of diasteroisom ers was subsequently resolved using 
chromatography (silica gel, 97:3 dichloromethane/ acetonitrile as eluent).
High-rf{d. 0.8) diasteromen colourless solid, m.p.: 100  °C. "Umax/cm"^ : 3230, 
1705, 1680, 1510, 1230. Ô h (CDCI3): 1.52 (3H, d, J=5 Hz), 1.87-1.96 (1 H, m), 
2.44-2.79 (3H, m), 4.90-5.0 (IH , m), 53-5.35 (IH, m), 7.0-7.21 (lOH, m), 8.90 (IH , 
d, J= 5 Hz), m/z (%): 308 (15) ( M+* ), 293 (10) ( M+- - Me), 188 (10) ( M+' - 
PhCHCHoNH), 160 (2 0 ) ( M+ -PhCHCH^NHCO), 1 2 0  (100).
(rf. 0.5) diasteromen colourless oil: Umax/cm"  ^ : 3240, 1700, 1670, 
1520, 1 2 2 0 . Ô H (CDCI3 ): 1.52 (3H, d, J=5 Hz), 1.85-2.00 (1  H, m), 2.40-2.70 (3H, 
m), 4.90-5.05 (IH, m), 5.35-5,45 (IH , m), 7.10-730 (lOH, m), 8.91 (IH, d, J-5Hz). 
m/z (%): 308 (15) (M+-), 293 (10) (M+- - Me), 188 (10) (M+* - PhCHCH2NH), 160 
(20) (M+- -PhCHCH2NHC0), 120 (100).
R- and S -5-Phenyl-2-pyrrolid inone (enantiom erically pure)^»^»^: A 
solution of diasterometically pure N-[(S)-N’-(l-phenylethyl)carbamoyl]-5 -phenyl-2 - . 
pyrrolidinone (5.0 mmol; 1.54 g) and sodium methoxide (17.6 mmol; 0.95 g) in 
tetrahydrofuran (150 cm^) was refluxcd for 48 h. After cooling to room temperature, 
saturated ammonium chloride ( 100 cm^) and 3M hydrochloric acid ( 100 cm^) were added 
successively, and the organic phase was separated, washed with brine and dried 
(MgS0 4 ). After filtration and concentration, the residue was chromatographed on silica 
gel with ethyl acetate as the mobile phase. The desired lactam was collected and, after 
recrystallization pure 5-phenyl-2-pyrrolidinone was obtained. The absolute configuration 
of the lactams was confirmed by using the NMR chiral resolving agent (S)-2,2,2-
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trifluoro-l-(9-anthryl)ethanol as rep o rted .6 ;7 ;8  m.p. 107 °C. 'Umax/cm'*: 3450, 1710,
1670, 1580. Ôh(CDC13): 2.76 (4H, m), 4.6 (IH, t, J=7 Hz), 6.7 (IH, br.), 7.05 (5H, 
s). m/z(%): 161 ( 100) (M+-), 107(60) (M +*-NCO), 84(45) (M+'-Ph), 7 7  (4 5 ) (Ph+). 
CioHiiNO requires: C: 74.53 %; H: 6.83 %; N: 8.69 %. Found: for R: C: 74.50 %; H:
7.00 %; N: 8.55 % For S: C: 74.45 %; H: 6 .8 8  %; N: 8.40 %
R- and S -N -M ethyl-5-phenyl-2-pyrrolid inone: R- or S-5-Phenyl-2- 
pyrrolidinone (3 mmol, 483 mg) is dissolved in dry tetrahydrofuran (50 cm^) and 
maintained under a No atmosphere. With continuos stirring sodium hydride (33  mmol;
79.2 mg) followed by iodomethane (15 mmol, 2.13 g) was added and left at room 
temperature for 48 h. After removal the solvent the solid residue was resuspended in ethyl 
acetate (20 cm^), washed with water ( 2 x 1 0  cm^) and dried (MgS0 4 ). A fter 
concentration, the product was purified by silica gel chromatography using 3 :1  ethyl
a c e ta te /h e x a n e  as th e  mobile phase. Umax/cm- :^ 1720, 1660, 1580. Ôh (C D C I3 ): 2.76 
(4H, m), 3.2 (3H, s), 4.6 (IH , t, J= 7 Hz), 7.05 (5H, s). m/z (%): 175 (70) (M+"), 145 
(50) (M+* - M e N ), 117 (60) (M+* - M e N C O ) , 98 (40) (M+* -Ph), 77 (40) (Ph+). 
C 11H 13N O  requires: C: 75.43 %; H: 7.43 %; N: 8.00 % Found: for R: C: 75.80 %; H: 
7.65 %; N: 8.30 %. For S: C: 75.60 %; H: 7.78 %; N: 8.20 %
N -M ethyl-4-oxo-4-phenylbutanam ide: A solution of 3-benzoylpropionic 
acid (15 mmol, 2.67 g) and triethylamine (15 mmol, 2.1 cm^) in dry tetrahydrofuran (25 
cm3) was cooled at -10° C. A solution of ethyl chloroformate (15 mmol, 1 .6  g) in 
tetrahydrofuran (25 cm^) was added dropwise with stirring. After 30 minutes a large 
excess of dry methylamine was added and the solution was left at room temperature for 1 
h. The solution was filtered and the oil obtained after solvent evaporation was dissolved 
in dichloromethane (50 cm3), washed with 0 .1  M hydrochloric acid (2  x 10  cm^), 
aqueous saturated sodium bicarbonate (2  x 10 cm^) and dried (MgS0 4 ). Evaporation of 
the solvent gave the desired product. Umax/cm" :^ 3300, 1680, 1640, 1580. ÔH (CDCI3 ): 
2.3-2.72 (4H, m), 3.28 (3H, d), 6 .1  (IH , hr.), 7.2-7.48 (5H, m). m/z (%): 191 (20) 
(M+-), 174(10) (M+* -OH), 161 (15) (M+* -NHCH3 ), 133 (20) (M+- -MeNCO), 114
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(30) (M+' -Ph), 105 (100), 77 (60). C 11H 13NO2 requires; C: 69.09 %; H; 6.85 %; N:
7.32 %. Found: C: 68.87 %; H: 7.02 %; N: 7.22 %.
4-O xo-4-phenylbutanainide: The procedure used for N-methyl-4-oxo-4- 
phenyibutanamide was followed using ammonia in place of methylamine. *Umax/cm"*• 
3410, 3250, 1700, 1650; 1580. 0 h(CDC13): 2.6 (2H, t, J= 5Hz), 3.2 (2H, t, J= 5 Hz),
5.7 (IH, br.), 5.8 (IH, br), 7.2-7.52 (5H, m). m/z (%): 177 (20) (M+-). 160 (10) ( M+' 
-OH), 133 (10) (M+- -NH2CO), 105 (100), 77 (60). C 10H 11NO2 requires: C: 67.78 %; 
H: 6.26 %; N: 7.90 %. Found: C: 67.41 %; H: 6.20 %; N: 7.80 %.
N -C hlorom ethyl-N -m ethylform am ide: N-Methylformamide (0 .0 2  mol, 
1.18 g), was dissolved in trimethylsilylchloride (50 cm^). Paraformaldehyde (2.0 g) was 
added and the solution refluxed for 2 h. After cooling the solvent was removed to give the 
desired product. 'Uma.x/cm'^ : 1680, 1610, 1280, 1260. ô H (CDCI3): 3.00 (3H, s), 5.56 
(2H, s), 8.28 (IH, s). m/z (%): 107 (15) (M+-), 58 (40) (M+* - CH2CI), 4 3  (100), 29 
( 10).
N -C hlorom ethyl-N -m ethylacetam ide: was synthesised following the 
method reported by Moreira eîal.^
N -#cr/-B uty l-N -form yl-N -hydroxy-N -m ethyl-1 -p h en y l-1 ,2 - 
diam inoethane (PBN-DM F adduct): N-Chloromethyl-N-methylformamide (0.01 
mol, 1.07 g) and PEN ( 0.01 mol, 1.77 g), were dissolved in dry acetonitrile (20 cm^) 
and refluxed. A so lu tion  of ace to n itr ile  (5 cm^) con ta in ing  1,1- 
azobis(cyclohexanecarbonitrile) (0.001 mol, 0.24 g) and tributyltin hydride (0.(X)1 mol, 
0.29 g) was added dropwise within 30 minutes. The mixture was refluxed for a further 
30 minutes. After cooling, the solvent was removed and the solid residue purified by 
silica gel chromatography using diethyl ether as eluent. Umax/cm' :^ 3460, 1700, 1610, 
1508, 1460, 1380, 1200, 1100. Ôh(CDC13): 2.0 (9H, s), 3.05 (3H, s), 3.7 (2H, d, J=5 
Hz), 4.7 (IH, t , J=5 Hz), 7.28 (5H, m), 8.15 (IH, m). m/z (%): 250 (10), 234 (10), 
192(15), 162 (30), 77 (100).
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N ,N -D im ethyl-2-(N ’-/er/-butylhydroxylamino)phenylacetamide
(PBN-DMF adduct II): N,N-dimethylcarbamyl chloride (0.01 mol, 1.07 g) and PBN 
( 0.01 mol, 1.77 g), were dissolved in dry acetonitrile (20 cm3) and refluxed. A solution 
of acetonitrile (5 cm3) containing 1,1 -azobis(cyclohexanecarbonitrile) (0.001 mol, 0.24 
g) and tributyltin hydride (0.001 mol, 0.29 g) was added dropwise within 30 minutes. 
The mixture was refluxed for a further 30 minutes. After cooling, the solvent was 
removed and the solid residue purified by silica gel chromatography using diethyl ether as 
eluent. Umax/cm-1: 3440 1700, 1600, 1525, 1420. 0h(C D C 13): 2.05 (9H, s), 3.10 (3H, 
s), 5.3 (IH, t , J=5 Hz), 7.40 (5H, m), 8 .6  (IH, br). m/z (%): 250 (8 ), 233 (20), 206 
(25), 190 (30), 77 (100).
N-Acetyl-N-/er/-butyl-N-hydroxy-N’-methyI-l-pheny!-l,2-
diam inoethane (PBN-DMAC adduct): N-Chloromethyl-N-methyl acetamide (0.01 
mol, 1.21 g) and PBN ( 0.01 mol, 1.77 g), were dissolved in dry acetonitrile ( 2 0  cm^) 
and refluxed. A so lu tion  of ace ton itrile  (5 cm^) con ta in ing  1,1- 
azobis(cyclohexanecarbonitrile) (0.001 mol, 0.24 g) and tributyltin hydride (0.001 mol, 
0.29 g) was added dropwise within 30 minutes. The mixture was refluxed for a further 
30 minutes. M ier cooling, the solvent was removed and the solid residue purified by 
silica gel chromatography using diethyl ether as eluent. 'Umax/cm'^- 3500, 1705, 1600, 
1520, 1440, 1380, 1210, 1110. ÔH (CDCI3): 1.90 (9H, s), 2.34 (3H, s) 3.12 (3H, s),
3.6 (2H, d J=4.5Hz), 4.5 (IH , t, J=5 Hz), 7.12 (5H, m). n/z (%): 263 (15), 248 (10), 
206(15), 176 (40), 77 (100).
N -(3 -B u ty n y l) fo r m a m id e :  Formamide (0.02 mol; 0.6 g) was dissolved dry 
tetrahydrofuran (20 cm^). To this solution, under No and at -10 °C, lithium 
diisopropylacetamide (0.018 mol) was added dropwise. After 15 minutes dry 
tetrahydrofuran (10 cm^) containing3-butynyl-4-toluenesulfonate (0.02 mol, 2.66 g) was 
added dropwise; the solution was left at room temperature for 1 h then refluxed for 
further 3 h. The solvent was removed and the solid residue was resuspended in 
dichloromethane (50 cm^), washed with water (2 x 30 cm^) and dried (MgS0 4 ). After
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concentration, the crude mixture was purified by silica gel chromatography using 7/3
dichloromethane/methanol as eluent. Dmax/cm"^-3350, 3300, 3150, 1710, 1650, 1550, 
1500, 1480. ÔH(CDCb): 19  (IH , t, J= 2.0 Hz), 2.3 (2H, m, Ji=2 Hz, Jo= 5 Hz), 3.2 
(2H, m, J= 5 Hz), 6 .8  (IH , br.), 8.28 (IH , m). m/z (%): 97 (30), 73 (15), 53 (50), 43 
(100). C5H7NO requires: C: 61.85 %; H: 7.21 %; N: 14.43 %. Found: C: 62.00 %; H: 
731 %; N: 14.00 %.
N -(3-B atynyl)-N -m ethylform ain ide: The method employed for N-(3- 
butynyl)formamide was followed substituting N-methylformamide for formamide. 
'Umax/cm"^ : 3050, 1650, 1580, 1550, 1520, 1500, 1480, 1400, 1350, 1300, 1280. Ôh 
(CDCb): 1.9 (IH, t, J= 2.0 Hz), 2.3 (2 H, m, Ji= 2  Hz, ]]= 5 Hz), 2.92 (3H, s), 3.2 
(2H, m, J= 5 Hz), 8.31 (IH , m). m/z (%): 111 (18), 96 (70), 87 (10), 58 (100). 
C6H9NO requires: C: 64.86 %; H: 8.11 %; N: 12.61 %. Found: C: 64.60 %; H: 8.26 %; 
N: 12.75 %.
N -(3-B utynyl)-N -chlorom ethylform am ide: N-(3-butynyl)formamide
(0.02 mol, 1.94 g), was dissolved in of trimethylsilyl chloride (50 cm^). 
Paraformaldehyde (2.0 g) was added and the solution refluxed for 2 h. After cooling the 
solvent was removed to give the desired product 'Umax/cm' :^ 3050, 1650, 1580, 1550, 
1520, 1500, 1480, 1400, 1350, 1300, 1280. Ô H(CDCb): 1.9 (IH, t, J= 2.0 Hz), 2.3 
(2H, m, Ji=2 Hz, J2= 5 Hz), 3.2 (2H, m, J= 5 Hz), 5.30 (2H, s), 8.40 (IH, m). m/z 
(%): 147 (5) (M+- ), 110 (25), 96 (55) (M+" - CH2CI), 56 (100).
N -M ethyl-2 ,4-piperidinediQ ne: Methyl acrylate (0.5 mol; 56 g) was 
dissolved in methanol (200 cm^) and this solution 6 M methylamine in methanol was 
added (92 cm^, 0.55 mol). The solution was left under stirring at room temperature for 2 
days, after which time the solvent was removed and the oily residue distilled, at 56-60“ 
C, 17 mmHg. The pure methyl-3-methylaminopropionate obtained from distillation (0.05 
mol, 5.61 g) was dissolved in dry diethyl ether (100 cm^). Triethylamine (0.055 mol; 
5.61 g) was added the mixture cooled to 0 " C, and a dry diethyl ether solution (2 0  cm^)
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containing methyl malonylchloride (0.05 mol; 6.1 g) was added. The temperature was
brought to 18-20" C and the mixture left under vigorous stirring for 1 hour. At the end of
the reaction, solid triethylaminehydrochloride was filtered off, the organic phase washed
with water (2  x 50 cm^), dried (M0SO4) and the solvent was removed under reduced
pressure to give a yellow oil. This oil (0.02 mol; 4.34 g) was dissolved in methanol (50
cm^), to which sodium methoxide (0 .0 2 2  mol. 1 .2 g) was added, and mixture was
refluxed for 3 hours. After cooling, the solvent was removed and the solid residue
dissolved in 10 % (w/v) aqueous HCl and extracted with ethyl acetate (3 X 30 cm^). The
organic phase was washed with water (2  x 2 0  cm^), dried (MgS0 4 ) and the solvent was
removed under reduced pressure to give a pale yellow oil. The oily residue was
suspended in 0.5 M NaOH (50 cm^) and the mixture refluxed for 30 minutes. After
cooling to 0" C, concentrated hydrochloric acid was added to obtain a pH 4 ~ 5, the
solution extracted with dichloromethane (3 x 30 cm^). the organic phase was collected,
washed with water ( 2  X 20 cm^), dried (MgS0 4 ) and the solvent was removed under
reduced pressure to give the desired  product.'Umax/cm'^: 1750, 1670, 1550, 1520, 1500,
1480, 1400, 1350, 1300, 1280. 0 h(CDC13): 2.5 (2H, m ), 3.0 (2H, s ), 3.2 (2H, m),
3.4 (3H, s). m/z (%): 127 (15), 112 (100), 71 (25). C6H9NO2 requires: C: 56.70 %; H:
7.08 %; N: 11.02 %. Found: C: 56.60 %; H: 7.28 %; N: 11.25 %.
N -F orm yl-4-p iperid inone: Acetic formic anhydride was generated by 
dropwise addition of 98% formic acid ( 160 mmol; 7 3  g) to acetic anhydride ( 130 mmol;
13.5 g) maintained at 0" C under a No atmosphere followed by gentle heating (50- 60" 
C). The mixture was cooled to room temperature and dry tetrahydrofuran (20 cm^) was 
added. To this solution was added a tetrahydrofuran (20 cm^) solution containing 4- 
piperidinone hydrochloride (50 mmol; 6.7 g). The mixture was maintained at room 
temperature with vigorous stirring for 3 h. The volatile components were removed under 
reduced pressure to give the product. "Umax/cm"^ : 1710, 1670, 1550, 1520. ÔH (CDCI3):
2.0 (4H, m ), 3.3 (4H, m), 9.1 (IH , s). m/z (%): 127 (35),110 (35), 98 (100).
241
___________________________________________________   C h ap te r  8
C6H9NO2 requires: C: 56.70 %; H: 7.08 %; N: 11.02 %. Found: C: 56.95 %; H: 7.50 
%; N: 11.40%.
N ,N -D lm e th y lfo rin a in id e > h a c in  a d d u c ts :  N-Chloromethyl-N-
methylform-amide (0.01 mol, 1.07 g) and hemin (1.5 mmol, 1.0 g), were dissolved in 
dry acetonitrile (20 cm^) and refluxed. A solution of acetonitrile (5 cm^) containing 1,1- 
azobis(cyclohexanecarbonitrile) (0.001 mol, 0.24 g) and tributyltin hydride (0.01 mol, 
0.29 g) was added dropwise over 30 minutes. The mixture was refluxed for 30 minutes 
and after cooling, the solvent was removed. The solid residue was resuspended in 
diisopropylamine/methanol (25:975v/v) (1 cm^) and analysed by HPLC as indicated.
8.4 M icrosomes
Phenobarbital-induced rat liver microsomes were obtained from Institute of 
Cancer Research, Cancer Research Campaign Laboratory, Sutton, Surrey, U.K. 
Pyridine-induced microsomes were from Institute of Occupational Medicine, University 
of Padua, Italy.
P450-specific contents were 0.70 and 1.95 nmol/nig microsomal protein for 
pyridine- and phenobarbital-induced microsomes respectively.
8.5 M icrosomal incubations
These were performed in 0.1 M pH 7.4 phosphate buffer, using microsomal 
concentrations of 2.0 and 1.5 mg protein/cm^ for pyridine- and phenobarbital-induced 
microsomes respectively, in the presence of an NADPH regenerating system constituted 
by: 6.25 nmol/cm^ of glucose-6-phosphate, 1.25 mmol/cm^ of NADP, 6 mmol/cm^ of 
MgCl2 and 2.5 U/cm^ of glucose-6-phosphate dehydrogenase. The incubations were 
stabilised at 36“ C in a shaking bath for 10 minutes, and the reaction started by addition of 
the substrate dissolved in 0.1 M pH 7.4 phosphate buffer or in methanol. Substrates 
concentrations used for the kinetic studies were between 0.5 and 10 mM. Aliquots of 
incubation mixture were collected for the preparation of the analytical sample.
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8.6 Biomimetic system incubations
A 2 mM solution of TPP in dry dichloromethane ( 2.5 cm^) in the presence of 
/e/t-butylhydroperoxide 0.8 M was used. This solution was stabilised at 30“ C for 10 
minutes in a shaking bath, and the reaction started by addition of the substrate dissolved 
in dichloromethane. Substrate concentrations used were 0.5-10 mM. Aiquots of 
incubation mixture were collected for the preparation of the analytical sample.
8.7 Analytical procedure
8.7.1 Sample preparation from microsomal incubations
Aliquots (100 pi) of microsomal incubation mixtures were withdrawn at time 
intervals and added to a 10% (w/v) solution of trichloroacetic acid (200 pi) to precipitate 
protein. After centrifugation (5 minutes, 4500 rpm) the supernatant (200 pi) was treated 
with 1 M NaOH (200 pi) for 10 minutes, then acidified with IM HCl (200 pi). Samples 
were then analysed using the appropriate analytical method.
8.7.2 Sample preparation from biomimetic system incubations
Aliquots (100 pi) of biomimetic incubation mixtures were withdrawn at time 
intervals, added to ethanol (200 pi) to terminate the reaction, subjected to IM methanolic 
KOH (200 pi), left for 10 minutes then acidified with IM methanolic HCl (200 pi). The 
samples were dried and resuspended in 1:1 methanol/water (1 cm^) for HPLC analysis or 
in dry acetonitrile (1 cm^) for gas chromatographic analysis.
8.7.3 Gas chromatographic analysis
For all methods a Perkin Elmer 8410 Gas Chromatograph was used with direct 
on column injection. Column: aluminium 12 m, 0.5 mm i.d. BPl 0.1pm thickness. 
Carrier gas He. Detector FID at 250“ C. Injection temperature 210“ C.
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For the analysis of the products from the reactions of N-methyl-2-piperidione,
N-methyl-2-pyrrolidinone and N-methylcaprolactam, two gas chromatographic methods 
were developed. The first, for the analysis of N-methyl-2-piperidinone, N-methyl-2- 
pyrrolidinone, N-methylcaprolactam, N-methylglutarimide, N-methylsuccinimide and N- 
methyladipimide, was isothermal at 90" for 10 minutes. For the analysis of glutarimide, 
0-valerolactam, succinimide, 2-pyrrolidinone, adipimide and caprolactam a derivatization 
method was employed. The sample was dried under N2 flow and resuspended in 100 pi 
of dry acetonitrile; 50 pi of this solution were added to N-methyl-N-re/t- 
butyldimethylsilyltrifluoroacetamide(MTBSFA) (50 pl)j sonicated for 5 minutes and 
heated at 100“ C for 2h. After cooling the sample was analysed using thermal gradient 
system: 2 minutes isothermal at 90“ C, thermal gradient from 90“ C to 140“ C with a ramp 
rate of 5" C/min, isothermal at 140“ C for 1 minute.
For the determination of the products from the microsomal oxidation of DMF 
and DMAC an isothermal system at 70" C for 10 minutes was used.
8.7.4 HPLC analysis
Separation of the amides was achieved using a 5 pm C18 25 cm Jones 
Chromatography column and an eluent consisting of by: solvent A): 5% acetonitrile in 
phosphate buffer 0.05 M pH 2; solvent B): 60% acetonitrile in phosphate buffer 0.05 M 
pH 2. A gradient method was used as follows: T= 0 min to T= 15 min from 40% to 0% 
solvent A, T= 15 min toT =  18, min 100% solvent B, T=18 min to T= 19 min from 0% to 
40% solvent A. Flow :1 cm^/min. The wavelength used for detection was 254 nm. The 
identification of the products of the reactions was achieved by comparison of their diode 
array UV-VIS spectra with those of synthetic standards. Injection loop: 20 p i . Separate 
injections were reproducible to ± 1.5 % and the concentrations of products determined by 
this technique were accurate to ± 2%.
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8.7.5 Gas Chrom atographic/M ass spectra (GC/MS) analysis o f the
products of the microsomal oxidations of amides
For all methods a Hewlett Packard 5890 Gas Chromatograph was used with 
direct on column injection. Column: SGE25Q C3 BP5 0.5 12 m, 0.22 mm i.d. BP5 
0.25 pm thickness. Carrier gas He. Mass spectrometer VG Mass Lab, VG 20-250, 
Micromass UK Ltd. Interface at 280“ C, source 200 El.
Samples for the GC/MS analysis from the metabolites of the microsomal 
oxidations of the amides, were prepared via direct extraction of the reaction mixture 
(previously sutured by addition of ammonium acetate) using ethyl acetate (2 cm^). The 
organic phase was collected, dried (MgSO^) and directly injected (0.5 pi) into the gas 
chromatograph without dilution. The following thermal gradient systems were used:
N,N-dimethylaniline, N,N-dimethylbenzamide and N-cyanomethyl-N- 
methylaniline: 2 minutes isothermal at 110“ C, thermal gradient from 110“ C to 190 “ C 
with a ramp rate of 10“ C/min, isothermal at 190“ C for 10 minutes.
N,N-dimethyl-2-vinyl benzamide and N,N-dimethyl-2-hydroxy benzamide: 1 
minute isothermal at 85“ C, thermal gradient from 85“ C to 270 “ C with a ramp rate of 
10" C/min, isothermal at 270“ C for 20 minutes.
N-butynyl and N-butenyl substrates: 1 minute isothermal at 110“ C,.thermal 
gradient from 85“ C to 270 “ C with a ramp rate of 10“ C/min, isothermal at 270“ C for 10 
minutes.
8.7.6 ESR analysis of PBN spin-trapped radicals
Typical microsomal incubations containing the amide and the PBN spin trap, 
were performed for 30 minutes at 37“ C. The reaction mixture was extracted using 
chloroform/methanol 2:1 (2 cm^ of extraction solvent for each 1 cm^ of incubation 
mixture). The organic phase was separated and the volume reduced to 0.5 cm^ by a flow
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of No. The solution from the reaction between the chemical generated radical and PBN
were dried by a No flow and dissolved in chlorofom/methanol 2:1 (1 cm^).
The sample was placed in an ESR tube and analysed using the following 
conditions: scan range ± 200 G, time constant 0.5s, modulation amplitude 1 G, 
modulation frequency 100 KHz, receiver gain 6 X 10^, microwave power 10 mW, 
temperature 25“ C, microwave frequency 9.155074 GHz.
8.7.7 Determination of microsomal protein
The concentration of the microsomal proteins content was determined by the 
method of Lowry  ^using bovine serum albumin as standard.
8.7.9 Determination of cytochrome P450
Cytochrome P450 content was determined following the method of Omura and 
Sato^O; 11 from the difference of absorbance between 490 and 450 nm in the spectrum of 
the P450-CO complex
8.7.10 Determination o f microsomal haem
Microsomal haem was determ ined by two different assays, the 
pyridine/haemochromogen method 12 and the measurement of the fluorescence of 
protoporphyrin IX by the m ethod of M orrison.1^  B riefly , i n  the  
haemochomogen/pyridine method, 300 pi of incubation mixture were added to of a 
pyridine/ 0.3 M NaOH solution (9:5, v/v) (700 pi). To this mixture a few crystals of
sodium dithionite were added and the absolute spectrum was recorded in a wavelength 
range of 500-560 nm. Determination of the haem was achieved using S  mM(557-54i)=
20.7 mM’l • cm'l suggested by Falk. The determination of the haem by the porphyrin 
fluorescence technique was performed by converting the haem into protoporphyrin IX in 
saturated oxalic acid at 100’ C for 30 minutes. The fluorescence using an excitation 
wavelength of 408 nm and an emission wavelength of 604 nm was recorded.
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Quantification of the content of protoporphyrin IX in the sample was obtained by
comparison with the fluorescence of a standard of protoporphyrin IX dimethyl ester. 
8.7.11. HPLC analysis of m icrosom al haem
For the HPLC analysis of microsomal haem, 200 pi of reaction mixture were 
added to diisopropylamine/methanol (25/975 v/v) (9800 pi) solution. The mixture was 
centrifuged for 20 minutes at 1600 g., then 50 pi of supernatant were directly injected 
into the HPLC. Separation was achieved using a PLR PS column (5 pm, 100 A, 25 cm,
4.6 mm i.d.) and an elution system of di isopropyl ami ne/ water/ methanol (25/75/900) 
isocratically at a flow of 1.0 cm^/min for 20 minutes. Haem was detected at a wavelength 
of 400 nm.
8 .8 .D eterm ination  o f  th e  k in e tic  p a ram e te rs  of the P 4 5 0 -m ed ia ted  
oxidations
The microsomal oxidations of the indicated substrates were carried out at 37“ C 
as previously described. The rate of the of the reactions was monitored over two hours. 
The plot of the formation of the metabolites versus time showed, in all the oxidations 
analysed, the presence of an initial linear phase subsequently followed by a “tailing-off’ 
in the reaction progress. Thus, for the determination of the kinetic parameters the initial 
linear rate (vi) was measured. The kinetic parameters (Vmax and IVmax/Km) of the 
reactions were determined from the Michaelis-Menten equation (eq. VIII. 1, where [S] is 
the initial substrate concentration in the reaction) by using the Hanes linearization method 
(eq. VIII. 2).
V: =
‘ [S]+K^
m . -  K m  . [S]
(VIII. 1)
Vj Vmax Vmax
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The choice of the Hanes plot over the more common linearization Lineweaver-
Burke method is because the latter is biased towards the values of Vj that possess greatest 
error.
8.9 Molecular orbital Calculation
Structural determination and heats of formation (AHf) for the amides and their 
postulated intermediate radicals and radical cations, were calculated using the semi- 
empirical AMI self-consistent-field molecular-orbital program within the MOPAC 
pack ag e . Rad ica l  structures were determined using unrestricted Hartree-Fock 
calculations. All the structures were geometrically optimised using the Broyden-Fletcher- 
Goldfarb-Shanno procedure. Computations were performed using a Silicon Graphic Indy 
workstation computer.
Differences in the heats of formation between the parent amide and the radical 
intermediates (A AHf) were used as an estimate for the energy of activation Ea, from 
which relative rate constants could be calculated as follows:
^  _  - E ^ / R T  
1 for amide 1
^  _  - E ^ / R T
^ 2  ~ ® for amide 2
K -
or In
K ,  E ^ - E ^  A A H f - A A H [
k7 if if
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